v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/Glioblastoma Derived Oncogene Homolog (Avian) c.2325_2326ins12
v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/Glioblastoma Derived Oncogene Homolog (Avian) c.2324_2325ins12
Partial monosomy of the long arm of chromosome 13
Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion
v-akt Murine Thymoma Viral Oncogene Homolog 1 Gene Mutation
High-grade squamous intraepithelial lesion with features suspicious for invasion
Janus Kinase 2 (A Protein Tyrosine Kinase) Gene Variant
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha Protein Variant
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation
v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1405G_1407GGA>AGT
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1396G>C
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E545Q
EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1405G_1407GGA>AGC
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha H1047R
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha H1047Q
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha H1047T
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha H1047Y
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha H1047X
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha H1047L
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.35_36GT>AA
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1799T>G
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1799T>C
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1799T>A
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1406G>A
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1406G>C
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1406G>T
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.38_39GC>TG
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.37_39GGC>CGT
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog C.36T>C
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34G>A
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34G>C
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34G>T
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1791A>G
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.180_181TC>CA
EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Resistance
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1798_1799GT>AA
Tyrosine Kinase-Type Cell Surface Receptor HER2 Protein Variant
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.180_181TC>AA
Muscle fiber atrophy, mixed type I and II
Epidermal Growth Factor Receptor Gene c.2254_2277del24 EGFR c.2254_2277del24
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34_35GG>TT
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34_35GG>TA
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.39C>T
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.39C>G
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.39C>A
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34_36GGT>TGC
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34_36GGT>TGG
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.35_36GT>TC
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1799_1800TG>AA
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1799_1800TG>AT
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34_35GG>CT
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34_35GG>AT
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34_35GG>AA
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1397G>C
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1397G>A
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1397G>T
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E545X
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E545V
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E545K
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E545A
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E545G
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E545D
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1789_1790CT>TC
Impaired intestinal epithelial cell transport of amino acids
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.38_39GC>TT
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.181C>G
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.181C>A
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.38G>C
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.38G>T
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.35_36GT>AC
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1790T>G
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1790T>A
Muscle fibre atrophy, mixed type I and II
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.38G>A
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.182A>T
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.182A>C
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.182A>G
Simultaneous Trisomies of Chromosomes 4, 10, and 17
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.183A>C
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.183A>T
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1789C>G
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.35_36GT>AG
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1798G>T
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1798G>A
Chromosomes 1 and 2, monosomy 2q duplication 1p
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.35G>T
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.35G>A
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1405G>A
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1405G>C
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.38_39GC>AA
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.38_39GC>AG
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.38_39GC>AT
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.35G>C
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1798_1799GT>AG
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.37G>A
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.37G>C
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.37G>T
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform Protein Variant
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha C420R
v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.37_38GG>AA
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1797_1799AGT>GAG
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E542Q
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E542V
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E542X
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E542G
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 110 kDa Catalytic Subunit Alpha E542K
v-akt Murine Thymoma Viral Oncogene Homolog 1 c.49G>A
v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1405_1406GG>TC
Hormonal pattern incompatible with age and history
Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement
X chromosome, duplication Xq13 1 q21 1
Chromosome 7, partial deletion of short arm
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.181_182CA>AG
Monoclonal Immunoglobulin Kappa Light Chain Gene Rearrangement
Fibroblast Growth Factor Receptor 1 Gene Amplification
Unmutated Immunoglobulin Heavy Chain Variable Region Gene
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.181_183CAA>AAG
Platelet-Derived Growth Factor Receptor, Alpha Polypeptide c.2525A>T
Fibroblast Growth Factor Receptor 2 Gene Amplification
Fibroblast Growth Factor Receptor 2 Gene Activation
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E545K
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E545G
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E545A
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E545X
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E545V
ABL1 and ABL2 Tyrosine Kinase Protein Overexpression
Chromosome 4, Partial Monosomy of Distal 4q
Deletion and duplication of mitochondrial deoxyribonucleic acid
Fibroblast Growth Factor Receptor 1 Gene Activation
Immunoglobulin Heavy Chain Locus Variable Region Mutation
Atypical Endocervical Glandular Cells of Undetermined Significance
Monoclonal T-Cell Receptor Gamma Chain Gene Rearrangement
Fibroblast Growth Factor Receptor 2 Protein Variant
Simultaneous Trisomies of Chromosomes 4 and 10
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.182_183AA>GG
Fibroblast Growth Factor Receptor 2 Gene Mutation
Loss of Chromosome 3p FHIT Gene Locus
Chromosome 1, q42 11 q42 12 duplication
Clonal T-Cell Receptor Gamma Chain Gene Rearrangement
Atypical Endocervical Glandular Cells of Uncertain Significance
C-abl and ARG Tyrosine Kinase Protein Overexpression
Impaired intestinal epithelial cell transport of fats
TGF-beta Receptor Type II Tumor-Suppressor Gene Inactivation
Impaired intestinal epithelial cell transport of carbohydrates
Familial spastic paraplegia with neuropathy and poikiloderma
Clonal T-Cell Receptor Beta Chain Gene Rearrangement
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.182_183AA>TG
Monoclonal Immunoglobulin Lambda Light Chain Gene Rearrangement
Platelet-Derived Growth Factor Receptor Alpha Gene Mutation
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E542X
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E542V
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E542Q
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E542K
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E542G
Loss of Chromosome 11q ATM Gene Locus
Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.180_181AC>TA
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform C420R
Atypical Endocervical Glandular Cell of Undetermined Significance
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform H1047L
Atypical endocervical glandular cells of uncertain significance
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform H1047X
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform H1047Y
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform H1047T
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform H1047Q
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform H1047R
Platelet-Derived Growth Factor Receptor Alpha Protein Overexpression
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.181C>A
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.181C>G
Monoclonal T-Cell Receptor Beta Chain Gene Rearrangement
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.181_182CA>TT
Surface alteration of special sense organ cell
Atypical Endocervical Glandular Cell of Uncertain Significance
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E545D
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform E545Q
Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation
Chromosomal alterations of group G and Y
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.183A>G
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.183A>C
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.183A>T
Platelet-Derived Growth Factor Receptor Alpha Protein Variant
Chromosomal alterations of group C and X
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.182A>T
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.182A>G
Neuroblastoma RAS Viral (v-ras) Oncogene Homolog c.182A>C
Deregulation of Protein and Messenger RNA Expression
Epidermal Growth Factor Receptor Gene c.2235_2246del12
Epidermal Growth Factor Receptor Gene c.2320_2321ins12
Epidermal Growth Factor Receptor Gene c.2283_2284ins12
Epidermal Growth Factor Receptor Gene c.2319_2320insAACCCCCAC
EGFR Tyrosine Kinase Inhibitor Resistant Mutation
Fibroblast Growth Factor Receptor 2 K659E
Epidermal Growth Factor Receptor Gene c.2290_2291ins12
Fibroblast Growth Factor Receptor 2 c.1115C>G
Fibroblast Growth Factor Receptor 2 c.1144T>C
Trisomy 18 - mitotic nondisjunction mosaicism
Epidermal Growth Factor Receptor Gene c.2319_2320insCCCCAC
Epidermal Growth Factor Receptor Gene c.2303_2304ins9
Epidermal Growth Factor Receptor Gene c.2310_2311insGGT
Alteration of filamentous portion of nucleolus
Atypical Glandular Cells of Uncertain Significance
Epidermal Growth Factor Receptor Gene c.2154_2155GG>TT
Fibroblast Growth Factor Receptor 2 Pro253Arg
Mouse Double Minute 2 Gene Amplification
Epidermal Growth Factor Receptor Gene c.2239_2262del24
Paternal uniparental disomy of chromosome 13
Epidermal Growth Factor Receptor G719X; NP_005219.2:p.Gly719Xxx
Chromosome replaced with ring or dicentric
Fibroblast Growth Factor Receptor 2 Cys382Arg
establishment or maintenance of heterochromatin architecture
Epidermal Growth Factor Receptor Gene c.2156G>A
Epidermal Growth Factor Receptor Gene c.2156G>C
Epidermal Growth Factor Receptor Gene c.2307_2308ins15
Epidermal Growth Factor Receptor Gene c.2238_2252del15
Epidermal Growth Factor Receptor Gene c.2310_2311ins9
Fibroblast Growth Factor Receptor 2 c.1124A>G
Aberrant DNA Methylation of MGMT Gene
Epidermal Growth Factor Receptor Gene c.2156delG
Epidermal Growth Factor Receptor Gene Activation
Atypical glandular cells of undetermined significance
Fibroblast Growth Factor Receptor 2 c.758C>G
Fibroblast Growth Factor Receptor 2 Asn549His
atypical glandular cells of uncertain significance
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide Protein Variant
Epidermal Growth Factor Receptor Gene c.2318_2319insCCCCCA
Atypical endocervical cells of undetermined significance
Positive Regulation of Oxidative Stress Process
Epidermal Growth Factor Receptor Gene c.2236_2237ins18
Epidermal Growth Factor Receptor Gene c.2239_2247del9
Paternal uniparental disomy for chromosome 11
Fibroblast Growth Factor Receptor 2 C382R
Epidermal Growth Factor Receptor Gene c.2322_2323insCACGTG
Atypical squamous cells, cannot exclude HSIL
Epidermal Growth Factor Receptor Gene c.2253_2276del24
Epidermal Growth Factor Receptor Gene c.2582T>G
Chromosome 5, trisomy 5pter p13 3
Atypical glandular cells of uncertain significance
Epidermal Growth Factor Receptor Gene c.2369C>T
Fibroblast Growth Factor Receptor 2 P253R
Epidermal Growth Factor Receptor Gene c.334_1137del804
Epidermal Growth Factor Receptor Gene c.2310_2311insAACCCCCAC
Epidermal Growth Factor Receptor Gene c.2311_2312ins12
Monoclonal Immunoglobulin Light Chain Gene Rearrangement
Monoclonal Immunoglobulin Heavy Chain Gene Rearrangement
Epidermal Growth Factor Receptor Gene c.2313_2314insAAC
Fibroblast Growth Factor Receptor 2 Y375C
Epidermal Growth Factor Receptor Gene c.2257_2277del21
Atypical Glandular Cell of Undetermined Significance
Clonal Immunoglobulin Light Chain Gene Rearrangement
SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA
Epidermal Growth Factor Receptor Activating Mutation
FLT3 Tyrosine Kinase Domain Point Mutation
Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT
Epidermal Growth Factor Receptor Gene c.2581C>G
Clonal Immunoglobulin Heavy Chain Gene Rearrangement
Epidermal Growth Factor Receptor Gene c.2572C>T
Epidermal Growth Factor Receptor Gene c.2572C>A
Fibroblast Growth Factor Receptor 2 Ser252Trp
Maternal uniparental disomy of chromosome 13
Atypical Glandular Cells of Undetermined Significance
Epidermal Growth Factor Receptor Gene c.2310_2311insGGGTTA
Chromosome 7, trisomy 7p13 p12 2
Epidermal Growth Factor Receptor Gene c.2239_2256del18
Epidermal Growth Factor Receptor Gene c.2310_2311insGGGGAC
Epidermal Growth Factor Receptor Gene c.2311_2312ins9
Epidermal Growth Factor Receptor Gene c.2302_2303ins9
Platelet-Derived Growth Factor Receptor Alpha Asp842Val
Alteration of amorphous portion of nucleolus
Epidermal Growth Factor Receptor Gene c.2315_2316insGACACACCC
Fibroblast Growth Factor Receptor 2 Tyr375Cys
Chromosome 4, partial trisomy distal 4q
Epidermal Growth Factor Receptor Gene c.2308_2309ins9
Epidermal Growth Factor Receptor Gene c.2219_2220ins18
Fibroblast Growth Factor Receptor 2 c.1647T>G
Fibroblast Growth Factor Receptor 2 c.1647T>A
Epidermal Growth Factor Receptor Gene c.2246_2260del15
Epidermal Growth Factor Receptor Gene c.2125_2129delGAAAC
Molecular Biology, Restriction Fragment Length Polymorphisms
Keratinocyte Growth Factor Receptor Protein Variant
Fibroblast Growth Factor Receptor 2 c.755C>G
Receptor Tyrosine-Protein Kinase erbB-2 Protein Variant
Absence of Biallelic TCRgamma Locus Deletion
Epidermal Growth Factor Receptor Gene c.2254_2277del24
Fibroblast Growth Factor Receptor 2 Asn549Lys
Epidermal Growth Factor Receptor Gene c.2307_2308insTGCGTG
Epidermal Growth Factor Receptor Gene c.2240_2254del15
Fibroblast Growth Factor Receptor 2 Ser372Cys
Monosomies and deletions from the autosomes
Epidermal Growth Factor Receptor Gene c.2309_2310ins14
Epidermal Growth Factor Receptor Gene c.2307_2308ins9
Chromosome 3, deletion of distal 3p
EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation
Epidermal Growth Factor Receptor Gene c.2322_2322G>CCACGTG
Epidermal Growth Factor Receptor Gene Mutation
Fibroblast Growth Factor Receptor 2 N549K
Fibroblast Growth Factor Receptor 2 N549H
abnormal glandular cells of undetermined significance
Epidermal Growth Factor Receptor Gene c.2308_2309insACGGCG
Fibroblast Growth Factor Receptor 2 S372C
Fibroblast Growth Factor Receptor 2 c.1975A>G
Fibroblast Growth Factor Receptor 2 c.1645A>C
Epidermal Growth Factor Receptor Gene c.2235_2249del15
Epidermal Growth Factor Receptor Gene c.2231_2232ins18
Deletion and duplication of mitochondrial DNA
Epidermal Growth Factor Receptor Gene c.2310_2311insGGC
Epidermal Growth Factor Receptor Gene c.2247_2273del27
Epidermal Growth Factor Receptor Gene c.2155G>A
Platelet-Derived Growth Factor Receptor Alpha D842V
Spastic Paraplegia With Neuropathy And Poikiloderma
Epidermal Growth Factor Receptor Protein Variant
Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation
Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation
Epidermal Growth Factor Receptor Gene c.2309_2310AC>CCAGCGTGGAT
Epidermal Growth Factor Receptor Gene c.2235_2252del18
Epidermal Growth Factor Receptor Gene c.2319_2320insCAC
Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG
Epidermal Growth Factor Receptor Gene c.2572_2573CT>AA
Epidermal Growth Factor Receptor Gene c.2298_2299insGCCATA
Epidermal Growth Factor Receptor Gene c.2232_2233ins18
Receptor Tyrosine-Protein Kinase erbB-1 Protein Variant
Epidermal Growth Factor Receptor Gene c.2250_2273del24
Epidermal Growth Factor Receptor Gene c.2155G>T
Epidermal Growth Factor Receptor Gene Amplification
Fibroblast Growth Factor Receptor 2 S252W
Epidermal Growth Factor Receptor Gene c.2321_2322insCCACGT
Epidermal Growth Factor Receptor Gene c.2573T>G
Epidermal Growth Factor Receptor Gene c.2573T>A
Epidermal Growth Factor Receptor Gene c.2233_2247del15
Mouse Double Minute 2 Gene Mutation
Epidermal Growth Factor Receptor Gene c.2234_2236delAGG
atypical glandular cells of undetermined significance
Chromosome 3, trisomy 3q13 2 q25
Chromosome 1, uniparental disomy 1q12 q21
Tyrosine Kinase-Type Cell Surface Receptor A775_G776insYVMA
Trisomy 13 - mitotic nondisjunction mosaicism
Epidermal Growth Factor Receptor Gene c.2310_2311insAAC
Epidermal Growth Factor Receptor Gene c.2852T>A
Epidermal Growth Factor Receptor Gene c.2239_2253del15
Epidermal Growth Factor Receptor Gene c.2236_2253del18
Fibroblast Growth Factor Receptor 2 Lys659Glu
Atypical Glandular Cell of Uncertain Significance
Epidermal Growth Factor Receptor Gene c.2236_2250del15
Janus Kinase 2 Protein Variant
Epidermal Growth Factor Receptor vIII
Epidermal Growth Factor Receptor A750_E758del
Cyclin D2 Messenger RNA Overexpression
Endometrial cells out of cycle
Epidermal Growth Factor Receptor V774del
Epidermal Growth Factor Receptor N756_L760del
Serine/Threonine-Protein Kinase B-raf Protein Variant
Muscle fiber atrophy, type I
Receptor Tyrosine-Protein Kinase erbB-1 R748_P753del
Receptor Tyrosine-Protein Kinase erbB-1 V769_D770insGVV
Chromosomal alterations of group B
Chromosomal alterations of group A
Chromosomal alterations of group F
Chromosomal alterations of group D
Chromosomal alterations of group E
p210 BCR-ABL1 Fusion Protein Expression
Epidermal Growth Factor Receptor S752_V769del
Receptor Tyrosine-Protein Kinase erbB-1 P772_H773insYNP
Chromosome 8, partial monosomy 8p2
Cytosine to Thymidine Transition Abnormality
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide H1047L
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide H1047Q
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide H1047T
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide H1047X
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide H1047Y
Chromosome 17, trisomy 17p11 2
Keratinocyte Growth Factor Receptor C382R
Receptor Tyrosine-Protein Kinase erbB-1 E746_T751del
Epidermal Growth Factor Receptor P772_H773insTHP
Keratinocyte Growth Factor Receptor N549K
Keratinocyte Growth Factor Receptor N549H
Partial deletion of chromosome Y
Transforming Protein N-Ras Protein Variant
Receptor Tyrosine-Protein Kinase erbB-1 A763_Y764insFQEA
Thymidine to Cytosine Transition Abnormality
Receptor Tyrosine-Protein Kinase erbB-1 S768_V769insAWT
Epidermal Growth Factor Receptor H773_V774insNPH
Muscle fibre small group atrophy
p230 BCR/ABL1 Fusion Protein Expression
FLT3 Juxtamembrane Domain Point Mutation
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E545X
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E545V
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E545Q
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E545K
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E545D
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E545G
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E545A
Receptor Tyrosine-Protein Kinase erbB-1 A767_S768insTLA
Receptor Tyrosine-Protein Kinase erbB-2 A775_G776insYVMA
Epidermal Growth Factor Receptor N771_P772insH
Chromosome 1, trisomy 1q32 qter
Epidermal Growth Factor Receptor H773_V774insGH
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insGD
Receptor Tyrosine-Protein Kinase erbB-1 A750_K757del
Plasma membrane receptor site alteration
Cytosine to Guanosine Transversion Abnormality
Monoclonal T-Cell Receptor Gene Rearrangement
Epidermal Growth Factor Receptor V834del
Chromosome 22, trisomy q11 q13
Epidermal Growth Factor Receptor D770fs*61
Chromosome 22, microdeletion 22 q11
Epidermal Growth Factor Receptor K745_E749del
Epidermal Growth Factor Receptor I789_L792del
Receptor Tyrosine-Protein Kinase erbB-1 I740_P741insPVAIKI
Atypical glandular cells, favour neoplastic
Receptor Tyrosine-Protein Kinase erbB-1 G719V
Receptor Tyrosine-Protein Kinase erbB-1 G719S
Birt Hogg Dube Gene Mutation
Receptor Tyrosine-Protein Kinase erbB-1 G719X
Receptor Tyrosine-Protein Kinase erbB-1 G719D
Receptor Tyrosine-Protein Kinase erbB-1 G719C
Receptor Tyrosine-Protein Kinase erbB-1 G719A
Dual red blood cell population
Inactivation of p53 Tumor-Suppressor Gene
Receptor Tyrosine-Protein Kinase erbB-1 E746_A750del
Epidermal Growth Factor Receptor V769_D770insASV
Receptor Tyrosine-Protein Kinase erbB-1 H773_V774insG
Receptor Tyrosine-Protein Kinase erbB-1 H773_V774insH
RAC-alpha Serine/Threonine-Protein Kinase Protein Variant
Epidermal Growth Factor Receptor H773_V774insH
Epidermal Growth Factor Receptor H773_V774insG
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.3139C>T
Receptor Tyrosine-Protein Kinase erbB-1 Y764_V765insHH
Post-Radiation Cytologic Changes with Dysplasia
free radical oxidation of tissue
Keratinocyte Growth Factor Receptor K659E
Receptor Tyrosine-Protein Kinase erbB-1 T751_E758del
Epidermal Growth Factor Receptor S768_V769insAWT
Epidermal Growth Factor Receptor T790M
Epidermal Growth Factor Receptor D770_N771insN
Epidermal Growth Factor Receptor D770_N771insG
Epidermal Growth Factor Receptor D770_N771insD
Receptor Tyrosine-Protein Kinase erbB-1 I789_L792del
Receptor Tyrosine-Protein Kinase erbB-1 V769_D770insDNV
Receptor Tyrosine-Protein Kinase erbB-1 A750_E758del
Guanosine to Adenosine Transition Abnormality
Duplication 1q42 11 q42 12
Duplication with other complex rearrangement
Epidermal Growth Factor Receptor E746_A750del
Cytosine to Adenosine Transversion Abnormality
Keratinocyte Growth Factor Receptor Pro253Arg
X chromosome, trisomy Xpter Xq13
Chromosome 5, Trisomy 5p, Complete
Keratinocyte Growth Factor Receptor Tyr375Cys
Keratinocyte Growth Factor Receptor Asn549His
Receptor Tyrosine-Protein Kinase erbB-1 N771_P772insH
Thymidine to Adenosine Transversion Abnormality
Epidermal Growth Factor Receptor E746_P753del
Receptor Trposine-Protein Kinase erbB-1 L858W
Muscle fiber hypertrophy, type II
Muscle fiber small group atrophy
Receptor Tyrosine-Protein Kinase erbB-1 p.K745_A750del
Receptor Tyrosine-Protein Kinase erbB-1 V769_D770insMASVD
Change in cytochemical muscle architecture
type ii muscle fiber atrophy
hMLH1 Mismatch Repair Gene Inactivation
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1624G>C
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1624G>A
Impaired intestinal epithelial cell transport
Receptor Tyrosine-Protein Kinase erbB-1 L861F
Receptor Tyrosine-Protein Kinase erbB-1 L861Q
Receptor Tyrosine-Protein Kinase erbB-1 L861P
Receptor Tyrosine-Protein Kinase erbB-1 L861V
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide H1047R
Uniparental disomy of chromosome 11
Uniparental disomy of chromosome 13
Epidermal Growth Factor Receptor V769_D770insGSV
Keratinocyte Growth Factor Receptor Asn549Lys
Chromosome 1q, duplication 1q12 q21
Partial Tandem Duplication of MLL
Chromosome 1, duplication 1p21 p32
Receptor Tyrosine-Protein Kinase erbB-1 V769_D770insCV
Chromosome 3, Distal 3q2 Trisomy
Epidermal Growth Factor Receptor L747_K754del
Receptor Tyrosine-Protein Kinase erbB-1 V774_C775insHV
Guanosine to Cytosine Transversion Abnormality
Epidermal Growth Factor Receptor G719fs*29
Receptor Tyrosine-Protein Kinase erbB-1 I744_K745insKIPVAI
Muscle fibre atrophy, type I
Chromosome 2, monosomy 2pter p24
Epidermal Growth Factor Receptor V769_D770insCV
Receptor Tyrosine-Protein Kinase erbB-1 L858A
Receptor Tyrosine-Protein Kinase erbB-1 H773_V774insGNPH
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insAPW
Epidermal Growth Factor Receptor S752_I759del
Epidermal Growth Factor Receptor E746_T751del
Epidermal Growth Factor Receptor A767_S768insTLA
Epidermal Growth Factor Receptor V769_D770insMASVD
Receptor Tyrosine-Protein Kinase erbB-1 E746_R748del
Epidermal Growth Factor Receptor P772_H773insQV
Epidermal Growth Factor Receptor L747_P753del
Epidermal Growth Factor Receptor D770_N771insDG
Epidermal Growth Factor Receptor E709fs*1
Atypical Cell of Uncertain Significance
Epidermal Growth Factor Receptor P772_H773insDHP
Adenosine to Guanosine Transition Abnormality
Monosomy and deletion from autosome
Epidermal Growth Factor Receptor L747_A755del
KIT Tyrosine Kinase Protein Overexpression
Receptor Tyrosine-Protein Kinase erbB-1 G719fs*29
Chromosome 4, monosomy 4p14 p16
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.3140A>G
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.3140A>T
Receptor Tyrosine-Protein Kinase erbB-1 V769_D770insGSV
Epidermal Growth Factor Receptor Overexpression
Muscle fibre large group atrophy
Chromosome 5, Trisomy 5p, Partial
Epidermal Growth Factor Receptor K745_L747del
Chromosome 1, monosomy 1q32 q42
Epidermal Growth Factor Receptor H773_V774insGNPH
Epidermal Growth Factor Receptor D770_N771insAPW
Receptor Tyrosine-Protein Kinase erbB-1 P772_H773insQV
Receptor Tyrosine-Protein Kinase erbB-1 A750_K754del
Epidermal Growth Factor Receptor L858G
Epidermal Growth Factor Receptor L858A
Epidermal Growth Factor Receptor L858M
Epidermal Growth Factor Receptor L858K
Epidermal Growth Factor Receptor L858W
Epidermal Growth Factor Receptor L858R
Epidermal Growth Factor Receptor L858P
Epidermal Growth Factor Receptor L858Q
Receptor Tyrosine-Protein Kinase erbB-1 M766_A767insAI
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1635G>C
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1635G>T
Chromosome 1, deletion q21 q25
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.3141T>G
Receptor Tyrosine-Protein Kinase erbB-1 P772_H773insTHP
Epidermal Growth Factor Receptor L861V
Epidermal Growth Factor Receptor L861R
Epidermal Growth Factor Receptor L861P
Epidermal Growth Factor Receptor L861Q
Epidermal Growth Factor Receptor L861F
Guanosine to Thymidine Transversion Abnormality
Epidermal Growth Factor Receptor A750_K757del
Cyclin D1 Messenger RNA Overexpression
PMS1 Mismatch Repair Gene Inactivation
Chromosome 4, trisomy 4q25 qter
p230 BCR-ABL1 Fusion Protein Expression
BCR-ABL Tyrosine Kinase Inhibitor-Resistant Mutation
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insNPH
Duplication Xq13 1 q21 1
hSNF5/INI1 Tumor Suppressor Gene Inactivation
Receptor Tyrosine-Protein Kinase erbB-1 D770fs*61
Receptor Tyrosine-Protein Kinase erbB-1 P753_I759del
Smooth endoplasmic reticulum membrane alteration
Chromosome 3, monosomy 3q21 23
Chromosome 3, monosomy 3p14 p11
Chromosome 8, monosomy 8p23 1
Receptor Tyrosine-Protein Kinase erbB-1 P772_H773insDHP
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E542G
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E542K
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E542V
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E542Q
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide E542X
Chromosome 4, Partial Trisomy 4p
Adenosine to Cytosine Transversion Abnormality
Epidermal Growth Factor Receptor D761_E762insEAFQ
Type III EGF Deletion-Mutant Receptor
Epidermal Growth Factor Receptor K745_E746insVPVAIK
Mitochondrial Complex II Gene Mutation
Receptor Tyrosine-Protein Kinase erbB-1 P772_H773insDNP
Keratinocyte Growth Factor Receptor P253R
Keratinocyte Growth Factor Receptor Y375C
Inactivation of Retinoblastoma Tumor-Suppressor Gene
Pituitary Tumor Transforming Gene Overexpression
Receptor Tyrosine-Protein Kinase erbB-1 T790M
CD117 Tyrosine Kinase Protein Overexpression
Epidermal Growth Factor Receptor D770_N771insMATP
Chromosome 1, monosomy 1p34 p32
Epidermal Growth Factor Receptor N771_P772insN
Thymidine to Guanosine Transversion Abnormality
Epidermal Growth Factor Receptor L747_A750del
Impaired intestinal epithelial cell digestion
MAP2K4 Tumor Suppressor Gene Inactivation
Keratinocyte Growth Factor Receptor Ser252Trp
Receptor Tyrosine-Protein Kinase erbB-1 H773_V774insPH
atrophy fibers ii muscle type
Chromosome 17, deletion 17q23 q24
Receptor Tyrosine-Protein Kinase erbB-1 E746_S752del
Receptor Tyrosine-Protein Kinase erbB-1 E746_E749del
Muscle fibre hypertrophy, type II
Atypical cells of undetermined significance
Monoclonal Antigen Receptor Gene Rearrangement
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1633G>C
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1633G>A
Absence of Biallelic TCRgamma Deletion
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insGL
Chromosome 1, monosomy 1p31 p22
Receptor Tyrosine-Protein Kinase erbB-1 H773_V774insNPH
Mutation of the BRCA1 Gene
hMSH2 Mismatch Repair Gene Inactivation
Epidermal Growth Factor Receptor E746_S752del
Receptor Tyrosine-Protein Kinase erbB-1 L747_T751del
C-KIT Tyrosine Kinase Protein Overexpression
MKK4 Tumor Suppressor Gene Inactivation
Mutation in Sporadic Breast Tumor
Adenosine to Thymidine Transversion Abnormality
Atypical Cell of Undetermined Significance
Receptor Tyrosine-Protein Kinase erbB-1 E746_P753del
Receptor Tyrosine-Protein Kinase erbB-1 L747_E749del
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insDG
Receptor Tyrosine-Protein Kinase erbB-1 L747_A750del
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1625A>G
Muscle fiber large group atrophy
Epidermal Growth Factor Receptor E746_E749del
Keratinocyte Growth Factor Receptor Lys659Glu
Epidermal Growth Factor Receptor D770_N771insSVP
Epidermal Growth Factor Receptor D770_N771insSVQ
Epidermal Growth Factor Receptor D770_N771insSVD
Receptor Tyrosine-Protein Kinase erbB-1 R748_S752del
Epidermal Growth Factor Receptor L747_S752del
Atypical cells of uncertain significance
Receptor Tyrosine-Protein Kinase erbB-1 V834del
Tyrosine-Protein Kinase JAK2 Protein Variant
Deletion of part of autosome
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1634A>G
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1634A>C
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1634A>T
MYST3-Various Partners Fusion Protein Expression
hMSH6 Mismatch Repair Gene Inactivation
Keratinocyte Growth Factor Receptor Cys382Arg
Mutation of the Nucleophosmin Gene
PMS2 Mismatch Repair Gene Inactivation
Trisomy Xq13 1 q21 1
Keratinocyte Growth Factor Receptor Ser372Cys
Receptor Tyrosine-Protein Kinase erbB-1 E709fs*1
Receptor Tyrosine-Protein Kinase erbB-1 N771_P772insN
Receptor Tyrosine-Protein Kinase erbB-1 K745_L747del
Chromosome 1, monosomy 1q25 q32
Tumor Suppressor Gene Inactivation Process
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insMATP
Janus Kinase 2 Gene Variant
Muscle fiber atrophy, type II
Trisomy 1q42 11 q42 12
Epidermal Growth Factor Receptor V765_M766insMAS
Post-radiation cytologic changes with dysplasia
Epidermal Growth Factor Receptor R748_S752del
Chromosome 4 short arm deletion
Thickening of the basement membrane
Epidermal Growth Factor Receptor P753_I759del
Epidermal Growth Factor Receptor P772_H773insPR
Chromosome 9 inversion or duplication
Uniparental disomy of chromosome 2
Epidermal Growth Factor Receptor P772_H773insDNP
Receptor Tyrosine-Protein Kinase erbB-1 L861R
Receptor Tyrosine-Protein Kinase erbB-1 K745_E746insVPVAIK
Deregulation of Programmed Cell Death
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1258T>C
Epidermal Growth Factor Receptor L747_E749del
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN
Mutation of the BRCA2 Gene
Chromosome 21, uniparental disomy of
Epidermal Growth Factor Receptor p.K745_A750del
X chromosome, monosomy Xp22 pter
Rough endoplasmic reticulum cavity alteration
Receptor Tyrosine-Protein Kinase erbB-1 V774del
Epidermal Growth Factor Receptor V774_C775insHV
Epidermal Growth Factor Receptor H773_V774insPH
Epidermal Growth Factor Receptor T751_E758del
Keratinocyte Growth Factor Receptor S252W
Epidermal Growth Factor Receptor V769_D770insDNV
Epidermal Growth Factor Receptor A763_Y764insFQEA
Epidermal Growth Factor Receptor E746del
Receptor Tyrosine-Protein Kinase erbB-1 L747_A755del
Chromosome 1, trisomy 1q42 qter
Receptor Tyrosine-Protein Kinase erbB-1 N756_L760del
Receptor Tyrosine-Protein Kinase erbB-1 S752_I759del
Clonal T-Cell Receptor Gene Rearrangement
Epidermal Growth Factor Receptor Y764_V765insHH
Epidermal Growth Factor Receptor G719D
Epidermal Growth Factor Receptor G719C
Epidermal Growth Factor Receptor G719A
Epidermal Growth Factor Receptor G719X
Epidermal Growth Factor Receptor G719S
Inflammatory alteration of cellular material
Chromosome 1, monosomy 1p22 p13
Clonal Antigen Receptor Gene Rearrangement
Duplication seen only at prometaphase
Receptor Tyrosine-Protein Kinase erbB-1 L747_P753del
Epidermal Growth Factor Receptor L747del
Epidermal Growth Factor Receptor L747_T751del
Receptor Tyrosine-Protein Kinase erbB-1 V769_D770insASV
Receptor Tyrosine-Protein Kinase erbB-1 S752_V769del
Receptor Tyrosine-Protein Kinase erbB-1 S768_V769insVAS
Whole chromosome trisomy, mitotic nondisjunction
Lymphoblastic Transformation, Intrinsic Defect in
Deletion seen only at prometaphase
Receptor Tyrosine-Protein Kinase erbB-1 L747_S752del
p190 BCR/ABL1 Fusion Protein Expression
CFTR gene.p.IVS8 polyT 7T/9T variant
Receptor Tyrosine-Protein Kinase erbB-1 V765_M766insMAS
TGF-beta RII Tumor-Suppressor Gene Inactivation
Receptor Tyrosine-Protein Kinase erbB-1 H773_V774insGH
Epidermal Growth Factor Receptor A750_K754del
Chromosome 6, deletion 6q13 q15
Chromosome 11, partial trisomy 11q
Epidermal Growth Factor Receptor E746_R748del
TEL-PDGFbeta Receptor Fusion Protein Expression
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insG
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insD
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insN
Atypical glandular cells, favor neoplastic
p210 BCR/ABL1 Fusion Protein Expression
Receptor Tyrosine-Protein Kinase erbB-1 D761_E762insEAFQ
Chromosome 2, trisomy 2pter p24
Receptor Tyrosine-Protein Kinase erbB-1 E746del
Receptor Tyrosine-Protein Kinase erbB-1 L858M
Receptor Tyrosine-Protein Kinase erbB-1 L858K
Receptor Tyrosine-Protein Kinase erbB-1 L858G
Receptor Tyrosine-Protein Kinase erbB-1 L858R
Receptor Tyrosine-Protein Kinase erbB-1 L858Q
Receptor Tyrosine-Protein Kinase erbB-1 L858P
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insSVQ
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insSVP
Epidermal Growth Factor Receptor M766_A767insAI
Receptor Tyrosine-Protein Kinase erbB-1 D770_N771insSVD
Chromosome 2, trisomy 2p13 p21
Zeta-Associated Protein-70 Messenger RNA Overexpression
Chromosome 10, trisomy 10pter p13
p190 BCR-ABL1 Fusion Protein Expression
Epidermal Growth Factor Receptor G719V
Epidermal Growth Factor Receptor R748_P753del
Epidermal Growth Factor Receptor P772_H773insYNP
Chromosome 10, uniparental disomy of
Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide C420R
Epidermal Growth Factor Receptor D770_N771insNPH
Receptor Tyrosine-Protein Kinase erbB-1 L747_K754del
Unbalanced Translocation of Chromosome 1
Chromosome inversion in normal individual
KAT6A-Various Partners Fusion Protein Expression
Muscle fibre hypertrophy, type I
Epidermal Growth Factor Receptor D770_N771insGL
Epidermal Growth Factor Receptor D770_N771insGD
Epidermal Growth Factor Receptor I744_K745insKIPVAI
Smooth endoplasmic reticulum cavity alteration
Receptor Tyrosine-Protein Kinase erbB-1 L747del
Rough endoplasmic reticulum membrane alteration
Receptor Tyrosine-Protein Kinase erbB-1 K745_E749del
Epidermal Growth Factor Receptor V769_D770insGV
Formation of Bistrand Abasic Site
Epidermal Growth Factor Receptor I740_P741insPVAIKI
Muscle fibre atrophy, type II
Keratinocyte Growth Factor Receptor S372C
Chromosome 3, distal 3p monosomy
Receptor Tyrosine-Protein Kinase erbB-1 P772_H773insPR
Epidermal Growth Factor Receptor S768_V769insVAS
MOZ-Various Partners Fusion Protein Expression
Various Partners-MLL Fusion Protein Expression.
Epidermal Growth Factor Receptor V769_D770insGVV
Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide c.1625A>T
Chromosome 13, partial monosomy 13q
Muscle fiber hypertrophy, type I
Clonal BCL3 Gene Rearrangement
Chromosome 14q, partial deletions
Chromosome 8, mosaic trisomy
Cyclin D2 mRNA Overexpression
MEN1 Tumor-Suppressor Gene Inactivation
AML1/ETO Fusion Protein Expression
NPM1/RARA Fusion Protein Expression
Serine/Threonine-Protein Kinase B-raf Gly466Glu
E2A/PBX1 Fusion Protein Expression
Smooth endoplasmic reticulum fragmentation
FUS/DDIT3 Fusion Protein Expression
BCL-2 Messenger RNA Overexpression
Trisomy 3q13 2 q25
Single Stranded DNA Breaks
PSF-TFE3 Fusion Protein Expression
CD44 Messenger RNA Overexpression
TCF12/NR4A3 Fusion Protein Expression
Chromosome 2, trisomy 2q37
Chromosome 5, uniparental disomy
OTT-MAL Fusion Protein Expression
IRF4/MUM1 Messenger RNA Overexpression
CD332 Antigen Protein Variant
Severe urothelial cell atypia
EWSR1/ERG Fusion Protein Expression
Chromosome 20, duplication 20p
CBFbeta-MYH11 Fusion Protein Expression
Tyrosine-Protein Kinase JAK2 Met929Ile
Alteration of mitochondrial matrix
Moderate Columnar Cell Atypia
Deletion 2q duplication 1p
Out of Frame Mutation
CD117 Exon 13 Mutation
Chromosome 11, deletion 11p
RAC-alpha Serine/Threonine-Protein Kinase Glu17Lys
RPN1-MECOM Fusion Protein Expression
NPM1-RARA Fusion Protein Expression
Severe squamous cell atypia
DEK/NUP214 Fusion Protein Expression
Gain of Chromosome 12q
Gain of Chromosome 12p
KIT Somatic Point Mutation
Tyrosine-Protein Kinase JAK2 G935R
MADH4 Tumor-Suppressor Gene Inactivation
OTT/MAL Fusion Protein Expression
Chromosome 9, trisomy 9p
Signal Transduction Pathway Deregulation
EWS/NR4A3 Fusion Protein Expression
EWS-CHOP Fusion Protein Expression
Rough endoplasmic reticulum alteration
NF-2 Tumor-Suppressor Gene Inactivation
Loss of Chromosome 1p36
Extracellular electron dense deposit
BIRC3/MALT1 Fusion Protein Expression
EWSR1-ETV4 Fusion Protein Expression
NF-1 Tumor-Suppressor Gene Inactivation
Loss of Chromosome 9p
TEL/AML1 Fusion Protein Expression
Gain of Chromosome 10p
PAX3-FKHR Fusion Protein Expression
DNA Single Strand Break
EWS/FLI1 Fusion Protein Expression
Cytosine to Thymidine Transition
RUNX1/RUNX1T1 Fusion Protein Expression
Loss of Chromosome 14q
Extracellular ground substance alteration
Abnormal cellular hormonal pattern
Janus Kinase 2 Val617Phe
STAT5-RARalpha Fusion Protein Expression
BCL6 Messenger RNA Overexpression
Cell surface interdigitation alteration
Janus Kinase 2 V617F
ALK Fusion Protein Expression
Loss of Chromosome 3
AML1-ETO Fusion Protein Expression
Loss of Chromosome 9
Cellular AND/OR subcellular abnormality
RPN1/EVI1 Fusion Protein Expression
Gain in Chromosome 12
SS18-SSX2 Fusion Protein Expression
NF2 Tumor-Suppressor Gene Inactivation
Deletion of long arm
ETV6/JAK2 Fusion Protein Expression
Serine/Threonine-Protein Kinase B-raf Gly469Ala
EWS-FLI1 Fusion Protein Expression
Transforming Protein N-Ras G13X
Loss of Chromosome 5q
Chromosome 3, trisomy 3p25
PRCC-TFE3 Fusion Protein Expression
Gain of Chromosome 14
Gain of Chromosome 13
Gain of Chromosome 11
FAS Ligand Gene Mutation
FIP1L1/PDGFRalpha Fusion Protein Expression
Philadelphia chromosome, Ph1, present
Tyrosine-Protein Kinase JAK2 Y931C
Tyrosine-Protein Kinase JAK2 Glu985Lys
BCR/PDGFRA Fusion Protein Expression
Janus Kinase 2 Ile960Val
T (Brachyury) Gene Duplication
Formation of Apurinic Site
EWS-ETV1 Fusion Protein Expression
MLL/AFF1 Fusion Protein Expression
Reading Frame Shift Mutation
X chromosome, trisomy Xq25
Mild squamous cell atypia
Serine/Threonine-Protein Kinase B-raf L597R
Serine/Threonine-Protein Kinase B-raf L597S
Serine/Threonine-Protein Kinase B-raf L597Q
Serine/Threonine-Protein Kinase B-raf L597V
Serine/Threonine-Protein Kinase B-raf G466A
Chromosome 2, monosomy 2q24
ZBTB16-RARA Fusion Protein Expression
RAC-alpha Serine/Threonine-Protein Kinase E17K
FLT3 Internal Tandem Duplication
Chromosome 20, deletion 20p
Loss of Chromosome 7q
Isochromosome for short arm
Gain of Chromosome 12q15-qter
Bone marrow maturation arrest
STAT5B-RARA Fusion Protein Expression
Chromosome 18, trisomy 18p
PAX3/FOXO4 Fusion Protein Expression
JAZF1/JJAZ1 Fusion Protein Expression
Gain of Chromosome 1q
Moderate Glandular Cell Atypia
Severe glandular cell atypia
Gain of Chromosome 16
Gain of Chromosome 17
Gain of Chromosome 15
Gain of Chromosome 12
Gain of Chromosome 10
Gain of Chromosome 18
Gain of Chromosome 19
X chromosome, trisomy Xq
NUMA1-RARA Fusion Protein Expression
Whole chromosome trisomy syndrome
ETV6-RUNX1 Fusion Protein Expression
PAX7-FOXO1 Fusion Protein Expression
Gain of Chromosome 20q13
CBFB-MYH11 Fusion Protein Expression
NuMA-RARalpha Fusion Protein Expression
Loss of Chromosome 12
Loss of Chromosome 13
Loss of Chromosome 10
Loss of Chromosome 11
Loss of Chromosome 17
MLL-AF4 Fusion Protein Expression
Loss of Chromosome 1p
Chromosome 16, uniparental disomy
Chromosome 7, monosomy 7q21
Muscle fiber perifascicular atrophy
X chromosome, monosomy Xq28
SS18/SSX Fusion Protein Expression
Severe Transitional Cell Atypia
PAX3-AFX Fusion Protein Expression
Chromosome 3, monosomy 3q13
Janus Kinase 2 Met929Ile
Gain of Chromosome 3q
EWS/FEV Fusion Protein Expression
K-Ras 2 Protein Variant
MECT1-MAML2 Fusion Protein Expression
EWS-ERG Fusion Protein Expression
ETV6-CBFalpha2 Fusion Protein Expression
KIT Exon 11 Mutation
Serine/Threonine-Protein Kinase B-raf G469E
Serine/Threonine-Protein Kinase B-raf G469A
Serine/Threonine-Protein Kinase B-raf G469V
Serine/Threonine-Protein Kinase B-raf G469S
Serine/Threonine-Protein Kinase B-raf G469R
Severe Squamous Cell Atypia
Clonal BCL6 Gene Rearrangement
Gain of Chromosome 18q
Janus Kinase 2 Arg938Leu
ETV6/ABL1 Fusion Protein Expression
Loss of Chromosome 18
Loss of Chromosome 19
deletion of short arm
STAT5B/RARA Fusion Protein Expression
Loss of Chromosome 16
Loss of Chromosome 3p
Loss of Chromosome 3q
Loss of Chromosome 14
PAX7/FKHR Fusion Protein Expression
Gain of Chromosome 20
Chromosome 11q partial deletion
P53 Tumor-Suppressor Gene Inactivation
Intracytoplasmic electron dense material
Extracellular electron dense deposition
Gain of Chromosome 1p31
SFPQ/TFE3 Fusion Protein Expression
Moderate Squamous Cell Atypia
Restriction fragment length polymorphism
Loss of Chromosome 19q
Chromosome 6, monosomy 6p23
Gain of Chromosome 5p
Gain of Chromosome 5q
RAC-alpha Serine/Threonine-Protein Kinase p.Glu17Lys
SS18/SSX4 Fusion Protein Expression
Chromosome 4, trisomy 4q21
Muscle fibre perifascicular atrophy
MLL Partial Tandem Duplication
RUNX1-RUNX1T1 Fusion Protein Expression
X0 sex chromosome alteration
Serine/Threonine-Protein Kinase B-raf Val600Arg
Predominance of parabasal cells
Gain of Chromosome 1q21-31
Chromosome 6, monosomy 6q1
Chromosome 6, monosomy 6q2
COL1A1-PDGFbeta Fusion Protein Expression
Gain of Chromosome 9q34
EWS-NR4A3 Fusion Protein Expression
BRCA2 Tumor-Suppressor Gene Inactivation
NPM-ALK Fusion Protein Expression
Chromosome 14, trisomy mosaic
Monosomy 2q duplication 1p
EWSR1/WT1 Fusion Protein Expression
FUS/CREB3L2 Fusion Protein Expression
JAZF1-JJAZ1 Fusion Protein Expression
Cyclin E Protein Overexpression
Double Stranded DNA Breaks
Gain of Chromosome 22q
ASPL/TFE3 Fusion Protein Expression
Loss of Chromosome 17p
Loss of Chromosome 17q
Gain of Chromosome 7p
Gain of Chromosome 7q
Cytosine to Guanosine Transversion
FUS/CREB3L1 Fusion Protein Expression
Severe Glandular Cell Atypia
Chromosome 14q, terminal duplication
Gain of Chromosome 11q13
Mosiacism of chromosome 13q
MYST3-V Fusion Protein Expression
RBP56-CHN Fusion Protein Expression
Uniparental disomy of 10
Uniparental disomy of 11
Uniparental disomy of 13
Uniparental disomy of 15
Uniparental disomy of 16
COL1A1/PDGFB Fusion Protein Expression
V-MLL Fusion Protein Expression
MOZ/V Fusion Protein Expression
NONO-TFE3 Fusion Protein Expression
Loss of Chromosome 12p
Inner nuclear membrane alteration
PTCH Tumor-Suppressor Gene Inactivation
Gain of Chromosome 20q
Chromosome 2, monosomy 2p22
Gain of Chromosome 9p
Gain of Chromosome 9q
Plasma membrane globulin coating
Chromosome 17p Deletion Syndrome
EWSR1-NR4A3 Fusion Protein Expression
Mosaic trisomy 1q12 q21
EWS-CHN Fusion Protein Expression
Deletion of short arm
Chromosome 7, monosomy 7q2
Chromosome 7, monosomy 7q3
TFG/NR4A3 Fusion Protein Expression
MECOM/RUNX1 Fusion Protein Expression
SSXT-SSX2 Fusion Protein Expression
PML/RARA Fusion Protein Expression
Gain of Chromosome 5
EVI1-AML1 Fusion Protein Expression
Smooth endoplasmic reticulum alteration
Proto-Oncogene Neu Protein Variant
Microsatellite Mutation Pathway Deregulation
MLL/MLLT3 Fusion Protein Expression
RPN1-EVI1 Fusion Protein Expression
Thymidine to Cytosine Transition
Loss of E-cadherin Expression
Abnormal nucleotide base sequence
CDH1 Tumor-Suppressor Gene Inactivation
Moderate squamous cell atypia
TFG-ALKlong Fusion Protein Expression
Chromosome 12p partial deletion
Restriction Fragment Length Polymorphisms
CRTC1/MAML2 Fusion Protein Expression
Monoclonal BCL-6 Gene Rearrangement
Loss of Chromosome 13q
COL1A2-PLAG1 Fusion Protein Expression
SS18-SSX4 Fusion Protein Expression
TAF15-NR4A3 Fusion Protein Expression
EWSR1-PATZ1 Fusion Protein Expression
API2/MLT Fusion Protein Expression
Janus Kinase 2 c.1849G>T
C-KIT Somatic Point Mutation
Intranuclear electron dense deposition
TCF3/PBX1 Fusion Protein Expression
RPN1/MECOM Fusion Protein Expression
Janus Kinase 2 c.1848_1849TG>CT
MLL/AF10 Fusion Protein Expression
BCR-PDGFRAlpha Fusion Protein Expression
Tyrosine-Protein Kinase JAK2 Ile960Val
Janus Kinase 2 G935R
APC Tumor-Suppressor Gene Inactivation
Chromosome 9, duplication 9q21
Lengthening of short arm
MYH9-ALK Fusion Protein Expression
Chromosome 11p, partial deletion
TCF3-PBX1 Fusion Protein Expression
c-erbB2 Messenger RNA Overexpression
genetics of colorectal cancer
RBM15-MKL1 Fusion Protein Expression
Alteration of mitochondrial membrane
Loss of Chromosome 11p
Loss of Chromosome 11q
PLZF/RARA Fusion Protein Expression
Serine/Threonine-Protein Kinase B-raf Val600Leu
PML-RARalpha Fusion Protein Expression
KIT Exon 9 Mutation
Philadelphia chromosome, Ph<sup>1</sup>, present
Gain of Chromosome 3q24-qter
ETV6-PDGFRB Fusion Protein Expression
Chromosome 11 uniparental disomy
SSXT-SSX Fusion Protein Expression
EWS/ATF1 Fusion Protein Expression
Janus Kinase 2 E985K
CD140a Antigen Protein Variant
A-myb Messenger RNA Overexpression
Serine/Threonine-Protein Kinase B-raf V600E
GTPase NRas Protein Variant
LKB1 Tumor-Suppressor Gene Inactivation
p230 Fusion Protein Expression
Deletion with complex rearrangement
MLL/MLLT10 Fusion Protein Expression
Impaired Cell Membrane Integrity
Extracellular lipid aggregate alteration
PAX3/FKHR Fusion Protein Expression
Tumor Suppressor Gene Inactivation
SS18-SSX1 Fusion Protein Expression
Chromosome 1, monosomy 1q4
RBP56/CHN Fusion Protein Expression
Janus Kinase 2 Tyr931Cys
Mitochondria deoxyribonucleic acid deletion
Thymidine to Guanosine Mutation
PAX3-FOXO1 Fusion Protein Expression
TFG-NR4A3 Fusion Protein Expression
EWSR1/NR4A3 Fusion Protein Expression
CD95 Apoptotic Pathway Deregulation
TEL/ABL Fusion Protein Expression
EGFR exon 18 G719X
MLL-MLLT3 Fusion Protein Expression
EWSR1-WT1 Fusion Protein Expression
CBFB/MYH11 Fusion Protein Expression
EWS-ZSG Fusion Protein Expression
FIP1L1-PDGFRA Fusion Protein Expression
Janus Kinase 2 Glu985Lys
FUS/ATF1 Fusion Protein Expression
Severe columnar cell atypia
NPM-RARalpha Fusion Protein Expression
RAC-alpha Serine/Threonine-Protein Kinase p.E17K
BRD4-NUT Fusion Protein Expression
XXY sex chromosome alteration
FAS Apoptosis Pathway Deregulation
Atypia Suspicious for Malignancy
BRAF V600 Protein Variation
Serine/Threonine-Protein Kinase B-raf Val600Met
SYT-SSX4 Fusion Protein Expression
Serine/Threonine-Protein Kinase B-raf Gly466Val
Thymidine to Guanosine Transversion
PAX3/AFX Fusion Protein Expression
Loss of Merlin Expression
Loss of Chromosomes 1p/19q
Atypia suspicious for malignancy
LMO2 Messenger RNA Overexpression
Zeta-Associated Protein-70 mRNA Overexpression
NMYC Gene Amplification dysfunction
TAF15/NR4A3 Fusion Protein Expression
EWSR1/DDIT3 Fusion Protein Expression
CRTC1-MAML2 Fusion Protein Expression
DEK-CAN Fusion Protein Expression
Extracellular background material alteration
TSC1 Tumor-Suppressor Gene Inactivation
Cytoplasmic lipid droplet alteration
DNA Breaks, Double Stranded
Guanosine to Adenosine Mutation
Extracellular macromolecule aggregate alteration
STK11 Tumor-Suppressor Gene Inactivation
Deletions of chromosome 8
PAX3-FOXO4 Fusion Protein Expression
NuMA/RARA Fusion Protein Expression
Casp 10 Gene Mutation
Proliferative spindle cell nodule
MECOM-RUNX1 Fusion Protein Expression
Squamous Metaplasia with Atypia
Chromosome 5, monosomy 5q35
TEL-AML1 Fusion Protein Expression
Ring chromosome 14 syndrome
ETV6-JAK2 Fusion Protein Expression
Intranuclear electron dense deposit
HAS2-PLAG1 Fusion Protein Expression
PAX3-NCOA1 Fusion Protein Expression
Gain of Chromosome Xq
Unbalanced translocation and insertion
MME Gene mRNA Overexpression
Denaturation of lens proteins
SS18L/SSX1 Fusion Protein Expression
Chromosome 15q, partial deletion
SSXT-SSX4 Fusion Protein Expression
Extracellular electron dense material
Mild Columnar Cell Atypia
Alteration of chromosome structure
E-CAD Tumor-Suppressor Gene Inactivation
DEK/CAN Fusion Protein Expression
ERBB2 Messenger RNA Overexpression
Gain of Chromosome 17q22-q24
Gain of Chromosome 13q
CD117 Somatic Point Mutation
Tyrosine-Protein Kinase JAK2 Val617Phe
Double Stranded DNA Break
Polymorphism, Restriction Fragment Length
Loss of Chromosome 22q
MLLT3-MLL Fusion Protein Expression
ALO17-ALK Fusion Protein Expression
Mild Squamous Cell Atypia
VHL Tumor-Suppressor Gene Inactivation
MLL-ENL Fusion Protein Expression
SYT/SSX2 Fusion Protein Expression
Fumarate Hydratase Gene Mutation
TFG-ALKshort Fusion Protein Expression
Intracytoplasmic electron dense deposit
Anaplastic Lymphoma Kinase Overexpression
Serine/Threonine-Protein Kinase B-raf Leu597Arg
Serine/Threonine-Protein Kinase B-raf Val600Gly
PAX3/NCOA1 Fusion Protein Expression
TGFbetaRII Tumor-Suppressor Gene Inactivation
JAZF1-SUZ12 Fusion Protein Expression
EWSR1/ETV4 Fusion Protein Expression
AKT Family Gene Mutation
Cytosine to Adenosine Mutation
Mild transitional cell atypia
Isochromosome for long arm
WT1 Tumor-Suppressor Gene Inactivation
Loss of Chromosome 18q21
MLL-MLLT1 Fusion Protein Expression
Loss of Chromosome 20q
Chromosome 4, monosomy 4q32
ASPSCR1/TFE3 Fusion Protein Expression
Adenosine to Guanosine Mutation
Grade 1 Intraepithelial Neoplasia
NPM1-ALK Fusion Protein Expression
Philadelphia chromosome, Ph^1^, present
Moderate columnar cell atypia
Restriction Fragment Length Polymorphism
Chromosome 22, monosome mosaic
Chromosome 18 mosaic monosomy
Tyrosine-Protein Kinase JAK2 Arg938Leu
MLL-AFF1 Fusion Protein Expression
Grade II Intraepithelial Neoplasia
Alteration of chromosome number
Guanosine to Adenosine Transition
Gain of Chromosome 17p
Gain of Chromosome 17q
Rough endoplasmic reticulum fragmentation
X chromosome, trisomy Xp3
PAX7/FOXO1 Fusion Protein Expression
Serine/Threonine-Protein Kinase B-raf Gly469Val
Chromosome 1, monosomy 1p32
EWSR1-ETV1 Fusion Protein Expression
Transforming Protein N-Ras G12X
Monoclonal Immunoglobulin Gene Rearrangement
Loss of Chromosome 4q
Cyclin D1 mRNA Overexpression
Trisomy 5pter p13 3
Tyrosine-Protein Kinase JAK2 M929I
Clonal BCL-2 Gene Rearrangement
TPM3-ALK Fusion Protein Expression
Philadelphia chromosome, Ph1, absent
Guanosine to Thymidine Transversion
EWSR1/ATF1 Fusion Protein Expression
Clonal BCL-6 Gene Rearrangement
SS18L1-SSX1 Fusion Protein Expression
JAZF1/SUZ12 Fusion Protein Expression
BRD4/NUT Fusion Protein Expression
colorectal cancer, genetics of
Chromosome 21, monosomy 21q22
EWSR1-FLI1 Fusion Protein Expression
MEN-1 Tumor-Suppressor Gene Inactivation
Single Stranded DNA Break
EWSR1/FLI1 Fusion Protein Expression
FHIT Tumor-Suppressor Gene Inactivation
Gain of Chromosome 15q
CD117 Exon 9 Mutation
Alteration of mitochondrial cristae
TFG-CHN Fusion Protein Expression
Fungal cytoplasmic inclusion body
Guanosine to Cytosine Transversion
Loss of Chromosome 6q
Loss of Chromosome 6p
Clonal BCL2 Gene Rearrangement
EWS-WT1 Fusion Protein Expression
PRCC/TFE3 Fusion Protein Expression
TMPRSS2-ERG Fusion Protein Expression
Low Grade Intraepithelial Neoplasia
SS18-SSX Fusion Protein Expression
TFG-ALK Fusion Protein Expression
c-KIT Exon 9 Mutation
Loss of Chromosome 9q
BRCA1 Tumor-Suppressor Gene Inactivation
Moderate transitional cell atypia
HMGIC-LPP Fusion Protein Expression
Single Strand DNA Breaks
MLL/AF9 Fusion Protein Expression
HMGA2/LPP Fusion Protein Expression
Serine/Threonine-Protein Kinase B-raf Gly469Ser
Chromosome 3, monosomy 3q27
Moderate Transitional Cell Atypia
MLL/EEN Fusion Protein Expression
CBFalpha2-ETO Fusion Protein Expression
SS18/SSX1 Fusion Protein Expression
V/MLL Fusion Protein Expression
DNA Double Strand Break
MOZ-V Fusion Protein Expression
MSN-ALK Fusion Protein Expression
Mottled basement membrane thickening
IGF2R Tumor-Suppressor Gene Inactivation
MLL-FEL Fusion Protein Expression
GTPase KRas Protein Variant
Beta Catenin Gene Mutation
Philadelphia chromosome, Ph<sup>1</sup>, absent
KIT Exon 13 Mutation
BCL-6 Messenger RNA Overexpression
EWS/CHOP Fusion Protein Expression
MLL-EEN Fusion Protein Expression
Thymidine to Adenosine Mutation
FUS/ERG Fusion Protein Expression
Elastic fibre cross linking
p210 Fusion Protein Expression
Cytosine to Guanosine Mutation
MLL/ENL Fusion Protein Expression
ASPSCR1-TFE3 Fusion Protein Expression
RCC17-TFE3 Fusion Protein Expression
FIP1L1-PDGFRalpha Fusion Protein Expression
BCR-JAK2 Fusion Protein Expression
SS18/SSX2 Fusion Protein Expression
Gain of Chromosome 22
Gain of Chromosome 21
Moderate urothelial cell atypia
KAT6A-V Fusion Protein Expression
PML-RARA Fusion Protein Expression
Gain of Chromosome 2p
PKCbeta1 Messenger RNA Overexpression
Sporadic Breast Tumor Mutation
BRD4-C15orf55 Fusion Protein Expression
Whole chromosome trisomy, mosaicism
Gain of Chromosome 7q32
Chromosome 14q, terminal deletion
Gain of Chromosome 19q
PAX3/FOXO1 Fusion Protein Expression
RB1 Tumor-Suppressor Gene Inactivation
DNA Damage, Radiation Induced
KAT6A/V Fusion Protein Expression
NONO/TFE3 Fusion Protein Expression
Loss of Chromosome 2q
Loss of Chromosome 2p
Loss of Chromosome 22
Loss of Chromosome 21
Increased NFkappaB Pathway Activation
Lengthening of long arm
SYT-SSX Fusion Protein Expression
Chromosome 9, trisomy 9q32
TSC2 Tumor-Suppressor Gene Inactivation
ZAP70 Messenger RNA Overexpression
MLL/MLLT1 Fusion Protein Expression
CD117 Exon 11 Mutation
Adenosine to Thymidine Mutation
XYY sex chromosome alteration
p190 Fusion Protein Expression
Gain of Chromosome 4q
Serine/Threonine-Protein Kinase B-raf Val600Ala
EWS/CHN Fusion Protein Expression
deletion of long arm
EWSR1/ETV1 Fusion Protein Expression
IRF4 Gene mRNA Overexpression
Elastic fiber cross linking
Chromosome 16, trisomy 16q
COL1A2/PLAG1 Fusion Protein Expression
TGFBR2 Tumor-Suppressor Gene Inactivation
Casp 8 Gene Mutation
WT-1 Tumor-Suppressor Gene Inactivation
Tyrosine-Protein Kinase JAK2 V617F
Ring Chromosome 14 Syndrome
Mild urothelial cell atypia
DEK-NUP214 Fusion Protein Expression
Chromosome 6, trisomy 6q
Chromosome 6, trisomy 6p
TCF12-NR4A3 Fusion Protein Expression
Cytosine to Thymidine Mutation
Serine/Threonine-Protein Kinase B-raf Gly466Ala
PML-RARa Fusion Protein Expression
BCR-FGFR1 Fusion Protein Expression
Clonal Immunoglobulin Gene Rearrangement
Double Strand DNA Breaks
TPM4-ALK Fusion Protein Expression
BRD4/C15orf55 Fusion Protein Expression
Severe transitional cell atypia
PSF/TFE3 Fusion Protein Expression
Tyrosine-Protein Kinase JAK2 R938L
Mild Glandular Cell Atypia
Guanosine to Cytosine Mutation
FUS-ATF1 Fusion Protein Expression
Loss of Chromosome 18q
Loss of Chromosome 18p
Gain of Chromosome 6q
Gain of Chromosome 6p
Chromosome 15 uniparental disomy
EVI1/RUNX1 Fusion Protein Expression
MLL/AF4 Fusion Protein Expression
Grade 2 Intraepithelial Neoplasia
EWSR1-FEV Fusion Protein Expression
Cyclin D1 Protein Overexpression
Mismatch Repair Gene Inactivation
Serine/Threonine-Protein Kinase B-raf Val600Asp
Intranuclear electron dense material
Adenosine to Thymidine Transversion
Adenosine to Guanosine Transition
BIRC3-MALT1 Fusion Protein Expression
Serine/Threonine-Protein Kinase B-raf Gly466Arg
Janus Kinase 2 I960V
Cyclin D1 Gene Overexpression
Janus Kinase 2 R938L
restriction fragment length polymorphism
Thymidine to Adenosine Transversion
c-KIT Exon 11 Mutation
SYT/SSX4 Fusion Protein Expression
TEL-JAK2 Fusion Protein Expression
MLL-ELL Fusion Protein Expression
PAX7-FKHR Fusion Protein Expression
Spastic paraplegia neuropathy poikiloderma
BCR-PDGFRA Fusion Protein Expression
Postoperative Spindle Cell Nodule
Loss of Chromosome 16q
Loss of Chromosome 16p
MYST3/V Fusion Protein Expression
Chromosome 8, partial trisomy
Janus Kinase 2 Y931C
Adenosine to Cytosine Transversion
EWSR1-ATF1 Fusion Protein Expression
Formation of Apyrimidine Site
EWS/ETV4 Fusion Protein Expression
Chromosome 3, monosomy 3p25
MLL-SH3GL1 Fusion Protein Expression
Janus Kinase 2 c.2792A>G
Loss of Chromosome 8p
ETV6/NTRK3 Fusion Protein Expression
FUS-ERG Fusion Protein Expression
Chromosome 18, deletion 18q23
Chromosome 22 mosaic monosomy
EWSR1-DDIT3 Fusion Protein Expression
Chromosome 7 uniparental disomy
ETV6/PDGFRB Fusion Protein Expression
ATIC-ALK Fusion Protein Expression
HAS2/PLAG1 Fusion Protein Expression
No oestrogen effect present
Clonal BCL-3 Gene Rearrangement
DPC4 Tumor-Suppressor Gene Inactivation
Loss of Chromosome 1
Loss of Chromosome 2
Loss of Chromosome 4
Loss of Chromosome 5
Loss of Chromosome 6
Loss of Chromosome 7
Loss of Chromosome 8
Cyclin D1 Gene Amplification
Loss of Chromosome X
Loss of Chromosome Y
Radiation Induced DNA Damage
COL1A1-PDGFB Fusion Protein Expression
Uniparental disomy of 21
Mild Transitional Cell Atypia
Serine/Threonine-Protein Kinase B-raf G466E
Serine/Threonine-Protein Kinase B-raf G466R
Serine/Threonine-Protein Kinase B-raf G466V
BCR/JAK2 Fusion Protein Expression
PLZF-RARalpha Fusion Protein Expression
Monoclonal BCL-2 Gene Rearrangement
Hyperplasia of Golgi structure
Tyrosine-Protein Kinase JAK2 Gly935Arg
Gain of Chromosome 12q13-14
CLTC-ALK Fusion Protein Expression
RBM15/MKL1 Fusion Protein Expression
Chromosome 15, trisomy mosaicism
Proto-Oncogene c-ErbB-1 Protein Variant
Hypertrophy of Golgi apparatus
Janus Kinase 2 Gly935Arg
EWSR1/FEV Fusion Protein Expression
Gain of Chromosome 12q13
SYT/SSX1 Fusion Protein Expression
EWS/WT1 Fusion Protein Expression
Gain of Chromosome 7p13-pter
TEL-ABL Fusion Protein Expression
Adenosine to Cytosine Mutation
Loss of Chromosome 12q
FUS-DDIT3 Fusion Protein Expression
SYT-SSX1 Fusion protein Expression
MLL-MLLT10 Fusion Protein Expression
Autosomal deletion - mosaicism
Chromosome 14q, proximal duplication
TCF12/CHN Fusion Protein Expression
ASPL-TFE3 Fusion Protein Expression
Gain of Chromosome 4
Gain of Chromosome 6
Gain of Chromosome 7
Gain of Chromosome 1
Gain of Chromosome 3
Gain of Chromosome 8
Gain of Chromosome 9
Guanosine to Thymidine Mutation
BCR-ABL1 Fusion Protein Expression
ETV6-ABL1 Fusion Protein Expression
Gain of Chromosome X
Gain of Chromosome Y
Chromosome 3, monosomy 3p2
Gain of Chromosome 8q
Postoperative spindle cell nodule
EWS-FEV Fusion Protein Expression
EWSR1-ERG Fusion Protein Expression
Trisomy 14 mosaicism syndrome
FUS/CHOP Fusion Protein Expression
Serine/Threonine-Protein Kinase B-raf V600M
Serine/Threonine-Protein Kinase B-raf V600L
Uniparental disomy of 5
Uniparental disomy of 2
Serine/Threonine-Protein Kinase B-raf V600K
Serine/Threonine-Protein Kinase B-raf V600D
Serine/Threonine-Protein Kinase B-raf V600G
Serine/Threonine-Protein Kinase B-raf V600A
Serine/Threonine-Protein Kinase B-raf Val600Lys
SSXT-SSX1 Fusion Protein Expression
Serine/Threonine-Protein Kinase B-raf V600R
MLL/SH3GL1 Fusion Protein Expression
NF1 Tumor-Suppressor Gene Inactivation
EWSR1/PATZ1 Fusion Protein Expression
ETV6/RUNX1 Fusion Protein Expression
Paternal uniparental disomy 13
BCR/ABL1 Fusion Protein Expression
Chromosome 9, trisomy mosaic
ZBTB16/RARA Fusion Protein Expression
Cyclin D1 Gene Activation
ETV6-NTRK3 Fusion Protein Expression
MLL/ELL Fusion Protein Expression
Tyrosine-Protein Kinase JAK2 E985K
Loss of Chromosome 10q
Loss of Chromosome 10p
Thymidine to Cytosine Mutation
FUS-CHOP Fusion Protein Expression
Severe Columnar Cell Atypia
Grade I Intraepithelial Neoplasia
MLL-AF10 Fusion Protein Expression
c-KIT Exon 13 Mutation
EWS-ATF1 Fusion Protein Expression
Tyrosine-Protein Kinase JAK2 Tyr931Cys
MECT1/MAML2 Fusion Protein Expression
EWS/ERG Fusion Protein Expression
Chromosome 5, trisomy 5p
BCL2 Gene mRNA Overexpression
Uniparental disomy 1q12 q21
Cytosine to Adenosine Transversion
Embryonic Lethal Mutation Abnormality
API2-MLT Fusion Protein Expression
Philadelphia chromosome, Ph^1^, absent
TCF12-CHN Fusion Protein Expression
EWS/ZSG Fusion Protein Expression
Tyrosine-Protein Kinase JAK2 I960V
DNA Breaks, Single Stranded
E2A-PBX1 Fusion Protein Expression
Janus Kinase 2 M929I
No estrogen effect present
Moderate glandular cell atypia
Serine/Threonine-Protein Kinase B-raf Leu597Val
CD10 Messenger RNA Overexpression
Fusion of foot processes
HMGA2-LPP Fusion Protein Expression
Plasma membrane coating alteration
Posttraumatic Spindle Cell Nodule
MLL-AF9 Fusion Protein Expression
Chromosome 17, trisomy 17q22
Chromosome 7, trisomy mosaic
SYT-SSX2 Fusion Protein Expression
Gene Product Sequence Variation
Impaired leukocyte chemotaxis, function
Trisomy 7p13 p12 2
Variable Number Tandem Repeat
Outer nuclear membrane alteration
Transforming Protein N-Ras Q61X
Mild glandular cell atypia
Transforming Protein N-Ras Q61R
Transforming Protein N-Ras Q61P
Transforming Protein N-Ras Q61L
Transforming Protein N-Ras Q61K
Transforming Protein N-Ras Q61H
Transforming Protein N-Ras Q61E
BCR/FGFR1 Fusion Protein Expression
EWS-E1AF Fusion Protein Expression
TEL/JAK2 Fusion Protein Expression
NUMA1/RARA Fusion Protein Expression
Formation of Abasic Site
SFPQ-TFE3 Fusion Protein Expression
Partial deletion of Y
HMGIC/LPP Fusion Protein Expression
PTEN Tumor-Suppressor Gene Inactivation
EWS/ETV1 Fusion Protein Expression
FUS-CREB3L1 Fusion Protein Expression
FUS-CREB3L2 Fusion Protein Expression
Intracytoplasmic electron dense deposition
Serine/Threonine-Protein Kinase B-raf Gly469Glu
Mild columnar cell atypia
TFG/CHN Fusion Protein Expression
TP53 Tumor-Suppressor Gene Inactivation
Atypical epidermoid metaplasia
Proto-Oncogene c-ErbB-1 A750_K757del
Squamous cell atypia
Mismatches, Base Pair
Leukocyte maturation arrest
PTPN11 Gene Mutation
Extracellular plasma alteration
EGFR delta Val774
Nuclear lead inclusion
DNA Break, Single-Stranded
Keratin Pearls Formation
Birt-Hogg-Dube Gene Mutation
CD332 Gene Mutation
Foot process alteration
Breaks, Single-Stranded DNA
BRCA2 Gene Inactivation
BMPR1A Gene Mutation
Effect, Viral Cytopathic
Proto-Oncogene c-ErbB-1 V774del
Proto-Oncogene c-ErbB-1 S768_V769insVAS
Benign lymphoepithelial lesion
FGFR2 Gene Mutation
HNF1A Gene Mutation
Proto-Oncogene c-ErbB-1 T751_E758del
Abnormal cell size
Numerical Chromosomal Abnormalities
ERBB Gene Mutation
Trisomy 9 mosaicism
HST-2 Gene Amplification
REL Gene Amplification
CD332 Antigen Ser372Cys
EGFR delta Val834
Cytoplasmic matrix alteration
Mild inflammatory atypia
Replication Error Phenotype
Inversion Mutation Abnormality
Endoplasmic reticulum fragmentation
Bone crystal alteration
Moderate Epithelial Dysplasia
Deoxyribonucleic acid damage
atrophy fibers muscle
Proto-Oncogene c-ErbB-1 D770_N771insSVQ
Proto-Oncogene c-ErbB-1 D770_N771insSVD
Ciliary centriole alteration
Cabot ring bodies
EGFR Protein Variant
AKT1 Protein Variant
JAK2 Gene Mutation
Structural Chromosome Anomalies
Tight junction alteration
PDGFRA Gene Amplification
frame shift mutation
EGFR-TKI Resistant Mutation
Elastic fiber fragmentation
Glandular Cell Atypia
Cell shape alteration
Basement membrane proliferation
Trisomy 22 mosaic
B-RAF Gene Mutation
Transitional Cell Atypia
Cabot ring body
Low-Frequency Microsatellite Instability
STK11 Gene Inactivation
Cytoplasmic fibre alteration
MYCL1 Gene Amplification
NRAS NP_002515.1 :p.Gln61Pro
Duplication 5pter p13.3
Deletion 1p31 p22
virus cytopathogenic effect
MADH4 Gene Inactivation
Abnormal cell structure
Mild Koilocytotic Atypia
Extracellular fibre alteration
Squamous Pearl Formation
Aberrant Chromosome 1
Proto-Oncogene c-ErbB-1 I744_K745insKIPVAI
Fragmentation of myofilaments
Proto-Oncogene c-ErbB-1 L747_A750del
Oxidative Stress Induction
PRKCB mRNA Overexpression
Glandular necrotizing metaplasia
Chromosome 13+18+21+X+Y aneuploidy
Proto-Oncogene c-ErbB-1 V774_C775insHV
Expansions, DNA Repeat
SMAD4/DPC4 Gene Inactivation
Ring Chromosome 14
Ring Chromosome 18
PI3KCA Gene Mutation
Chromosome 5q31-33 Deletion
Ring 9, Chromosome
CD44 mRNA Overexpression
Glandular cell atypia
FOS Gene Amplification
DNA Break, Double-Stranded
XY, female phenotype
NRAS NP_002515.1 :p.Gln61Lys
Cell size alteration
Phenotypes, Replication Error
Chromosome 18 ring
Error Phenotypes, Replication
Cell Membrane Process
Proto-Oncogene c-ErbB-1 D770_N771insNPH
Hypersegmentation of nucleus
Cell Stress Process
Expansion, Trinucleotide Repeat
Proto-Oncogene c-ErbB-1 S752_V769del
RB1 Gene Inactivation
RET Gene Mutation
Trisomy 1q42 qter
Abnormal eosinophil production
GTPase KRas G12S
CASP8 Gene Mutation
Muscle fiber hypertrophy
Premature Termination Abnormality
Monosomy 4p14 p16
Viral Cytopathogenic Effect
Trisomy 7 mosaicism
Plasma membrane reduplication
ERBB2 Protein Overexpression
Duplication 2pter p24
Leucocyte maturation arrest
Muscle fiber change
HER2/neu Gene Mutation
ERBB1 Gene Mutation
Homogeneously Staining Region
Plasma membrane rupture
Nuclear membrane reduplication
Repeat Expansions, DNA
CDC73 Gene Mutation
Proto-Oncogene c-ErbB-1 S752_I759del
Muscle fibre atrophy
Fibrocartilage matrix alteration
Chromosome 13p, trisomy
Antibody Dependent Enhancement
Chromosome 5p syndrome
Proto-Oncogene c-ErbB-1 E746_E749del
Multiple Nucleotide Abnormalities
Proto-Oncogene c-ErbB-1 H773_V774insGNPH
GATA1 Gene Mutation
Basement membrane-like material
PI3Kalpha Protein Variant
Mosaic trisomy 16
Mosaic trisomy 10
IRF4/MUM1 mRNA Overexpression
Interstitial deletion 17p
EGFR delta Leu747
MDM2 Gene Amplification
PKCbeta1 mRNA Overexpression
Multiple Transversion Abnormalities
de novo Mutation
NRAS Gene Mutation
Expansions, Trinucleotide Repeat
abnormal cell structure
Glandular necrotising metaplasia
NRAS NP_002515.1 :p.Gln61Arg
GTPase KRas A146X
Monosomy 1p31 p22
Parabasal cells predominate
EGFRvIII Gene Mutation
Major partial trisomy
Monosomy 3q21 23
FGFR1 Gene Activation
TNFSF6 Gene Mutation
Granulocyte granule deficiency
Break, Double-Stranded DNA
Columnar cell atypia
HRPT2 Gene Mutation
Polar body alteration
Proto-Oncogene c-ErbB-1 H773_V774insG
Proto-Oncogene c-ErbB-1 H773_V774insH
NPM1 Gene Mutation
CCND1 Gene Activation
Rearrangement of 8q11-13
BCL-6 mRNA Overexpression
ERBB2 mRNA Overexpression
CDKN2C Gene Mutation
Viral Cytopathic Effects
Proto-Oncogene c-ErbB-1 T790M
Trisomy 14 mosaic
MSH2 Gene Inactivation
RAS-RAF Pathway Deregulation
SDHB Gene Mutation
Increased mesangial matrix
Centric fusion translocation
Dominant-Negative Mutation Abnormality
N-myc Gene Amplification
Lymphocyte destruction, function
Break, Single-Stranded DNA
Cartilage matrix alteration
Chromosome 18 aneuploidy
Deletion 1q21 q25
Proto-Oncogene c-ErbB-1 A750_K754del
CD332 Antigen S252W
Mixed Nucleotide Abnormalities
Chromosome 8 deletion
Abnormal basophil production
duplication of chromosome
Proto-Oncogene c-ErbB-1 D770_N771insGL
Distal Duplication 15q
Moderate Cytologic Atypia
Proto-Oncogene c-ErbB-1 D770_N771insGD
PPARG Gene Rearrangement
Tumor-Suppressor Pathway Deregulation
Elastic fiber alteration
c-myc Gene Amplification
Unbalanced Chromosomal Rearrangement
CD332 Antigen Pro253Arg
Atypical Cell Present
SMARCB1 Gene Inactivation
DNA Break, Double-Strand
EGFR Protein Overexpression
NRAS Protein Variant
Proto-Oncogene c-ErbB-1 A767_S768insTLA
Chromosome 15 ring
Mild koilocytotic atypia
cytotoxic lymphocyte reaction
LKB1 Gene Inactivation
Epithelial cell abnormality
Y chromosome microdeletions
SMAD4 Gene Inactivation
Keratin pearl formation
NF2 Gene Mutation
Proto-Oncogene c-ErbB-1 E746_S752del
Ki-Ras Protein Variant
Trisomy mosaic 22
CD332 Antigen Cys382Arg
Deletion 1q32 q42
Golgi membrane alteration
Duplication 1q12 q21
Balanced Chromosomal Aberration/Rearrangement
p16/CMM2 Gene Inactivation
Radiation-Induced DNA Damage
Atypical cell present
Multiple Transition Mutations
c-myc Gene Activation
Terminal bar alteration
HST-1 Gene Amplification
severe epithelial dysplasia
Haematopoietic maturation arrest
NRAS NP_002515.1 :p.Gln61Xxx
Proto-Oncogene c-ErbB-1 V769_D770insGVV
Repeat Expansion, DNA
Microdeletion 22 q11
MYC Gene Amplification
dysplasia epithelial severe
Translation Initiation Abnormality
BRCA1 Gene Inactivation
CCND2 mRNA Overexpression
ERBB2 Protein Variant
Adrenal gland cytomegaly
T Gene Duplication
CDKN1C Gene Mutation
Myelin sheath alteration
Monosomy 6q13 q15
Extracellular fiber alteration
c-H-ras Gene Amplification
Hyposegmentation of nucleus
Abnormal basophil maturation
Repeat Expansions, Trinucleotide
Proto-Oncogene c-ErbB-1 D770_N771insSVP
LMO2 mRNA Overexpression
Plasma membrane alteration
NRAS G13 Mutation
Deletion Xp22 pter
Retrograde Degeneration, Transneuronal
Mosaic Monosome 22
PDGFRalpha Protein Overexpression
Proto-Oncogene c-ErbB-1 D770_N771insMATP
Gene Amplification Abnormality
Monosomy 8p23 1
Trisomy 14 mosaicism
Break, Single-Strand DNA
BRAF V600 Mutation
ATM Gene Mutation
Duplication 4q25 qter
FGFR1 Gene Rearrangement
CASP10 Gene Mutation
Proto-Oncogene c-ErbB-1 I740_P741insPVAIKI
Proto-Oncogene c-ErbB-1 K745_E746insVPVAIK
NOTCH1 Gene Mutation
Double-Strand DNA Breaks
Extracellular sap alteration
EGFRvIII Protein Variant
CDKN2C Gene Deletion
Double-Stranded DNA Breaks
Chromosome 8 Deletion
Trinucleotide Repeat, Expanded
CD332 Antigen P253R
Chromosome 17 deletion
FLCN Gene Mutation
Nucleotide base deletion
Somatic Mutation Abnormality
EGFR Gene Activation
GTPase NRas G12X
Duplication 14q proximal
Nuclear shape alteration
De novo mutation
RUNX1 Gene Mutation
Proto-Oncogene c-ErbB-1 V769_D770insASV
Severe Koilocytotic Atypia
Mitochondrial cristae fragmentation
ETV6 Gene Mutation
KRAS Gene Activation
PI3KCA Gene Amplification
c-erbB2 Gene Amplification
GTPase KRas G12E
Severe koilocytotic atypia
Transneuronal Retrograde Degeneration
Cytopathic Effects, Viral
Chromosome 7, monosomy
HER-2 Gene Amplification
CD140a Antigen D842V
Severe inflammatory atypia
Proto-Oncogene c-ErbB-1 P753_I759del
Basement membrane duplication
K-Ras 2 Q61L
K-Ras 2 Q61K
K-Ras 2 Q61D
K-Ras 2 Q61E
K-Ras 2 Q61X
K-Ras 2 Q61R
K-Ras 2 Q61P
Deletion 17q23 q24
Proto-Oncogene c-ErbB-1 G719fs*29
Rearrangement of 17p11-13
DNA Interstrand Crosslinking
Proto-Oncogene c-ErbB-1 G719A
Basement membrane thickening
Viral Cytopathic Effect
Gene Deletion Abnormality
Abnormal DNA Repair
Extracellular matrix alteration
Genotoxicity, Radiation Induced
PDGFR-Alpha Protein Variant
muscle fiber atrophy
Chromosome 19 ring
Mixed Nucleotide Mutations
Moderate inflammatory atypia
Proto-Oncogene c-ErbB-1 E746_R748del
Base Pair Mismatch
Proto-Oncogene c-ErbB-1 L861F
Deletion 17p Syndrome
BRAF NP_004324.2:p.V600 Mutation
Crystalline macromolecule alteration
Extracellular vacuole alteration
Proto-Oncogene c-ErbB-1 L747_E749del
Proto-Oncogene c-ErbB-1 N771_P772insH
DNA Degradation, Apoptotic
Proto-Oncogene c-ErbB-1 N771_P772insN
Nuclear membrane thickening
Apoptotic DNA Degradation
Abnormal hematopoietic maturation
Impaired leukocyte chemotaxis
Mechanical fragility, function
GTPase KRas Q61L
GTPase KRas Q61K
GTPase KRas Q61H
GTPase KRas Q61E
GTPase KRas Q61D
GTPase KRas Q61X
GTPase KRas Q61R
GTPase KRas Q61P
Protein Sequence Alteration
Moderate Koilocytotic Atypia
Effects, Viral Cytopathogenic
FGFR4 Gene Mutation
Proto-Oncogene c-ErbB-1 L747_T751del
NF2 Gene Inactivation
Cell Membrane Alteration
Ring 15, Chromosome
PIK3CA Protein Variant
ERBB2 Gene Mutation
Partial deletion 11p
Duplication 1p21 p32
ASXL1 Gene Mutation
VHL Gene Inactivation
Cell structure alteration
SDHD Gene Mutation
Chromosome 16, trisomy
WT1 Gene Inactivation
Duplication 3q13.2 q25
Impaired leucocyte chemotaxis
Cytopathogenic Effect, Viral
Golgi cavity alteration
Chromosome 10 ring
Additional X Chromosome
VIRAL CYTOPATHOGEN EFF
Proto-Oncogene c-ErbB-1 P772_H773insQV
PIK3CA Gene Amplification
Apoptotic Pathway Deregulation
Repeat, Expanded Trinucleotide
CCND1 mRNA Overexpression
Multiple Transversion Mutations
KRAS A146 Mutation
Cell Stress-Related Process
JUN Pathway Deregulation
Moderate koilocytotic atypia
K-Ras 2 G12N
K-Ras 2 G12L
K-Ras 2 G12I
K-Ras 2 G12F
K-Ras 2 G12D
K-Ras 2 G12E
K-Ras 2 G12C
K-Ras 2 G12A
K-Ras 2 G12Y
K-Ras 2 G12V
K-Ras 2 G12W
K-Ras 2 G12R
K-Ras 2 G12S
Trinucleotide Repeat Expansions
Chromosome 17 ring
Chromosome 12 aneuploidy
GTPase NRas Q61L
CCND1 Gene Amplification
Trisomy 10pter p13
K-Ras 2 G13D
ALK Gene Mutation
paired helical filament
K-Ras 2 G13V
Nuclear/cytoplasmic ratio increased
Proto-Oncogene c-ErbB-1 P772_H773insDNP
GTPase KRas G13N
GTPase KRas G13A
GTPase KRas G13C
GTPase KRas G13D
GTPase KRas G13E
GTPase KRas G13R
GTPase KRas G13S
GTPase KRas G13V
KRAS Protein Variant
Molecular Pathway Deregulation
Proto-Oncogene c-ErbB-1 V834del
BHD Gene Mutation
GNA11 Gene Mutation
Nonproliferative fibrocystic change
CD332 Antigen N549H
CD332 Antigen N549K
Columnar Cell Atypia
c-met Gene Mutation
IKZF1 Gene Mutation
Frameshift Mutation function
Deletion 11q partial
Ring chromosome 1
Ring chromosome 8
abnormalities cell epithelial
ERG Gene Rearrangement
MKK4 Gene Inactivation
P13K-AKT Pathway Deregulation
Molecular Sequence Variation
NRAS Q61 Mutation
MYB Gene Amplification
Cell membrane alteration
Fusion Protein Expression
temperature sensitive mutant
Nuclear membrane alteration
Coarsely dispersed chromatin
Restriction Site Polymorphism
DNA Breaks, Single-Stranded
Monosomy 11q partial
MSH6 Gene Inactivation
Trisomy 8 Mosaicism
EGFR delta E746
Rearrangement of 6q13
Degenerations, Transneuronal Retrograde
Golgi vesicle alteration
Endoplasmic Reticulum Stress
Hematopoietic maturation arrest
Frame Shift Mutations
Degeneration, Transneuronal Retrograde
LMYC Gene Amplification
Cytopathic Effect, Viral
Viral Cytopathogenic Effects
Monosomy 2pter p24
NRAS NP_002515.1 :p.Gln61His
UV Mutation Abnormality
Trisomy Xpter Xq13
Nuclear sap alteration
BEK Gene Mutation
Chromosome 14 ring
Proto-Oncogene c-ErbB-1 E709fs*1
Transitional cell metaplasia
Single-Stranded DNA Break
CD332 Antigen S372C
PMS1 Gene Inactivation
FGFR2 Gene Activation
Chromosome 22 ring
hSNF5/INI1 Gene Inactivation
Chromosome 9 Ring
HER1 Gene Mutation
v-fos Gene Amplification
Atypical apocrine metaplasia
FH Gene Mutation
short arm deletion
BCR-ABL TKI-Resistant Mutation
RET Gene Rearrangement
WRN Gene Mutation
Chromosome 4p deletion
Mutation, Frame Shift
PDGFRA Gene Mutation
DNA strand break
Deletion 1q25 q32
Abnormal nuclear/cytoplasmic ratio
Proto-Oncogene c-ErbB-1 M766_A767insAI
Break, Double-Strand DNA
Duplication 2p13 p21
NRAS G12 Mutation
Single-Strand DNA Breaks
Endoplasmic Reticulum Stresses
Deletion 6q16 q21
Frameshift Mutation Abnormality
Proto-Oncogene c-ErbB-1 R748_P753del
BRAF Gene Mutation
Muscle fibre hypertrophy
FASLG Gene Mutation
Partial trisomy 8
Proto-Oncogene c-ErbB-1 A763_Y764insFQEA
Proto-Oncogene c-ErbB-1 P772_H773insDHP
Foot process fusion
Proto-Oncogene c-ErbB-1 H773_V774insNPH
Duplication 10pter p13
CD332 Antigen Tyr375Cys
genetics colorectal cancer
Monosomy 1p22 p13
Mild epithelial dysplasia
BLM Gene Mutation
Numerical Chromosome Aberration
Effects, Viral Cytopathic
Basement membrane alteration
Duplication of chromosome
Nuclear size alteration
Premature Termination Mutation
FGF6 Gene Amplification
Reticulin fibril alteration
CTNNB1 Gene Mutation
AKT Gene Mutation
Proto-Oncogene c-ErbB-1 D770_N771insN
Proto-Oncogene c-ErbB-1 D770_N771insD
Proto-Oncogene c-ErbB-1 D770_N771insG
ERBB2 p. A775_G776insYVMA
Deletion 8p23 1
Rearrangement of 11q
GNAS Gene Mutation
FGFR2 Gene Amplification
Extracellular granule alteration
Chromosome 21 ring
HRAS Gene Mutation
Alteration of centromere
Atypical Apocrine Metaplasia
DNA Replication Damage
Thyrotropin, Biologically Inactive
Proto-Oncogene c-ErbB-1 A750_E758del
TP53 Gene Inactivation
Duplication 22q11 q13
Gene Duplication Abnormality
Chromosomal structural abnormalities
DNA Breaks, Double-Strand
PTEN gene mutation
Rearrangement of 8q21
Chromosome 13q monosomy
MET Gene Mutation
Proto-Oncogene c-ErbB-1 Y764_V765insHH
Defective molecular assembly
Proto-Oncogene c-ErbB-1 H773_V774insGH
Proto-Oncogene c-ErbB-1 L861P
Proto-Oncogene c-ErbB-1 L861Q
Proto-Oncogene c-ErbB-1 L861R
Proto-Oncogene c-ErbB-1 L861V
Monosomy 1q32 q42
Finely dispersed chromatin
Y chromosome deletion
EZH2 Gene Mutation
Tumor-Suppressor Gene Inactivation
Ring chromosome 17
Ring chromosome 14
Ring chromosome 13
Ring chromosome 10
Ring chromosome 19
Trisomy 14q proximal
DNA Breaks, Double-Stranded
FAS Gene Mutation
EGFR G719 Mutation
Nucleotide Transversion Abnormality
GTPase NRas Q61E
GTPase NRas Q61K
GTPase NRas Q61H
GTPase NRas Q61R
GTPase NRas Q61P
GTPase NRas Q61X
Proto-Oncogene c-ErbB-1 p.K745_A750del
Messenger RNA Overexpression
DNA Replicating Damage
GTPase NRas G13X
Proto-Oncogene c-ErbB-1 E746_P753del
PDGFRalpha Gene Mutation
PTCH Gene Inactivation
BRAF NP_004324.2:p.Val600 Mutation
TEMPERATURE-SENSITIVE LETHAL MUTATION
Diffuse oncocytic metaplasia
K-Ras 2 A146X
Expanded Trinucleotide Repeat
Balanced Chromosomal Alteration
Giant Rod Chromosome
Diffuse hyperplastic oncocytosis
Base Pair Mismatches
Muscle fiber atrophy
Proto-Oncogene c-ErbB-1 K745_L747del
Virus-Induced Cell Proliferation
HRAS Gene Amplification
PDGFRA gene rearrangements
MYCN Gene Amplification
PTCH1 Gene Inactivation
Monosomy 1p34 p32
K-SAM Gene Mutation
KGFR Protein Variant
Ring Chromosome 1
CD332 Antigen Y375C
CD332 Antigen Ser252Trp
Deletion 3p14 p11
c-erbB2 Gene Activation
BRAF p.Val600 Mutation
DNA Repeat Expansion
Rearrangement of 3q
Mutagenic Process, Pathologic
Structural Chromosomal Abnormality
Ring 14 Syndrome
Oncogene Activation Process
Distal Duplication 10q
EGFR-TKI Sensitizing Mutation
Proto-Oncogene c-ErbB-1 E746_A750del
DNA Repeat Expansions
Chromosome Xq trisomy
Proto-Oncogene c-ErbB-1 V769_D770insCV
Monosomy 1q21 q25
Abnormal macromolecular binding
Dilated endoplasmic reticulum
Proto-Oncogene c-ErbB-1 V769_D770insDNV
Chromosome 13 duplication
PMS2 Gene Inactivation
PALB2 Gene Mutation
Margination of chromatin
Nuclear chromatin alteration
Rearrangement of 1p11-q11
Nuclear membrane proliferation
Basement membrane fragmentation
Monosomy Xp22 pter
Mosaic trisomy 21
Proto-Oncogene c-ErbB-1 L747_S752del
JAK2 Protein Variant
Abnormal eosinophil maturation
Duplication Xpter Xq13
Erythrocyte destruction, function
Trisomy 2pter p24
deletions dna mitochondrial
Proto-Oncogene c-ErbB-1 H773_V774insPH
FGFR2 Protein Variant
Proto-Oncogene c-ErbB-1 E746_T751del
Cell Cycle Deregulation
Severe epithelial dysplasia
Double-Stranded DNA Break
NRAS NP_002515.1 :p.Gly12Xxx
Severe cytologic atypia
Proto-Oncogene c-ErbB-1 L858Q
Pinocytotic vacuole alteration
KRAS Q61 Mutation
Rearrangement of 2p23
Cytoplasmic fiber alteration
Duplication 7p13 p12.2
ALK Kinase Upregulation
Nuclear/cytoplasmic ratio decreased
NMYC Gene Amplification
Muscle fibre change
Philadelphia chromosome, Ph
Retrograde Degenerations, Transneuronal
Moderate cytologic atypia
long arm deletion
EGFR Gene Mutation
Transitional cell atypia
CDKN2A Gene Inactivation
HER2 Gene Mutation
Trisomy 4q25 qter
Proto-Oncogene c-ErbB-1 I789_L792del
Breaks, Single-Strand DNA
Abnormal molecular cross-linking
Trisomy 1p21 p32
Numerical Chromosomal Abnormality
Atypical squamous metaplasia
Monosomy 18 mosaicism
GPC3 Gene Inactivation
PIK3CA E545 Mutation
Trans Synaptic Degeneration
Proto-Oncogene c-ErbB-1 V769_D770insGV
Cytoplasmic filament alteration
BRCA2 Gene Mutation
EGFR Gene Amplification
Granulocyte destruction, function
Receptor site alteration
KIT Gene Mutation
c-K-ras Protein Variant
JAK2 Gene Variant
Deregulation of Apoptosis
CD332 Antigen Lys659Glu
Deletion 4p14 p16
Bistrand Abasic Site
EGFR delta V834
Proto-Oncogene c-ErbB-1 K745_E749del
Duplication 17p11 2
chromosome disorders duplication
Trisomy Partial 8
Stress, Endoplasmic Reticulum
Proto-Oncogene c-ErbB-1 D761_E762insEAFQ
Expansion, DNA Repeat
c-erbB1 Gene Amplification
Repeats, Expanded Trinucleotide
EGFR Activating Mutation
KGFR Gene Mutation
Protein Splicing Abnormality
DNA Intrastrand Crosslinking
Group chromosomal alteration
FHIT Gene Inactivation
Urothelial cell atypia
deletion short arm
Partial Monosomy 17p
Proto-Oncogene c-ErbB-1 V765_M766insMAS
Ring 22, Chromosome
NRAS NP_002515.1 :p.Gln61Leu
Single-Stranded DNA Breaks
Expanded Trinucleotide Repeats
c-met Gene Amplification
Breaks, Double-Stranded DNA
genetic colorectal cancer
DNA Strand Break
Diffuse cytologic atypia
Mutations, Frame Shift
Proto-Oncogene c-ErbB-1 R748_S752del
KRAS2 Gene Mutation
Focal cytologic atypia
Elastic fibre fragmentation
Proto-Oncogene c-ErbB-1 P772_H773insYNP
PIK3CA Gene Mutation
Mismatch, Base Pair
BRAF p.V600 Mutation
Moderate epithelial dysplasia
Phenotype, Replication Error
Chromosomal Translocation Process
SDHC Gene Mutation
Nuclear pore alteration
Squamous Pearls Formation
ALK Kinase Overexpression
Elastic fibre alteration
CDK4 Gene Inactivation
Abnormal chromosomal banding
Stresses, Endoplasmic Reticulum
DNA Break, Single-Strand
t(1;19) (q23;p13.3); PBX/E2A
Oxyphilic cell metaplasia
Proto-Oncogene c-ErbB-1 L747_K754del
CEBPA Gene Mutation
Reticulum Stresses, Endoplasmic
Trisomy 17p11 2
KRAS Gene Amplification
MUTYH Gene Mutation
mitochondrial dna deletion
Microtubule Dynamics Alteration
L-myc Gene Amplification
A-myb mRNA Overexpression
Severe Cytologic Atypia
Error Phenotype, Replication
Suspect cell present
Balanced Chromosomal Translocation
MLH1 Gene Inactivation
ERBB2 Gene Amplification
Protein Sequence Abnormality
DNA Degradation, Necrotic
CD332 Antigen C382R
Aberrant DNA Methylation
Sex chromosome mosaicism
Trinucleotide Repeat Expansion
Chromosome 13 ring
Proto-Oncogene c-ErbB-1 S768_V769insAWT
NRAS NP_002515.1 :p.Gln61Glu
WAS Gene Mutation
PDGFRA Gene Rearrangement
Chromosome 1 ring
Rearrangement of 11q13-21
Germline Mutation Abnormality
MYBL1 mRNA Overexpression
Rearrangement of 21q
EGFR delta V774
Chromosome 5q31.1 Deletion
Mild cytologic atypia
CHEK2 Gene Mutation
Partial trisomy syndromes
Proto-Oncogene c-ErbB-1 V769_D770insMASVD
p110alpha Protein Variant
CCNE1 Gene Amplification
NF1 Gene Inactivation
Tandem Repeat Variation
MYC Pathway Deregulation
Partial trisomy 10q
BRAF Protein Variant
Nissl substance alteration
KRAS-2 Gene Mutation
Atypical Squamous Metaplasia
Abnormal erythrocyte destruction
AKT1 Gene Mutation
Effect, Viral Cytopathogenic
MET Gene Amplification
KRAS Gene Mutation
de novo mutation
ZAP-70 mRNA Overexpression
Proto-Oncogene c-ErbB-1 V769_D770insGSV
Gsalpha Gene Mutation
Platelet destruction, function
Reactive cellular changes
Trisomy 9 translocation
Numerical Chromosome Anomaly
BCL-2 mRNA Overexpression
Unbalanced Chromosomal Alteration
Gene Fusion Abnormality
K-Ras 2 Q61H
Chromosome 13q deletion
RASSF1 Gene Inactivation
Squamous Cell Atypia
FGFR1 Gene Amplification
Spindle cell nodule
TGFBR2 Gene Inactivation
Proto-Oncogene c-ErbB-1 N756_L760del
Chromosome 20 ring
Chromosome 13 aneuploidy
Monosomy 6q16 q21
MEN1 Gene Inactivation
Transneuronal Retrograde Degenerations
PDGFRA Protein Variant
CD332 Antigen Asn549Lys
PDGFRB Gene Rearrangement
MYC Gene Mutation
Dentin crystal alteration
Proto-Oncogene c-ErbB-1 P772_H773insPR
Structural extracellular alteration
Frame Shift Mutation
Collagen fibril alteration
JAK-STAT Pathway Deregulation
PIK3CA H1047 Mutation
c-K-ras Gene Amplification
Proto-Oncogene c-ErbB-1 L747_P753del
TSC2 Gene Inactivation
epithelial cell abnormality
mild epithelial dysplasia
RB-E2F Pathway Deregulation
DNA Adduct Formation
MAP2K4 Gene Inactivation
Monosomy 3p14 p11
Neuronal axonal change
Reactive cytologic changes
FGFR3 Gene Mutation
Abasic Site Formation
Endoplasmic reticulum alteration
Macromolecular defective synthesis
Duplication 1q42 qter
Bone matrix alteration
IGF2R Gene Inactivation
Mitochondria DNA deletion
Necrotic DNA Degradation
chromosome number abnormality
Cell content alteration
Balanced Chromosomal Rearrangement
Repeat Expansion, Trinucleotide
Trisomy 9 mosaic
Abnormal haematopoietic maturation
Deletion 3q21 23
GNAQ Gene Mutation
Deletion 2pter p24
Deletion 6q13 q15
CD10 mRNA Overexpression
CD140a Antigen Asp842Val
Monosomy 17q23 q24
p16 Gene Inactivation
Nucleotide Transition Abnormality
Monosomy 1q25 q32
ECT1 Gene Mutation
Trisomy 22q11 q13
Trisomy 2p13 p21
Single-Strand DNA Break
Rearrangement of 12q13
K-Ras 2 G13N
K-Ras 2 G13A
K-Ras 2 G13C
K-Ras 2 G13E
K-Ras 2 G13S
K-Ras 2 G13R
Balanced autosomal translocation
Viral Cell Proliferation
APC Gene Inactivation
Deletion 1p34 p32
Chromosome 8 ring
Chromosome uniparental disomy
N-RAS Gene Mutation
BEK Gene Amplification
Reticulum Stress, Endoplasmic
Additional sex chromosome
Proto-Oncogene c-ErbB-1 L747_A755del
GTPase KRas G12I
GTPase KRas G12N
GTPase KRas G12L
GTPase KRas G12C
GTPase KRas G12A
GTPase KRas G12F
GTPase KRas G12D
GTPase KRas G12Y
GTPase KRas G12R
GTPase KRas G12W
GTPase KRas G12V
Proto-Oncogene Neu A775_G776insYVMA
Ring 21, Chromosome
BRCA1 Gene Mutation
Protein Truncation Abnormality
RASSF1A Gene Inactivation
KRAS2 Gene Amplification
Golgi vacuole alteration
Deletion 1p22 p13
Cabot's ring body
PTEN Gene Mutation
c-fos Gene Amplification
Surface receptor alteration
CD332 Antigen Asn549His
PI3K Gene Mutation
Duplication 1q32 qter
Cell centre alteration
Cabot's ring bodies
Cell center alteration
Proto-Oncogene c-ErbB-1 P772_H773insTHP
Replication Error Phenotypes
AKT2 Gene Amplification
TNFRSF6 Gene Mutation
CD332 Antigen K659E
c-K-ras Gene Mutation
Trinucleotide Repeats, Expanded
Cytopathogenic Effects, Viral
Breaks, Double-Strand DNA
Numerical Chromosome Anomalies
Chromosome 13p duplication
Proto-Oncogene c-ErbB-1 L858W
Proto-Oncogene c-ErbB-1 L858P
Proto-Oncogene c-ErbB-1 L858R
Proto-Oncogene c-ErbB-1 L858M
Proto-Oncogene c-ErbB-1 L858K
Proto-Oncogene c-ErbB-1 L858G
Proto-Oncogene c-ErbB-1 L858A
NRAS NP_002515.1 :p.Gly13Xxx
PDL2 Gene Overexpression
THYROTROPIN, BIOLOGICALLY INACTIVE
PDCD1LG2 Gene Overexpression
Plasma membrane thickening
High-Frequency Microsatellite Instability
Proto-Oncogene c-ErbB-1 G719X
Proto-Oncogene c-ErbB-1 G719S
Abnormal megakaryocyte production
Proto-Oncogene c-ErbB-1 G719V
Proto-Oncogene c-ErbB-1 G719C
Proto-Oncogene c-ErbB-1 G719D
CDH1 Gene Inactivation
EGFR p. K29_n298insG
MDM2 Gene Mutation
PI3K Gene Amplification
Cancer Gene Mutation
Proto-Oncogene c-ErbB-1 L747del
CCND1 Gene Overexpression
TSC1 Gene Inactivation
FGF4 Gene Amplification
Unbalanced Chromosomal Alteration/Rearrangement
Triploidy and polyploidy
Mild Cytologic Atypia
Double-Strand DNA Break
PTEN Gene Inactivation
c-myc Gene Mutation
Ring 14 syndrome
NEU Gene Mutation
BCL2 Gene Translocation
Reactive endocervical cells
EGFR delta L747
PIK3CA E542 Mutation
Proto-Oncogene c-ErbB-1 D770_N771insDG
colorectal cancer genetics
Mild Epithelial Dysplasia
Mitochondrial DNA deletions
DNA Breaks, Single-Strand
Rearrangement of 6q25
Embryonic Lethal Mutation
Rearrangement of 1p11-13
Structural Chromosome Aberration
Trisomy 15 mosaicism
FGFR-2 Protein Variant
EGFR delta Glu746
MSX1 Gene Mutation
Trisomy 1q32 qter
Central neuronal chromatolysis
Multiple Transition Abnormalities
RECQL4 Gene Mutation
Proto-Oncogene c-ErbB-1 D770fs*61
Myelin body formation
Proto-Oncogene c-ErbB-1 E746del
ERBB c.2236_2237ins18
BCL-2 Translocation
Antibody-Dependent Enhancements
EGFR NP_005219.2:p.E746del
EGFR c.2156G>A
EGFR c.2156G>C
Mitotic alteration
EGFR Val774del
KRAS c.180_181delTCinsAA
C-H cell
abnormal chromosome
transneuronal degeneration
B-RAF1 c.1798G>A
B-RAF1 c.1798G>T
Axonal Reactions
EGFR p.Leu747del
Chromosomal Rearrangement
Polyploidy syndrome
ERBB c.2246_2260del15
K-SAM c.1647T>A
K-SAM c.1647T>G
EGFR NP_005219.2:p.Glu709fs*1
Monosomy 21q22
BRAF c.1797_1799delAGTinsGAG
NRAS1 c.183A>G
NRAS1 c.183A>C
ERBB1 c.2321_2322insCCACGT
NRAS1 c.183A>T
Trisomy 9q32
NRAS c.181_182delCAinsAG
BRAF NP_004324.2:p.L597V
C-KIT Mutation
BRAF NP_004324.2:p.L597R
BRAF NP_004324.2:p.L597S
BRAF NP_004324.2:p.L597Q
DNA Adduction
JAK2 p.V617F
BRAF NP_004324.2:p.G469V
BRAF NP_004324.2:p.G469S
BRAF NP_004324.2:p.G469R
BRAF NP_004324.2:p.G469E
BRAF NP_004324.2:p.G469A
EGFR NM_005228.3:c.2319_2320insAACCCCCAC
Imbalances, Allelic
EGFR p.V769_D770insMASVD
EGFR L747_S752del
EGFR S768_V769insVAS
Nucleolar enlargement
Disease-causing Mutation
ERBB c.2232_2233ins18
FGFR-2 Tyr375Cys
KRAS NP_004976.2:p.Gly12Ser
EGFR NM_005228.3:c.2246_2260del15
Deletion 6p23
EGFR NM_005228.3:c.2311_2312insTGGCCACCCCCA
Chromosome Fragility
ERBB c.2572C>A
PIK3CA NP_006209.2:p.Cys420Arg
KGFR Ser372Cys
EGFR NM_005228.3:c.2236_2237ins18
ERBB c.2572C>T
KRAS p.Gln61Glu
robertsonian translocation
KRAS NM_004985.3:c.180_181delTCinsAA
Monosomy 4p
EGFR NM_005228.3:c.2154_2155delGGinsTT
EGFR c.2311_2312ins9
HER1 c.2322_2322G>CCACGTG
FLT3/ITD Mutation
KRAS p.Gly13Cys
BRAF p.Val600Ala
Oncogene Fusion
Duplication 4p
BRAF NM_004333.4:c.1789C>G
Trisomy 3p25
EGFR R748_P753del
EGFR p.Gly719Ala
KRAS p.Gln61Arg
BRAF c.1396G>C
EGFR NM_005228.3:c.2125_2129delGAAAC
C-K-RAS c.34_35GG>AT
Proteostasis Dysfunctions
Unbalanced Translocation
Preneoplastic Change
PIK3CA c.3139C>T
PIK3CA His1047Gln
EGFR NP_005219.2:p.Asn771_Pro772insHis
EGFR NP_005219.2:p.L747_K754del
BRAF c.1789_1790CT>TC
PI3K c.1633G>A
FGFR-2 N549H
PI3K c.1633G>C
EGFR Leu861Val
JAK2 p.E985K
HER1 c.2235_2252del18
KRAS c.38_39GC>TG
Reaction, Axon
C-K-RAS c.35_36GT>AG
KRAS c.38_39GC>TT
Chromosomal instability
EGFR NM_005228.3:c.2257_2277del21
ERBB1 c.2156delG
JAK2 NP_004963.1:p.V617F
Trisomy Xp3
EGFR NP_005219.2:p.Pro772_His773insThrHisPro
EGFR p.P772_H773insTHP
NRAS1 c.181_183CAA>AAG
inversions pericentric
koilocytotic atypia
NRAS c.181_183delCAAinsAAG
Proteostasis Deficiencies
ERBB1 c.2239_2256del18
Genome Instabilities
EGFR NP_005219.2:p.R748_S752del
BRAF NP_004324.2:p.V600K
BRAF NP_004324.2:p.V600M
BRAF NP_004324.2:p.V600L
BRAF NP_004324.2:p.V600A
BRAF NP_004324.2:p.V600E
BRAF NP_004324.2:p.V600D
BRAF NP_004324.2:p.V600G
BRAF NP_004324.2:p.V600R
Deletion 2p22
EGFR p.Leu858Pro
Deletion 3p25
KRAS p.Gly12Leu
NRAS1 c.182A>T
Concentric hypertrophy
BRAF G466E
EGFR NM_005228.3:c.2156delG
BRAF G466A
NRAS1 c.182A>G
NRAS1 c.182A>C
BRAF G466V
BRAF G466R
NRAS NM_002524.4:c.182_183delAAinsTG
PIK3CA p.His1047Thr
Chromosome Abnormalities
Gene Insertions
KRAS2 c.39C>G
KRAS2 c.39C>A
chromosomes translocation
KRAS2 c.39C>T
Aberration, Chromosomal
BRAF c.1405_1406GG>TC
KRAS c.34_35delGGinsTA
EGFR c.2236_2250del15
KRAS c.34_35delGGinsTT
Autosome Abnormalities
NRAS NP_002515.1:p.Q61E
PDGFRA c.2525A>T
NRAS NP_002515.1:p.Q61L
Deletion, Chromosome
NRAS NP_002515.1:p.Q61H
NRAS NP_002515.1:p.Q61K
NRAS NP_002515.1:p.Q61P
NRAS NP_002515.1:p.Q61X
genomes instability
EGFR p.Y764_V765insHH
ERBB1 c.2154_2155GG>TT
Inversion Mutation
Pseudotrisomy 18
genome instability
hypersegmented neutrophil
EGFR c.2319_2320insCCCCAC
Insertions, Gene
KRAS Gln61Lys
EGFR NP_005219.2:p.V769_D770insMASVD
BRAF NP_004324.2:p.Val600Ala
moderate dysplasia
EGFR NP_005219.2:p.His773_Val774insAsnProHis
KRAS p.Gly12Arg
aplastic crisis
AKT c.49G>A
PIK3CA c.1634A>T
BRAF p.L597V
BRAF p.L597Q
BRAF p.L597R
BRAF p.L597S
Break, Chromosome
EGFR Val834del
Sequence Deletion
JAK2 p.M929I
BRAF p.Gly469Ala
Primary hypertrophy
EGFR NM_005228.3:c.2318_2319insCCCCCA
Golgi hypertrophy
EGFR c.2322_2322G>CCACGTG
EGFR c.2231_2232insTAAAATTCCCGTCGCTAT
concentric hypertrophy
EGFR p.A750_K754del
N-ras c.181_183CAA>AAG
Deletion 14qter
PIK3CA p.Glu545Ala
EGFR NP_005219.2:p.K745_E746insVPVAIK
ERBB c.2236_2253del18
KRAS NM_004985.3:c.180_181delTCinsCA
BRAF NP_004324.2:p.Gly466Glu
FGFR-2 S372C
KGFR S252W
isochromosome 12p
Duplication 6p
Duplication 6q
EGFR NP_005219.2:p.A750_K757del
Severe dysplasia
EGFR NP_005219.2:p.Leu747_Pro753del
EGFR p.G719S
BRAF NM_004333.4:c.1405G>A
Gastric metaplasia
EGFR NP_005219.2:p.N771_P772insN
EGFR NP_005219.2:p.N771_P772insH
Chromocentre alteration
Deletions, Sequence
Secondary degeneration
EGFR NP_005219.2:p.L747_S752del
EGFR NM_005228.3:c.2235_2252del18
EGFR P753_I759del
EGFR c.2307_2308ns9
FGFR2 Asn549His
EGFR NM_005228.3:c.2320_2321ins12
HER1 c.2236_2253del18
EGFR E746_R748del
NRAS c.183A>T
KRAS c.34_35GG>CT
NRAS c.183A>C
NRAS c.183A>G
KRAS2 c.182A>G
Mutations, Suppressor
KRAS2 c.182A>C
BRAF NP_004324.2:p.Gly469Ser
KRAS2 c.182A>T
Chromosome Aberration
EGFR T751_E758del
JAK2 NP_004963.1:p.Arg938Leu
EGFR G719D
EGFR G719C
EGFR G719A
EGFR G719V
Chromosomal Amplification
ERBB c.2319_2320insCAC
EGFR G719S
EGFR G719X
EGFR Leu858Ala
transition mutation
EGFR c.2236_2237insTTCCCGTCGCTATCAAGG
c-K-ras A146X
Robertsonian Translocation
KRAS NM_004985.3:c.37_38delGGinsAA
EGFR NP_005219.2:p.Leu747_Ala750del
KGFR c.1115C>G
INJ DNA
PIK3CA NP_006209.2:p.C420R
Monosomy 3q27
EGFR NP_005219.2:p.His773_Val774insGlyHis
C-K-RAS c.38G>C
BRAF p.Leu597Val
atypia inflammatory
EGFR NM_005228.3:c.2310_2311insGGGTTA
HER1 c.2239_2256del18
ERBB1 c.2253_2276del24
KRAS c.38G>T
JAK2 G935R
ERBB2 NM_004448.2p.2325_2326ins12
Degeneration, Trans-Synaptic
Mixed Mutations
KRAS c.38G>C
Gene Insertion
EGFR NP_005219.2:p.R748_P753del
virus pathogenesis
EGFR L861V
EGFR L861R
EGFR L861Q
EGFR L861P
EGFR NP_005219.2:p.Tyr764_Val765insHisHis
EGFR Leu858Trp
Inversion, Chromosome
EGFR NM_005228.3:c.2236_2253delGAATTAAGAGAAGCAACA
ERBB c.2309_2310ins14
Binucleate cell
Point Mutations
FGFR2 Cys382Arg
EGFR c.2307_2308ins15
FGFR2 c.1647T>A
Decreased elasticity
FGFR2 c.1647T>G
EGFR NP_005219.2:p.D770_N771insN
C-K-RAS c.35G>T
C-K-RAS c.35G>A
C-K-RAS c.35G>C
EGFR NP_005219.2:p.H773_V774insGH
DNA Injury
KGFR c.1975A>G
Stresses, Oxidative
Gastric Metaplasia
Double Minutes
new mutation
EGFR NM_005228.3:c.2322delGinsCCACGTG
KRAS Gly12Val
EGFR NP_005219.2:p.Asn756_Leu760del
B-RAF1 c.1396G>C
Chromosome breakage
Chromosome Anomalies
HER1 c.2315_2316insGACACACCC
JAK2 c.1848_1849delTGinsCT
EGFR NP_005219.2:p.Leu858Trp
Monosomy 12p11
EGFR NM_005228.3:c.2307_2308ins9
ERBB c.2313_2314insAAC
Tricentric chromosome
KRAS G12V
KRAS G12W
KRAS G12R
KRAS G12S
ERBB1 c.2290_2291ins12
KRAS G12Y
KRAS G12F
KRAS G12D
KRAS G12E
KRAS G12C
KRAS G12A
KRAS G12N
KRAS G12I
CEBPA Mutation
Duplication 16q
NRAS c.182A>C
KRAS2 c.183A>T
NRAS c.182A>G
Transition Mutations
Robertsonian translocation
KRAS2 c.183A>C
NRAS c.182A>T
KRAS c.34_35GG>AA
KRAS c.34_35GG>AT
Chromosomal Inversion
JAK2 M929I
EGFR NM_005228.3:c.2309_2310delACinsCCAGCGTGGAT
EGFR NM_005228.3:c.2239_2253del15
Heterodisomy, Uniparental
HER-2/neu c.2324_2325ins12
FGFR2 c.1144T>C
KRAS NM_004985.3:c.34G>T
KRAS NM_004985.3:c.34G>A
KRAS NM_004985.3:c.34G>C
Degeneration, Retrograde
K-SAM c.1645A>C
EGFR NM_005228.3:c.2572_2573delCTinsAG
Degenerations, Trans-Synaptic
HER2 c.2325_2326ins12
KRAS NP_004976.2:p.Gln61His
EGFR p.Leu858Trp
Chromosome Abnormality
TRK Rearrangement
Duplication 9q32
C-K-RAS c.34_36GGT>TGG
EGFR NP_005219.2:p.D770_N771insAPW
abnormal chromosomes
EGFR c.2239_2247del9
CD332 c.758C>G
HER2 c.2324_2325ins12
p110alpha E545X
p110alpha E545Q
p110alpha E545V
Nonsense Mutation
p110alpha E545K
NRAS NM_002524.4:c.180_181delACinsTA
p110alpha E545A
p110alpha E545D
p110alpha E545G
BRAF p.G469S
BRAF p.G469R
BRAF p.G469V
BRAF p.G469A
EGFR NP_005219.2:p.Val769_Asp770insGlySerVal
BRAF p.G469E
Koilocytotic Atypia
EGFR NP_005219.2:p.Asp761_Glu762insGluAlaPheGln
JAK2 V617F
HER1 c.2156delG
EGFR S752_V769del
Pathology, Cellular
EGFR E746_S752del
EGFR Thr790Met
BRAF NM_004333.4:c.1790T>G
Aberrant Chromosome
ERBB1 c.2309_2310AC>CCAGCGTGGAT
EGFR NP_005219.2:p.V769_D770insCV
EGFR p.V769_D770insCV
Chromosomal Translocations
Trisomy Xq
tubular aggregates
FGFR2 p.Asn549Lys
Lymphocyte destruction
PIK3CA NP_006209.2:p.E545K
PIK3CA NP_006209.2:p.E545D
PIK3CA NP_006209.2:p.E545G
Cytocentrum alteration
PIK3CA NP_006209.2:p.E545A
PIK3CA NP_006209.2:p.E545X
PIK3CA NP_006209.2:p.E545V
PIK3CA NP_006209.2:p.E545Q
KRAS1 c.38_39GC>AA
EGFR E746_A750del
KRAS1 c.38_39GC>AG
Abnormality, Autosome
KRAS1 c.38_39GC>AT
PI3K c.1258T>C
NRAS Gln61Pro
FGFR2 p.Y375C
axotomy response
EGFR p.D770_N771insDG
EGFR NP_005219.2:p.Thr790Met
BRAF Gly466Ala
EGFR c.2308_2309ins9
B-RAF1 c.1789C>G
Radiation-Induced Recombination
PDGFRA p.Asp842Val
C-K-RAS C.36T>C
ECT1 c.1144T>C
KRAS NM_004985.3:c.35_36delGTinsAA
KRAS NM_004985.3:c.35_36delGTinsAC
KRAS NM_004985.3:c.35_36delGTinsAG
HER1 c.2246_2260del15
EGFR c.2303_2304insTGTGGCCAG
KRAS NM_004985.3:c.39C>A
EGFR c.2308_2309insCCAGCGTGG
EGFR NM_005228.3:c.2320_2321insGCAACCCCCACG
BRAF c.1789C>G
degeneration nerves
B-RAF1 c.1789_1790CT>TC
B-RAF1 c.1799T>G
B-RAF1 c.1799T>C
B-RAF1 c.1799T>A
PPAR-gamma Rearrangement
BRAF Leu597Val
EGFR c.2572_2573CT>AA
EGFR c.2572_2573CT>AG
EGFR L747_A755del
Compensatory hypertrophy
EGFR p.Leu858Arg
Mutation, Nonsense
KRAS NM_004985.3:c.182A>C
Protein Deregulation
HER1 c.2309_2310AC>CCAGCGTGGAT
FGFR2 NM_000141.4:c.1647T>A
FGFR2 NM_000141.4:c.1647T>G
KRAS NM_004985.3:c.182A>G
c-K-ras G13N
c-K-ras G13C
c-K-ras G13A
c-K-ras G13E
c-K-ras G13D
EGFR NP_005219.2:p.Ser768_Val769insAlaTrpThr
c-K-ras G13S
c-K-ras G13R
AKT1 NP_001014431.1:p.Glu17Lys
PTTG1 Overexpression
Dicentric chromosome
FGFR2 NP_000132.3:p.P253R
BRAF p.Val600Gly
Epithelial metaplasia
JAK2 NP_004963.1:p.Y931C
ERBB c.2322_2322G>CCACGTG
BRAF p.Val600Glu
C-K-RAS c.37_39GGC>CGT
C-K-RAS c.183A>T
Monosomy 6p23
C-K-RAS c.183A>C
Proto-Oncogene c-ErbB-1D770_N771insAPW
C-K-RAS c.39C>T
C-K-RAS c.39C>G
EGFR c.2310_2311insAGCGTGGAC
C-K-RAS c.39C>A
EGFR NM_005228.3:c.2307_2308ins15
Epidermoid metaplasia
PIK3CA p.E542G
PIK3CA p.E542K
PIK3CA p.E542Q
PIK3CA p.E542V
PIK3CA p.E542X
Injuries, DNA
BRAF c.1799T>C
BRAF c.1799T>A
BRAF c.1799T>G
NP_002515.1 :p.Gln61Xxx
PDGFRA Asp842Val
B-RAF1 c.1790T>A
B-RAF1 c.1790T>G
ERBB c.2235_2252del18
EGFR NM_005228.3:c.2311_2312insGCGTGGACA
Monosomy 5p
KRAS c.35_36delGTinsTC
EGFR p.I740_P741insPVAIKI
Nuclear degeneration
EGFR NP_005219.2:p.L747_T751del
EGFR NP_005219.2:p.E746_A750del
EGFR NP_005219.2:p.H773_V774insH
Focal dysplasia
EGFR NP_005219.2:p.H773_V774insG
Degenerations, Neuron
Inflammatory atypia
EGFR NP_005219.2:p.Met766_Ala767insAlaIle
EGFR c.2309_2310ins14
Chromosomal Duplications
Degeneration, Nerve
EGFR NP_005219.2:p.Asp770_Asn771insSerValAsp
ERBB c.2310_2311insAAC
PIK3CA NM_006218.1:c.3140A>G
KRAS NP_004976.2:p.Gly12Tyr
C-K-RAS c.37G>C
C-K-RAS c.37G>A
EGFR NP_005219.2:p.Val769_Asp770insGlyVal
PIK3CA NM_006218.1:c.3140A>T
ERBB1 c.2311_2312ins9
Centriole alteration
Stresses, Genotoxic
ERBB1 c.2319_2320insCAC
Nick, DNA
C-K-RAS c.34_35GG>AA
NRAS NP_002515.1:p.G12X
EGFR NP_005219.2:p.Asp770_Asn771insAspGly
KRAS NP_004976.2:p.Q61X
ERBB1 c.2235_2246del12
HER1 c.2310_2311ins9
KRAS NP_004976.2:p.Q61P
KRAS NP_004976.2:p.Q61R
PTEN Loss
KRAS NP_004976.2:p.Q61H
KRAS NP_004976.2:p.Q61K
KRAS NP_004976.2:p.Q61L
KRAS NP_004976.2:p.Q61E
KRAS NP_004976.2:p.Q61D
Secondary hypertrophy
EGFR NP_005219.2:p.L747_A755del
KRAS Gly13Ser
HER1 c.2231_2232ins18
Golgi hyperplasia
ERBB2 NM_004448.2p.2324_2325ins12
Gene Amplification
Cytoplasmic alteration
EGFR NM_005228.3:c.2310_2311ins9
EGFR c.2253_2276del24
NRAS1 c.182_183AA>GG
FGFR2 NP_000132.3:p.Tyr375Cys
FGFR2 NM_000141.4:c.1975A>G
Cytogenetic Abnormalities
FGFR-2 N549K
EGFR NP_005219.2:p.M766_A767insAI
PIK3CA p.H1047L
chromosome abnormalities
PIK3CA p.H1047R
PIK3CA p.H1047T
PDGFR2 c.2525A>T
EGFR NM_005228.3:c.2319_2320ins9
ERBB c.2310_2311insGGGTTA
HER1 c.2247_2273del27
KRAS p.Q61R
Oncogene Fusions
KRAS p.Q61P
KRAS p.Q61X
KRAS p.Q61D
KRAS p.Q61E
KRAS p.Q61L
KRAS p.Q61K
KRAS p.Q61H
NRAS Gln61Arg
ERBB c.2155G>T
ERBB c.2155G>A
JAK-2 c.1849G>T
EGFR p.Leu858Ala
oncocytic metaplasia
FGFR-2 Y375C
Atypical dysplasia
KRAS1 c.38G>T
BRAF NM_004333.4:c.1797_1799delAGTinsGAG
KRAS1 c.38G>C
KRAS1 c.38G>A
C-K-RAS c.182A>G
C-K-RAS c.182A>C
Duplication 3p25
ERBB c.2231_2232ins18
C-K-RAS c.182A>T
Trans-Synaptic Degenerations
KRAS Gly12Asp
KRAS Gly12Asn
EGFR P772_H773insDNP
PIK3CA Glu542Val
EGFR p.N771_P772insN
EGFR p.N771_P772insH
chromosomal translocations
EGFR c.2302_2303insTCCAGGAAGCCT
EGFR c.2235_2252del18
chromosomal anomalies
C-K-RAS c.38G>A
C-K-RAS c.38G>T
suppressor mutation
KRAS c.38G>A
HER1 c.2311_2312ins12
Mutation, Point
KRAS p.Gly12Phe
ERBB c.2302_2303ins9
Polysomy 3
null allele
ERBB c.2320_2321ins12
transversion mutation
KRAS1 c.34_35GG>TA
KGFR Y375C
Chromosomal Deletion
KI-RAS c.35G>T
CASP8 Mutation
KI-RAS c.35G>C
KI-RAS c.35G>A
KRAS NP_004976.2:p.Gln61Glu
Physiologic hypertrophy
Trisomy, XXY
ERBB1 c.2254_2277del24
Temperature-sensitive mutation
BRAF NM_004333.4:c.1790T>A
KRAS c.38_39delGCinsTG
PIK3CA Glu545Asp
KRAS c.38_39delGCinsTT
HEMOPOIETIC PROLIFERATION
axon chromatolysis
FGFR2 NM_000141.4:c.1124A>G
EGFR c.2311_2312insTGGCCACCCCCA
Cytoplasmic aggregate
Monosomy 3p2
EGFR Leu858Lys
EGFR p.L858W
BEK c.1115C>G
ERBB1 c.2283_2284ins12
EGFR NM_005228.3:c.2573_2574delTGinsGT
HER1 c.2238_2252del15
EGFR c.2319_2320insAACCCCCAC
EGFR NP_005219.2:p.Lys745_Glu749del
EGFR NP_005219.2:p.Val765_Met766insMetAlaSer
EGFR NM_005228.3:c.2155G>T
EGFR NM_005228.3:c.2155G>A
genetic translocation
EGFR L858A
EGFR L858G
EGFR NP_005219.2:p.V769_D770insGV
EGFR L858K
EGFR L858M
EGFR p.R748_S752del
EGFR L858R
EGFR L858Q
EGFR L858P
EGFR L858W
Abnormality, Chromosome
pericentric inversion
EGFR NP_005219.2:p.P753_I759del
HER1 c.2154_2155GG>TT
BRAF NM_004333.4:c.1799_1800delTGinsAA
Trisomy 21
BRAF NM_004333.4:c.1799_1800delTGinsAT
EGFR NP_005219.2:p.K745_L747del
Translocation, Genetic
KRAS Gln61Glu
EGFR p.V774del
EGFR NM_005228.3:c.2239_2256del18
EGFR K745_L747del
ERBB c.2315_2316insGACACACCC
HER1 c.2572_2573CT>AA
KRAS NP_004976.2:p.Ala146Xxx
Gene Deletion
HER1 c.2572_2573CT>AG
Deletion 2q24
EGFR NP_005219.2:p.Asn771_Pro772insAsn
EGFR p.R748_P753del
dna damage
HER1 c.2310_2311insGGGTTA
KRAS p.G12Y
KRAS p.G12V
KRAS p.G12W
KRAS p.G12R
KRAS p.G12S
KRAS p.G12N
KRAS p.G12L
KRAS p.G12F
HER1 c.2307_2308ins15
KRAS p.G12E
KRAS p.G12C
EGFR p.H773_V774insPH
ERBB c.2319_2320ins9
KRAS1 c.39C>G
KRAS1 c.39C>A
EGFR NM_005228.3:c.2310_2311insGGGGAC
Deletion 20p
KRAS1 c.39C>T
KRAS1 c.180_181TC>AA
NRAS NM_002524.4:c.182_183delAAinsGG
EGFR NM_005228.3:c.2309_2310ins14
KRAS Gln61Xxx
ERBB1 c.2318_2319insCCCCCA
ERBB c.2290_2291ins12
KRAS c.180_181TC>CA
KRAS p.Gly12Asp
founder mutation
Trisomy 13p
Duplication 18p
PIK3CA p.Glu542Val
EGFR H773_V774insH
EGFR p.D770fs*61
Isodicentric Chromosome
EGFR NP_005219.2:p.L861V
EGFR NP_005219.2:p.L861R
EGFR NP_005219.2:p.L861Q
EGFR NP_005219.2:p.L861P
EGFR NP_005219.2:p.L861F
EGFR T790M
EGFR NP_005219.2:p.Leu858Pro
ERBB c.2235_2246del12
Instabilities, Genome
Flagella alteration
HER1 c.2236_2250del15
Microtubule alteration
NRAS Q61X
NRAS Q61R
KRAS p.G12I
NRAS Q61K
NRAS Q61H
NRAS Q61L
KRAS NP_004976.2:p.Gly12Leu
EGFR NM_005228.3:c.2235_2246del12
Germline Mutation
KRAS p.G12D
NRAS Q61E
BRAF V600R
BRAF V600A
BRAF V600G
BRAF V600E
BRAF V600D
BRAF V600K
KRAS p.G12A
BRAF V600M
BRAF V600L
Degeneration, Wallerian
NRAS1 c.181_182CA>AG
Monosomy 17
Monosomy 16
Monosomy 13
Monosomy 11
Monosomy 10
Chromosomal Abnormality
KGFR C382R
dysplasia severe
HER1 c.2573T>G
cells damage
ERBB1 c.2239_2253del15
Hypersegmented nucleus
Y-chromosome microdeletions
EGFR NM_005228.3:c.2308_2309insACGGCG
KRAS Gly12Ile
point mutations
EGFR NP_005219.2:p.Lys745_Leu747del
EGFR NM_005228.3:c.2239_2247delTTAAGAGAA
EGFR p.V834del
KRAS NP_004976.2:p.Gly12Cys
EGFR Leu858Met
EGFR NM_005228.3:c.2311_2312ins12
ERBB1 c.2302_2303ins9
EGFR p.Thr790Met
KRAS c.34_35GG>TA
KRAS c.34_35GG>TT
Instability, Chromosomal
KRAS Gly12Ala
ERBB1 c.2310_2311insAAC
EGFR c.2246_2260del15
Aberration, Cytogenetic
EGFR p.V769_D770insASV
ERBB c.2154_2155GG>TT
PIK3CA p.Glu545Gly
p110alpha H1047X
p110alpha H1047Y
p110alpha H1047T
p110alpha H1047R
p110alpha H1047Q
p110alpha H1047L
KRAS p.Gln61Asp
ECT1 c.1124A>G
FGFR2 p.K659E
BRAF c.1799_1800TG>AA
BRAF c.1799_1800TG>AT
KRAS1 c.180_181TC>CA
ERBB1 c.2310_2311ins9
EGFR NM_005228.3:c.2303_2304insTGTGGCCAG
EGFR c.2156delG
EGFR Gly719Ser
Abnormalities, Chromosome
ERBB c.2219_2220ins18
FGFR2 S252W
KRAS c.180_181TC>AA
Monosomy 6q1
Monosomy 6q2
EGFR c.2235_2246del12
NRAS c.182_183delAAinsGG
EGFR NM_005228.3:c.2369C>T
NRAS Gln61Glu
KRAS Gly12Cys
EGFR NP_005219.2:p.S752_V769del
BRAF NP_004324.2:p.Val600Met
KGFR K659E
chromosomal aberration
EGFR NP_005219.2:p.Asp770_Asn771insGlyLeu
BRAF NM_004333.4:c.1406G>T
FGFR2 Ser252Trp
BRAF NM_004333.4:c.1406G>C
BRAF NM_004333.4:c.1406G>A
Monosomy 1q4
EGFR NM_005228.3:c.2307_2308insATGGCCAGCGTGGAC
HER1 c.2125_2129delGAAAC
Out-of-Frame Mutations
HER1 c.2233_2247del15
cemental dysplasia
EGFR c.2320_2321insGCAACCCCCACG
Cytogenetic Aberrations
ERBB1 c.2239_2262del24
ERBB1 c.2320_2321ins12
EGFR NP_005219.2:p.H773_V774insPH
Monosomy 2q24
Deletion 1q4
Founder Mutation
BRAF c.1798_1799GT>AG
CD117 Mutation
EGFR Leu858Gly
KRAS1 c.37G>T
EGFR Leu858Gln
KRAS1 c.37G>C
KRAS1 c.37G>A
chromosome deletion
EGFR p.T751_E758del
KRAS c.37_39GGC>CGT
KI-RAS c.34_36GGT>TGG
KI-RAS c.34_36GGT>TGC
dysplasia moderate
PDGFRA NM_006206.4:c.2525A>T
ERBB c.2572_2573delCTinsAA
B-RAF1 c.1797_1799AGT>GAG
KRAS2 c.38G>A
EGFR NP_005219.2:p.D770fs*61
Mitochondrial vacuolation
EGFR D770_N771insG
EGFR D770_N771insD
EGFR D770_N771insN
NRAS NP_002515.1:p.Q61R
neuron degeneration
Lysosome alteration
HER1 c.2155G>A
Tetrasomy 7
Trisomy 6q
Trisomy 6p
HER1 c.2155G>T
Axon Reaction
KRAS p.Gly12Glu
DNA injury
ERBB c.2254_2277del24
PIK3CA Glu542Xxx
KRAS NM_004985.3:c.181C>G
KRAS NM_004985.3:c.181C>A
Transversion Mutations
Nuclear alteration
Hyaline plaque
KRAS G12L
BRAF p.Gly469Val
ERBB c.2298_2299insGCCATA
BRAF Gly466Glu
EGFR NP_005219.2:p.Leu861Gln
EGFR NP_005219.2:p.Glu746_Glu749del
B-RAF1 c.1791A>G
PI3Kalpha C420R
NRAS p.G13X
Sequence Inversions
BRAF c.1790T>G
Gene Abnormality
EGFR NP_005219.2:p.His773_Val774insHis
B-RAF1 c.1798_1799GT>AA
PIK3CA Glu542Gly
EGFR c.2320_2321ins12
PIK3CA Glu542Gln
EGFR NP_005219.2:p.Asp770_Asn771insGly
BEK c.758C>G
JAK2 p.Y931C
KRAS c.34_35delGGinsCT
ERBB1 c.2308_2309ins9
Autosome Abnormality
Nissl degeneration
HER1 c.2319_2320insCAC
KRAS c.34_36delGGTinsTGG
Desmosome alteration
KRAS c.34_36delGGTinsTGC
EGFR D770fs*61
EGFR NM_005228.3:c.2322_2323insCACGTG
BRCA2 Mutation
EGFR P772_H773insDHP
NRAS p.Gln61Leu
nerve degeneration
Protein Truncation
ERBB1 c.2233_2247del15
EGFR p.V769_D770insGV
HER1 c.2311_2312ins9
EGFR p.E746del
BRAF NM_004333.4:c.1405_1407delGGAinsAGT
DNA Crosslink
NRAS c.180_181delACinsTA
BRAF NM_004333.4:c.1405_1407delGGAinsAGC
EGFR A750_K754del
cell damage
Nicks, DNA
Deletion 7q21
EGFR NP_005219.2:p.A750_E758del
Mild Dysplasia
PI3Kalpha E545K
PI3Kalpha E545A
PI3Kalpha E545G
PI3Kalpha E545D
PI3Kalpha E545X
Point Mutation
EGFR c.2319_2320insCAC
PI3Kalpha E545Q
PI3Kalpha E545V
JAK2 c.1848_1849TG>CT
Defective phagocytosis
Deletion 3q13
EGFR c.2310_2311insGCACCGTGG
Monosomy 1p32
NRAS p.Gln61Glu
JAK2 E985K
EGFR NM_005228.3:c.2253_2276del24
degeneration neurons
KRAS NP_004976.2:p.Gly13Val
KRAS p.Gln61Leu
Pappenheimer bodies
EGFR NP_005219.2:p.P772_H773insPR
Granulocyte destruction
Imbalance, Allelic
ERBB1 c.2310_2311insGGT
ERBB1 c.2310_2311insGGC
EGFR L747_A750del
Duplication 20p
Trisomies, XXY
EGFR P772_H773insPR
KRAS Gly13Arg
KRAS c.34G>A
KRAS c.34G>C
EGFR NP_005219.2:p.D770_N771insDG
PIK3CA c.1634A>G
KRAS c.34G>T
ERBB c.2307_2308ins9
Oxidative stress
EGFR V769_D770insGVV
PIK3CA Glu545Lys
ERBB c.2311_2312ins9
PIK3CA p.Glu542Lys
Sequences, Inverted
Uniparental Isodisomies
EGFR p.H773_V774insNPH
ERBB1 c.2307_2308ins15
NRAS Q61P
HER1 c.2318_2319insCCCCCA
KRAS p.Gly12Val
Proteostasis Dysfunction
NRAS Gln61Xxx
EGFR V769_D770insGV
EGFR NP_005219.2:p.Leu858Gly
EGFR NP_005219.2:p.Leu858Gln
Epithelial Metaplasia
B-RAF1 c.1405G>A
B-RAF1 c.1405G>C
XXY trisomy
KRAS1 c.37_39GGC>CGT
EGFR NP_005219.2:p.E746_T751del
EGFR NP_005219.2:p.H773_V774insNPH
KRAS c.34_35delGGinsAA
Chediak-Higashi cell
KRAS c.34_35delGGinsAT
BRAF NM_004333.4:c.1798_1799delGTinsAG
KRAS2 c.34_36GGT>TGC
EGFR NP_005219.2:p.Leu858Arg
EGFR c.2232_2233insAAAATTCCCGTCGCTATC
chromosome mutations
Haemolytic crisis
Synovial metaplasia
BRAF NP_004324.2:p.Gly466Ala
HER1 c.2240_2254del15
KRAS1 c.35G>T
KRAS1 c.35G>C
EGFR p.P772_H773insDHP
KRAS c.35_36delGTinsAG
KRAS c.35_36delGTinsAA
KRAS c.35_36delGTinsAC
p110-alpha c.1258T>C
PIK3CA NP_006209.2:p.His1047Leu
JAK2 p.Ile960Val
KRAS c.38_39delGCinsAA
EGFR NP_005219.2:p.K29_N298insG
KRAS c.38_39delGCinsAG
EGFR p.L747_S752del
KRAS c.38_39delGCinsAT
Enhancement, Antibody-Dependent
chromosome deletions
BRAF Leu597Gln
EGFR p.A767_S768insTLA
BRAF NM_004333.4:c.1798G>T
HER1 c.2253_2276del24
BRAF NM_004333.4:c.1798G>A
Cytogenetic Abnormality
FLT3-TKD Mutation
Heterodisomies, Uniparental
FGFR2 p.Pro253Arg
NP_002515.1 :p.Gly12Xxx
Duplication 2q37
EGFR NP_005219.2:p.Y764_V765insHH
Fragility, Chromosome
cellular atypia
HER1 c.2310_2311insGGT
HER1 c.2310_2311insGGC
Monosomy, Partial
PIK3CA His1047Tyr
Degenerations, Nerve
BRAF Val600Ala
EGFR NP_005219.2:p.Val774_Cys775insHisVal
CBFalpha2 Mutation
EGFR c.2240_2254del15
Chromosome Translocation
KGFR c.755C>G
translocation robertsonian
EGFR c.2239_2253del15
NRAS c.180_181AC>TA
partial monosomy
EGFR c.2315_2316insGACACACCC
NRAS1 c.182_183AA>TG
Aberrations, Cytogenetic
HER1 c.2298_2299insGCCATA
Reaction, Axonal
Instability, Chromosome
Fused cristae
deletion chromosome
C-K-RAS c.34_35GG>TT
CD332 c.1115C>G
EGFR p.H773_V774insGH
KRAS1 c.34_36GGT>TGC
KRAS1 c.34_36GGT>TGG
KRAS Gln61Arg
Partial Monosomy
EGFR p.H773_V774insG
ECT1 c.1645A>C
EGFR p.H773_V774insH
Papillary proliferation
ERBB1 c.2572C>T
Paracentric Inversion
K-SAM c.1975A>G
ERBB1 c.2369C>T
KRAS NM_004985.3:c.38G>T
Chromosomal Duplication
FGFR2 NM_000141.4:c.755C>G
Epithelial pearl
EGFR NP_005219.2:p.L747_E749del
EGFR NP_005219.2:p.Val769_Asp770insCysVal
ERBB1 c.2156G>C
ERBB1 c.2156G>A
translocation reciprocal
Chromosomal Aberrations
EGFR p.E746_S752del
EGFR p.E746_P753del
EGFR p.I744_K745insKIPVAI
Null Allele
PIK3CA Glu545Val
Warburg Effect
RHEPDGFRA c.2525A>T
EGFR NP_005219.2:p.V769_D770insGSV
Monosomy 3p25
disorders mosaicism
Abnormality, Cytogenetic
Axonal swelling
KRAS p.Gly12Tyr
EGFR NM_005228.3:c.2240_2254delTAAGAGAAGCAACAT
XXY Trisomies
Cytologic Atypia
HER1 c.2573T>A
Replication Error
PIK3CA NP_006209.2:p.His1047Arg
Deletion 1p32
C-K-RAS c.38_39GC>TG
Monosomy 7
Monosomy 6
Monosomy 5
Monosomy 3
Monosomy 9
Monosomy 8
KI-RAS c.37_38GG>AA
FGFR-2 Asn549Lys
ERBB c.2572_2573CT>AA
ERBB c.2572_2573CT>AG
KRAS NP_004976.2:p.Gln61Leu
Monosomy 7q3
Monosomy 7q2
KRAS p.Gly13Arg
Derivative Chromosome
KGFR Asn549Lys
Sequence Inversion
BRAF p.G466V
BRAF p.G466R
BRAF p.G466E
BRAF p.G466A
EGFR NM_005228.3:c.2303_2304ins9
Dicentric Chromosome
NRAS1 c.180_181AC>TA
EGFR c.2235_2249del15
Hypersegmented neutrophils
N-ras c.180_181AC>TA
KGFR c.1645A>C
EGFR c.2310_2311insGGGGAC
FGFR2 NM_000141.4:c.1144T>C
PIK3CA NM_006218.1:c.1635G>T
Fibrocystic changes
PIK3CA NM_006218.1:c.1635G>C
Cytologic atypia
KRAS p.Gly13Glu
degeneration secondary
EGFR Leu861Arg
p110-alpha c.1634A>T
p110-alpha c.1634A>C
p110-alpha c.1634A>G
Insertion, Gene
NRAS p.Gln61Arg
deleterious mutation
FLT3-JM-PM Mutation
NRAS NM_002524.4:c.181_182delCAinsTT
FGFR-2 Ser252Trp
PIK3CA NP_006209.2:p.His1047Gln
KRAS1 c.35_36GT>AC
KRAS1 c.35_36GT>AA
KRAS1 c.35_36GT>AG
BRAF NP_004324.2:p.Val600Glu
BRAF NP_004324.2:p.Val600Gly
Glandular Metaplasia
Deletion 4q32
EGFR c.2250_2273del24
Genome Instability
gastric metaplasia
PI3K c.3140A>G
EGFR NP_005219.2:p.Leu861Val
EGFR NM_005228.3:c.2581C>G
PI3K c.3140A>T
Cemental dysplasia
ERBB1 c.2250_2273del24
atypical cell
marker chromosome
Chromosomal Breakage
Chromosome Instabilities
Allelic Imbalance
FGFR-2 Lys659Glu
Markers, Chromosome
Isochromosome 7q
ERBB1 c.2322_2323insCACGTG
JAK2 p.I960V
EGFR NP_005219.2:p.E746_E749del
EGFR NP_005219.2:p.T790M
Patch formation
Duplication, Chromosomal
B-RAF1 c.1397G>T
B-RAF1 c.1397G>C
B-RAF1 c.1397G>A
BRAF c.1799_1800delTGinsAT
B-RAF1 c.1798_1799GT>AG
BRAF c.1799_1800delTGinsAA
Monosomy 11p
Hemolytic crisis
Genetic inversion
Chromosome Marker
genetic inversion
Chromosome Break
EGFR p.E746_E749del
EGFR NP_005219.2:p.Gly719Cys
Deletion 12p13
Deletion 11p
PIK3CA E542Q
PIK3CA E542V
AKT1 p.Glu17Lys
PIK3CA E542X
PIK3CA E542K
Trisomy 14qter
EGFR NM_005228.3:c.2240_2254del15
KRAS Gln61Pro
KRAS c.37_38delGGinsAA
PAX5-IGH Translocation
PIK3CA NP_006209.2:p.Glu545Ala
JAK2 NP_004963.1:p.M929I
Point mutation
KRAS1 c.183A>T
ERBB c.2319_2320insCCCCAC
Dominant Negative
PIK3CA p.His1047Gln
KRAS p.Gly12Ser
KRAS C.36T>C
ERBB1 c.2236_2253del18
CD140A c.2525A>T
EGFR Leu747del
EGFR p.Leu861Val
Damage, DNA
EGFR Gly719Xxx
EGFR c.2233_2247del15
KGFR S372C
Diploid-Triploid Mosaicism
EGFR p.L747_A755del
ECT1 c.755C>G
EGFR NP_005219.2:p.I789_L792del
JAK2 NM_004972.3:c.1849G>T
p110alpha E542K
EGFR NP_005219.2:p.Leu747del
JAK2 p.Gly935Arg
EGFR NM_005228.3:c.2309_2310insATGGCCAGCGTGGA
cabot ring
NRAS p.Gly13Xxx
EGFR NP_005219.2:p.Asp770_Asn771insAsp
EGFR NP_005219.2:p.Asp770_Asn771insAsn
Dominant-Negative Mutant
BRAF Leu597Arg
Chromosome Breakage
BRAF p.Leu597Gln
Chromosome Markers
Monosomy 5q35
EGFR NP_005219.2:p.I740_P741insPVAIKI
DNA Nick
BRAF NP_004324.2:p.Leu597Gln
Polysome alteration
EGFR c.2290_2291ins12
HER1 c.2239_2253del15
PIK3CA c.1625A>G
PIK3CA c.1625A>T
Severe Dysplasia
Duplication 4q21
hypersegmented neutrophils
EGFR Leu861Pro
BRAF c.1789_1790delCTinsTC
EGFR H773_V774insPH
Cytoplasmic hyalinisation
EGFR NP_005219.2:p.Ser752_Val769del
Aberrations, Chromosome
chromosomes marker
KRAS2 c.35G>T
KRAS NP_004976.2:p.Gly12Ala
KRAS2 c.35G>C
KRAS2 c.35G>A
ERBB c.2156delG
Inversion, Sequence
Monosomy 2p22
cellular pathology
ERBB1 c.2307_2308ins9
ERBB2 c.2324_2325insATACGTGATGGC
KGFR N549K
KGFR N549H
EGFR V769_D770insCV
ERBB c.2235_2249del15
KRAS NP_004976.2:p.Gly13Arg
chromosome abnormality
HER1 c.2572C>T
BRAF NP_004324.2:p.Gly469Val
Monosomy 13q
EGFR NM_005228.3:c.2572C>T
EGFR NM_005228.3:c.2572C>A
Tubular aggregates
ERBB1 c.2315_2316insGACACACCC
FGFR2 NP_000132.3:p.Ser252Trp
EGFR NM_005228.3:c.2239_2247del9
Reciprocal Translocation
PIK3CA p.Glu545Gln
KRAS NP_004976.2:p.Gln61Pro
Axonal Reaction
KRAS2 c.181C>G
KRAS2 c.181C>A
Stress, Oxidative
Marker, Chromosome
Mutations, Nonsense
KRAS c.34_36GGT>TGG
KRAS c.34_36GGT>TGC
PIK3CA Glu542Lys
EGFR p.E746_T751del
PIK3CA NM_006218.1:c.1633G>C
PIK3CA NM_006218.1:c.1633G>A
BRAF p.Leu597Arg
JAK2 I960V
JAK2 NM_004972.3:c.2792A>G
EGFR NM_005228.3:c.2302_2303insTCCAGGAAGCCT
Allelic Imbalances
FGFR2 p.C382R
Monosomy 18q23
KGFR c.1124A>G
ERBB c.2321_2322insCCACGT
EGFR p.K745_E746insVPVAIK
EGFR NM_005228.3:c.2231_2232ins18
EGFR NM_005228.3:c.2254_2277delTCTCCGAAAGCCAACAAGGAAATC
FGFR2 NM_000141.4:c.1115C>G
Deletion 7q2
Deletion 7q3
Instabilities, Chromosome
KRAS2 c.34_35GG>CT
EGFR NP_005219.2:p.S768_V769insVAS
EGFR c.2154_2155delGGinsTT
EGFR c.2283_2284insGAAGCCTTCCAG
BRAF p.Gly466Val
KGFR Cys382Arg
Chromosome inversion
KRAS1 c.38_39GC>TT
EGFR NP_005219.2:p.His773_Val774insGlyAsnProHis
C/EBPalpha Mutation
KRAS1 c.38_39GC>TG
EGFR p.Val774del
NRAS G12X
EGFR NM_005228.3:c.2311_2312ins9
Deletions, Chromosome
Mitochondrial alteration
KRAS c.182A>G
JTK10 c.1848_1849TG>CT
BRAF NP_004324.2:p.Val600Arg
FGFR-2 C382R
EGFR NP_005219.2:p.V774_C775insHV
ABNORM AUTOSOME
BRAF c.1406G>A
ERBB1 c.2155G>A
FGFR2 p.S372C
BRAF c.1406G>T
Golgi enlargement
EGFR NP_005219.2:p.K745_A750del
KRAS Gly13Glu
Transversion Mutation
FGFR2 p.Ser372Cys
Mechanical fragility
Chromatid break
HER1 c.2310_2311insAACCCCCAC
Allele Imbalance
Chromocenter alteration
chromosomal translocation
JAK-2 c.1848_1849TG>CT
EGFR L747_K754del
Genomic Instability
EGFR p.V774_C775insHV
HER1 c.2250_2273del24
wallerian degeneration
BRAF NM_004333.4:c.1397G>T
Deficiency, Proteostasis
EGFR c.2310_2311insGGGTTA
EGFR p.I789_L792del
BRAF NM_004333.4:c.1396G>C
cell injury
FGFR2 NM_000141.4:c.758C>G
ERBB c.2369C>T
JAK2 c.2792A>G
Chromosomal Instability
Mutation Abnormality
ERBB c.2283_2284ins12
Hyposegmented nucleus
KRAS NP_004976.2:p.Gln61Arg
Deletion 18q23
EGFR NP_005219.2:p.Ser752_Ile759delSerProLysAlaAsnLysGluIle
EGFR NP_005219.2:p.D770_N771insSVD
Telomere Shortenings
EGFR NP_005219.2:p.D770_N771insSVQ
EGFR NP_005219.2:p.D770_N771insSVP
ERBB c.2318_2319insCCCCCA
Suppressor mutation
EGFR NP_005219.2:p.I744_K745insKIPVAI
EGFR NP_005219.2:p.Gly719fs*29
PIK3CA Glu545Xxx
metaplasia intestinal
EGFR NP_005219.2:p.Ala750_Lys754del
Shortenings, Telomere
KRAS p.Gly12Cys
EGFR Glu746del
KI-RAS c.38_39GC>TG
NP_002515.1 :p.Gln61His
fibrocystic changes
HER1 c.2582T>G
HER1 c.2582T>A
damage dna
EGFR NP_005219.2:p.Ile744_Lys745insLysIleProValAlaIle
EGFR NM_005228.3:c.2234_2236delAGG
Golgi alteration
EGFR p.L747_E749del
HER1 c.2307_2308insTGCGTG
ERBB c.2250_2273del24
Breakage, Chromosome
PDGFRA NP_006197.1:p.D842V
KRAS NP_004976.2:p.Gly12Asp
KRAS1 C.36T>C
KRAS NP_004976.2:p.Gly12Asn
EGFR V765_M766insMAS
ERBB c.2573T>A
ERBB c.2573T>G
EGFR p.P772_H773insQV
Mutation, Frameshift
NRAS Gln61Lys
Moderate Dysplasia
KRAS NP_004976.2:p.Gly12Val
JAK2 p.Tyr931Cys
Disomy, Uniparental
Inversions, Chromosomal
KRAS2 c.34_35GG>AA
Somatic Mutation
EGFR NP_005219.2:p.A767_S768insTLA
EGFR NP_005219.2:p.Pro772_His773insProArg
somatic mutations
HER1 c.2572C>A
K-SAM c.758C>G
EGFR c.delGinsCCACGTG
KRAS NP_004976.2:p.G13V
KRAS NP_004976.2:p.G13R
KRAS NP_004976.2:p.G13S
KRAS NP_004976.2:p.G13E
KRAS NP_004976.2:p.G13C
KRAS NP_004976.2:p.G13A
KRAS NP_004976.2:p.G13N
Breakages, Chromosome
Securin Overexpression
ERBB1 c.2240_2254del15
ERBB1 c.2309_2310ins14
Ki-Ras G12C
Ki-Ras G12A
JAK2 Glu985Lys
Ki-Ras G12D
Ki-Ras G12E
Ki-Ras G12I
Ki-Ras G12N
Ki-Ras G12L
Ki-Ras G12R
Ki-Ras G12V
Ki-Ras G12W
FGFR2 K659E
Ki-Ras G12Y
DNA Nicks
FGFR2 NP_000132.3:p.S372C
EGFR NP_005219.2:P772_H773insDHP
EGFR E709fs*1
EGFR c.2257_2277del21
FGFR2 p.Asn549His
AKT1 NP_001014431.1:p.E17K
Cytologic engulfment
NRAS c.182_183delAAinsTG
Mutations, Out-of-Frame
Fibrocystic change
Somatic mutation
FGFR2 c.1115C>G
JAK2 Y931C
K-SAM c.1124A>G
PIK3CA His1047Xxx
KRAS Gly12Tyr
FGFR2 S372C
PI3K c.1635G>T
Intestinal metaplasia
Instabilities, Genomic
PI3K c.1635G>C
Myofilament loss
EGFR NM_005228.3:c.2302_2303insCGCTGGCCA
BRAF p.V600R
KI-RAS c.34_35GG>AA
EGFR p.S752_V769del
Genetic Translocation
BRAF p.V600D
KI-RAS c.34_35GG>AT
BRAF p.V600M
BRAF p.V600L
K-SAM c.1115C>G
EGFR NP_005219.2:p.N756_L760del
Mesangium alteration
neural degeneration
EGFR NP_005219.2:p.Leu861Phe
JAK2 NP_004963.1:p.I960V
FGFR2 P253R
NRAS1 c.181_182CA>TT
Microvillus alteration
KRAS1 c.181C>A
KRAS1 c.181C>G
EGFR L861F
EGFR NM_005228.3:c.2239_2262del24
XXY Trisomy
Deletion 13q
Pathologic Mutagenesis
EGFR c.2125_2129delGAAAC
KRAS NP_004976.2:p.Gly13Glu
cytologic atypia
Deletion 6q2
Deletion 6q1
KGFR c.758C>G
EGFR c.2310_2311insAACCCCCAC
KI-RAS c.39C>T
KI-RAS c.39C>A
KI-RAS c.39C>G
EGFR NP_005219.2:p.Pro772_His773insTyrAsnPro
Trisomy 20p
ECT1 c.1647T>A
ECT1 c.1647T>G
FGFR2 NP_000132.3:p.Ser372Cys
BRAF p.Val600Arg
DNA Injuries
EGFR NP_005219.2:p.D761_E762insEAFQ
Deletion Xq28
HER1 c.2308_2309insACGGCG
JAK2 NM_004972.3:c.1848_1849TG>CT
Mild dysplasia
chromosomal mutations
EGFR p.D770_N771insSVQ
EGFR p.D770_N771insSVP
EGFR E746del
EGFR p.D770_N771insSVD
ERBB1 c.2303_2304ins9
K-SAM c.755C>G
KI-RAS c.37G>T
ERBB1 c.2573T>G
ERBB1 c.2573T>A
nonsense mutation
EGFR N756_L760del
KI-RAS c.37G>A
KI-RAS c.37G>C
ERBB c.2310_2311insGGT
Ring 14
tubular aggregate
FGFR2 NP_000132.3:p.N549H
FGFR2 NP_000132.3:p.N549K
ERBB c.2310_2311insGGC
Meiotic alteration
Koilocytotic atypia
KRAS G13D
DNA Damage
EGFR NM_005228.3:c.2310_2311insAAC
EGFR NP_005219.2:p.E746_S752del
EGFR NP_005219.2:p.D770_N771insG
EGFR NP_005219.2:p.D770_N771insD
HER1 c.2308_2309ins9
Metaplastic Change
BRAF Gly469Ser
Chromosome Breakages
EGFR NM_005228.3:c.2236_2253del18
EGFR p.P772_H773insDNP
Erythrocyte vacuolisation
CD332 c.755C>G
PIK3CA NM_006218.1:c.3141T>G
EGFR p.H773_V774insGNPH
EGFR NM_005228.3:c.2156G>C
EGFR NM_005228.3:c.2156G>A
PIK3CA p.Glu545Asp
EGFR NM_005228.3:c.2310_2311insAGCGTGGAC
Chromosomal Instabilities
KRAS p.Gly13Ser
Microtubule Process
Duplication 13p
HER1 c.2302_2303ins9
PIK3CA Glu545Gly
PIK3CA Glu545Gln
KGFR P253R
KRAS c.181C>G
KRAS NM_004985.3:c.36T>C
KRAS c.181C>A
EGFR NP_005219.2:p.S768_V769insAWT
Sequence Deletions
KRAS NM_004985.3:c.39C>G
Monosomy 3q13
p110-alpha c.1624G>A
KRAS NM_004985.3:c.39C>T
p110-alpha c.1624G>C
EGFR c.2307_2308insATGGCCAGCGTGGAC
KI-RAS c.34_35GG>CT
Granulation anomaly
EGFR I744_K745insKIPVAI
Diffuse Dysplasia
Pappenheimer body
Mutation, Transition
NRAS c.181C>A
NRAS c.181C>G
PIK3CA p.E545V
PIK3CA p.E545Q
PIK3CA p.E545X
PIK3CA p.E545G
PIK3CA p.E545D
PIK3CA p.E545A
PIK3CA p.E545K
mild dysplasia
EGFR c.2239_2256del18
EGFR NP_005219.2:p.P772_H773insTHP
Duplication Xq
BRAF NP_004324.2:p.Leu597Ser
BRAF NP_004324.2:p.Gly466Val
Abnormalities, Chromosomal
KRAS NM_004985.3:c.34_36delGGTinsTGC
EGFR NP_005219.2:p.Ser768_Val769insValAlaSer
KRAS NM_004985.3:c.34_36delGGTinsTGG
Chromosome Instability
Chromosomal Insertion
EGFR c.2219_2220ins18
Mesangial proliferation
FGFR2 C382R
Hypertonic cryohemolysis
PIK3CA p.Glu542Gln
PIK3CA p.Glu542Gly
C-K-RAS c.34_36GG>TA
Trans-synaptic degeneration
EGFR NP_005219.2:p.Gly719Xxx
EGFR H773_V774insNPH
Embryonic Mosaic
KRAS1 c.182A>T
KI-RAS c.38G>A
KI-RAS c.38G>C
KRAS1 c.182A>C
Moderate dysplasia
KRAS1 c.182A>G
KRAS p.Gly12Asn
FGFR2 NP_000132.3:p.Cys382Arg
EGFR NM_005228.3:c.2232_2233ins18
KI-RAS c.38G>T
KRAS NP_004976.2:p.Gly13Cys
JTK10 c.1849G>T
KRAS Gln61Leu
Ribosome alteration
EGFR NP_005219.2:p.Gly719Ala
EGFR NP_005219.2:p.Glu746_Ala750del
EGFR c.2581C>G
EGFR NP_005219.2:p.V30_R297delK29_N298insG
EGFR K745_A750del
EGFR c.2573T>A
EGFR c.2573T>G
PIK3CA NP_006209.2:p.Glu542Val
KI-RAS C.36T>C
Injury, DNA
NRAS Gln61His
EGFR c.2572_2573delCTinsAG
UV Mutagenesis
PIK3CA NM_006218.1:c.1625A>T
PIK3CA NM_006218.1:c.1625A>G
EGFR NP_005219.2:p.Val769_Asp770insAspAsnVal
JAK2 Gly935Arg
EGFR D770_N771insGL
Chromosome abnormalities
EGFR I740_P741insPVAIKI
Monosomy 20p
EGFR Gly719Ala
ERBB1 c.2238_2252del15
EGFR c.2308_2309insACGGCG
JAK2 NP_004963.1:p.Met929Ile
KRAS2 c.37G>A
KRAS2 c.37G>C
KRAS2 c.37G>T
HER1 c.2254_2277del24
ERBB c.2573_2574TG>GT
Masked Near-Haploidy
Chromosomal translocation
Deletion 5q35
somatic mutation
N-ras c.182A>T
N-ras c.182A>C
HER1 c.2236_2237ins18
N-ras c.182A>G
EGFR NP_005219.2:p.His773_Val774insGly
EGFR c.2302_2303insCGCTGGCCA
ERBB1 c.2235_2252del18
Sequence, Inverted
KRAS NM_004985.3:c.38G>A
KRAS NM_004985.3:c.38G>C
PIK3CA c.1635G>T
PIK3CA His1047Thr
PIK3CA c.1635G>C
BRAF Gly466Arg
KRAS2 c.38G>C
C-K-RAS c.34G>C
C-K-RAS c.34G>A
Inverted Sequences
C-K-RAS c.34G>T
Focal Dysplasia
EGFR NP_005219.2:p.V774del
EGFR NM_005228.3:c.2582T>A
Chromosome Duplication
CD332 c.1975A>G
DNA INJ
BRAF c.1397G>T
BRAF c.1397G>C
BRAF c.1397G>A
JAK2 NP_004963.1:p.Tyr931Cys
KRAS1 c.183A>C
EGFR NP_005219.2:p.Glu746_Arg748del
EGFR NM_005228.3:c.2308_2309ins9
Chromosomal Aberration
p110alpha E542G
p110alpha E542Q
Deceptive Imprinting
p110alpha E542V
p110alpha E542X
p110-alpha c.1633G>A
p110-alpha c.1633G>C
EGFR p.M766_A767insAI
NRAS p.Gln61His
Chromosomal Gain
EGFR NP_005219.2:p.Leu747_Ser752delLeuArgGluAlaThrSer
ERBB c.2239_2262del24
KRAS1 c.37_38GG>AA
Duplication Xq25
EGFR S768_V769insAWT
EGFR NP_005219.2:p.Val769_Asp770insMetAlaSerValAsp
BRAF p.Gly466Ala
EGFR NP_005219.2:p.Arg748_Ser752del
JAK2 p.Met929Ile
Partial monosomy
Erythrocyte vacuolization
Pericentric inversion
Ki-Ras A146X
FGFR2 p.Lys659Glu
hemolytic crisis
ERBB c.2311_2312ins12
BRAF p.Gly469Ser
IGH-MAF Translocation
EGFR p.Gly719Cys
EGFR p.Val834del
KRAS p.A146X
EGFR NP_005219.2:p.G719S
EGFR NP_005219.2:p.G719V
EGFR NP_005219.2:p.G719X
EGFR NP_005219.2:p.G719C
EGFR NP_005219.2:p.G719A
EGFR NP_005219.2:p.G719D
Stereocilia alteration
fibrocystic change
NP_004324.2:p.V600 Mutation
EGFR NM_005228.3:c.2219_2220insTCCCGTCGCTATTAAAAT
BRAF c.1798G>T
EGFR NM_005228.3:c.2310_2311insGCACCGTGG
KRAS2 c.38_39GC>TG
ERBB1 c.2313_2314insAAC
BRAF c.1798G>A
EGFR NM_005228.3:c.2321_2322insCCACGT
KRAS2 c.38_39GC>TT
KRAS p.Gln61His
FGFR2 p.Ser252Trp
Shortened telomeres
JAK2 NP_004963.1:p.Glu985Lys
Damages, DNA
KRAS G13V
KRAS G13S
KRAS G13R
IgVH Mutation
KRAS G13E
BRAF c.1791A>G
KRAS G13C
KRAS G13N
EGFR c.2236_2253del18
HER1 c.2156G>C
HER1 c.2156G>A
KGFR Ser252Trp
Trisomy 18p
severe dysplasia
Duplication 17q
EGFR c.2298_2299insGCCATA
EGFR NP_005219.2:p.V769_D770insASV
EGFR NM_005228.3:c.2308_2309insGCAGCGTGG
BRAF Gly469Ala
atypical cells
EGFR D770_N771insGD
DNA Damages
Proteostasis Deficiency
N-ras c.183A>G
N-ras c.183A>C
Chromosome Alterations
N-ras c.183A>T
Trisomy Xq25
Chromosomal Translocation
Deficiencies, Proteostasis
EGFR p.T790M
Duplication 9q21
API2-MLT Translocation
HER-2 c.2325_2326ins12
EGFR Gly719Asp
EGFR V774_C775insHV
KRAS c.35_36GT>TC
BRAF c.1797_1799AGT>GAG
EGFR NP_005219.2:p.Glu746del
EGFR NP_005219.2:p.Leu861Pro
KRAS2 c.37_38GG>AA
BRAF Leu597Ser
ERBB1 c.2310_2311insGGGGAC
KRAS2 c.34_35GG>TT
Telomere Shortening
EGFR Gly719Cys
ERBB2 c.2325_2326ins12
KRAS2 c.34_35GG>TA
KRAS NP_004976.2:p.Gly13Ser
NTRK1 Rearrangement
EGFR D770_N771insMATP
EGFR p.V769_D770insDNV
Pericentric Inversion
EGFR N771_P772insN
EGFR N771_P772insH
EGFR c.2236_2237ins18
JAK2 p.Glu985Lys
Mutation, Transversion
Contraction bands
EGFR p.S768_V769insVAS
EGFR V774del
Monosomy 4q32
EGFR A750_K757del
metaplasia squamous
BRAF NP_004324.2:p.G466E
Wallerian degeneration
BRAF NP_004324.2:p.G466V
BRAF NP_004324.2:p.G466R
NEU c.2325_2326ins12
EGFR NM_005228.3:c.2247_2273del27
NRAS Gly13Xxx
NRAS c.181_182CA>TT
BRAF c.1798_1799delGTinsAA
BRAF c.1798_1799delGTinsAG
ABNORM CHROMOSOMAL
FGFR-2 Pro253Arg
KRAS NM_004985.3:c.34_35delGGinsAT
N-ras c.182_183AA>TG
Mutations, Frameshift
KRAS NM_004985.3:c.34_35delGGinsAA
Partial Monosomies
EGFR NP_005219.2:p.Leu747_Thr751del
EGFR NM_005228.3:c.2298_2299insGCCATA
EGFR NP_005219.2:p.Ile740_Pro741insProValAlaIleLysIle
EGFR NM_005228.3:c.2308_2309insCCAGCGTGG
ERBB1 c.2319_2320insCCCCAC
HER1 c.2309_2310ins14
EGFR p.D770_N771insGL
EGFR p.D770_N771insGD
Transition Mutation
KI-RAS c.34_35GG>TT
PIK3CA p.Glu545Xxx
KI-RAS c.34_35GG>TA
EGFR NP_005219.2:p.Lys745_Ala750del
EGFR NP_005219.2:p.D770_N771insMATP
dysplasia mild
Uniparental Disomies
CD332 c.1645A>C
EGFR p.D770_N771insNPH
chromosomal abnormalities
FGFR2 Lys659Glu
Trisomy 16q
c-K-ras G12I
c-K-ras G12L
c-K-ras G12N
c-K-ras G12A
c-K-ras G12C
c-K-ras G12D
c-K-ras G12E
c-K-ras G12F
Monosomy 7q21
c-K-ras G12R
c-K-ras G12S
c-K-ras G12W
Suppressor Mutation
FGFR-2 Ser372Cys
Myelin figure
BRAF c.1790T>A
BRAF NP_004324.2:p.Gly466Arg
EGFR NP_005219.2:p.L747_A750del
Microtubule Alteration
IGH@/MAF Translocation
PIK3CA NP_006209.2:p.Glu542Xxx
BEK c.1647T>A
EGFR c.2573_2574delTGinsGT
Isodisomies, Uniparental
PI3K c.1625A>G
PI3Kalpha E542G
PIK3CA NM_006218.1:c.1258T>C
EGFR p.D770_N771insMATP
EGFR NM_005228.3:c.2310_2311insAACCCCCAC
Diffuse dysplasia
EGFR c.2369C>T
KRAS1 c.35_36GT>TC
EGFR NM_005228.3:c.2235_2249delGGAATTAAGAGAAGC
NRAS NM_002524.4:c.181_182delCAinsAG
PI3K c.3139C>T
PIK3CA NP_006209.2:p.Glu542Gln
NRAS NP_002515.1:p.G13X
Acentric chromosome
Monosomy 14q11
KI-RAS c.38_39GC>AA
KI-RAS c.38_39GC>AG
EGFR A750_E758del
Nissl Degeneration
KI-RAS c.38_39GC>AT
Isochromosome 17q
EGFR NP_005219.2:p.Asp770_Asn771insSerValGln
FGFR2 Ser372Cys
ERBB1 c.2219_2220ins18
EGFR c.2322_2323insCACGTG
ERBB c.2257_2277del21
AKT1 Glu17Lys
JAK2 NP_004963.1:p.E985K
JAK2 NP_004963.1:p.Ile690Val
FGFR2 Pro253Arg
KRAS2 c.35_36GT>AA
KRAS2 c.35_36GT>AG
EGFR p.Gly719Ser
BRAF c.1406G>C
EGFR c.2219_2220insTCCCGTCGCTATTAAAAT
p110-alpha c.1635G>T
KRAS NM_004985.3:c.35G>C
KRAS NM_004985.3:c.35G>A
p110-alpha c.1635G>C
Retrograde Degeneration
KRAS NM_004985.3:c.35G>T
TRANSLOCATION GENET
EGFR NP_005219.2:p.Leu858Met
GATA1 Mutation
EGFR c.2307_2308insTGCGTG
EGFR NP_005219.2:p.E746_R748del
EGFR NM_005228.3:c.2572_2573delCTinsAA
Cytoplasmic accumulation
Chromosomal Fragility
secondary degeneration
PIK3CA NM_006218.1:c.1634A>G
KRAS NM_004985.3:c.34_35delGGinsCT
PIK3CA NM_006218.1:c.1634A>C
PIK3CA NM_006218.1:c.1634A>T
ERBB1 c.2246_2260del15
Mutagenic Process
EGFR NP_005219.2:p.Pro772_His773insGlnVal
CD332 c.1647T>A
CD332 c.1647T>G
EGFR p.E746_A750del
KI-RAS c.34G>A
KI-RAS c.34G>C
BRAF NP_004324.2:p.G466A
KI-RAS c.34G>T
Multifocal dysplasia
EGFR c.2232_2233ins18
EGFR NP_005219.2:p.Asp770_Asn771insMetAlaThrPro
EGFR S752_I759del
EGFR p.L747_P753del
HER1 c.2235_2249del15
Chromosomal Loss
Aberrations, Chromosomal
EGFR P772_H773insYNP
Chromosome Aberrations
Chediak-Higashi cells
PIK3CA p.Glu542Xxx
EGFR p.A763_Y764insFQEA
KRAS A146X
PIK3CA Cys420Arg
NRAS c.182_183AA>GG
HER1 c.2290_2291ins12
ERBB1 c.2581C>G
HER1 c.2319_2320insCCCCAC
EGFR NP_005219.2:p.Leu747_Glu749delLeuArgGlu
BEK c.1645A>C
KRAS NP_004976.2:p.Gly12Glu
KI-RAS c.181C>A
KI-RAS c.181C>G
KRAS2 c.38_39GC>AT
PIK3CA NP_006209.2:p.Glu545Lys
PIK3CA NP_006209.2:p.His1047Tyr
JAK2 NP_004963.1:p.Val617Phe
AUTOSOME ABNORM
NRAS p.Q61L
NRAS p.Q61K
NRAS p.Q61H
NRAS p.Q61E
Glandular metaplasia
NRAS p.Q61X
NRAS p.Q61R
NRAS p.Q61P
EGFR NP_005219.2:p.Asp770_Asn771insSerValPro
BRAF c.1405_1407delGGAinsAGC
Toxic vacuolization
BRAF c.1405_1407delGGAinsAGT
EGFR c.334_1137del804
EGFR NM_005228.3:c.2307_2308insGACAACGTG
EGFR NP_005219.2:p.Arg748_Pro753del
Metaplastic keratinisation
C-K-RAS c.34_36GGT>TGC
EGFR H773_V774insGNPH
C-K-RAS c.35_36GT>TC
chromosome aberration
EGFR c.2572C>A
FGFR2 c.758C>G
EGFR c.2572C>T
Translocations, Genetic
NRAS p.Gly12Xxx
Genetic Change
KRAS Q61K
Tetrasomy 17
Tetrasomy 12
JAK-2 c.2792A>G
KI-RAS c.35_36GT>AA
KI-RAS c.35_36GT>AC
KI-RAS c.35_36GT>AG
EGFR Leu858Arg
KRAS p.G13S
KRAS p.G13R
Extravascular hemolysis
KRAS p.G13V
BRAF p.Leu597Ser
KRAS p.G13N
KRAS p.G13A
KRAS p.G13C
KRAS p.G13E
KRAS p.G13D
PIK3CA NP_006209.2:p.E542G
EGFR c.2234_2236delAGG
PIK3CA NP_006209.2:p.E542K
SEQ DELETION
PIK3CA NP_006209.2:p.E542V
PIK3CA NP_006209.2:p.E542Q
PIK3CA NP_006209.2:p.E542X
NP_002515.1 :p.Gly13Xxx
EGFR NM_005228.3:c.2308_2309insGGGTCGTGG
paracentric inversion
EGFR L747_T751del
PIK3CA p.His1047Xxx
EGFR NM_005228.3:c.2219_2220ins18
chromosome duplication
Chromosome inversions
NP_002515.1 :p.Gln61Glu
PIK3CA c.1624G>C
PIK3CA c.1624G>A
Nonsense Mutations
ERBB1 c.2310_2311insGGGTTA
EGFR NP_005219.2:p.Gly719Val
ERBB c.2239_2253del15
Genetic Translocations
KRAS Gly12Arg
Retrograde Degenerations
KRAS NM_004985.3:c.182A>T
ERBB2 NP_004439.2:p.Ala775_Gly776insTyrValMetAla
chromosome markers
NRAS1 c.181C>A
NRAS1 c.181C>G
JAK2 Ile960Val
Monosomy 14qter
ERBB1 c.2232_2233ins18
FGFR-2 S252W
EGFR NP_005219.2:p.Leu861Arg
EGFR NP_005219.2:p.G719fs*29
Trisomy 17q22
Genomic Instabilities
Genotoxic Stress
EGFR p.G719fs*29
Breakage, Chromosomal
ERBB1 c.2235_2249del15
PIK3CA p.Glu1047Arg
N-ras c.181_182CA>AG
PIK3CA Glu545Ala
Chromosomal Inversions
EGFR K745_E746insVPVAIK
EGFR H773_V774insG
Disomies, Uniparental
KRAS1 c.34_35GG>AA
KRAS1 c.34_35GG>AT
BRAF c.1405_1407GGA>AGT
KGFR Asn549His
BRAF c.1405_1407GGA>AGC
EGFR NP_005219.2:p.E746_P753del
PIK3CA NP_006209.2:p.Glu545Val
FGFR2 Asn549Lys
ERBB2 c.2324_2325ins12
KRAS NP_004976.2:p.Gln61Lys
ERBB c.2581C>G
EGFR NP_005219.2:p.D770_N771insNPH
EGFR NM_005228.3:c.2573T>G
EGFR NM_005228.3:c.2573T>A
EGFR P772_H773insTHP
Trisomy 4q21
Reciprocal translocation
ERBB1 c.2298_2299insGCCATA
EGFR I789_L792del
K-SAM c.1144T>C
chromosome translocation
EGFR A767_S768insTLA
EGFR p.D761_E762insEAFQ
Cellular Stress
Trisomy 16
Trisomy 10
Trisomy 13
Trisomy 18
Trisomy 19
Oncocytic metaplasia
KI-RAS c.37_39GGC>CGT
KRAS2 c.37_39GGC>CGT
HER-2 c.2324_2325ins12
EGFR p.Leu858Lys
Abnormalities, Autosome
PDGFRA D842V
Genotoxic Stresses
EGFR p.D770_N771insG
EGFR p.D770_N771insD
EGFR p.D770_N771insN
EGFR c.2310_2311insGGT
EGFR c.2310_2311insGGC
KRAS2 c.34_36GGT>TGG
KRAS NM_004985.3:c.183A>T
KRAS NM_004985.3:c.183A>C
EGFR G719fs*29
EGFR p.V769_D770insGVV
KRAS2 c.38G>T
JAK2 c.1849G>T
axonal swelling
Acquired dysplasia
KRAS p.Ala146Xxx
ERBB c.2310_2311ins9
PDGFR-Alpha Asp842Val
EGFR NM_005228.3:c.2283_2284insGAAGCCTTCCAG
FGFR2 c.1124A>G
t(1;19)(q23;p13.3); PBX/E2A
EGFR p.Gly719Val
BRAF NM_004333.4:c.1789_1790delCTinsTC
JAK2 NP_004963.1:p.G935R
FGFR2 NP_000132.3:p.Lys659Glu
ERBB1 c.2573_2574TG>GT
Trisomy 10q
KRAS c.35_36GT>AA
KRAS c.35_36GT>AC
KRAS c.35_36GT>AG
Cytogenetic Aberration
C-K-RAS c.38_39GC>AG
C-K-RAS c.38_39GC>AA
EGFR Leu858Pro
C-K-RAS c.38_39GC>AT
BRAF Gly469Val
EGFR c.2582T>G
EGFR c.2582T>A
EGFR NM_005228.3:c.2307_2308insTGCGTG
FGFR2 NM_000141.4:c.1645A>C
Instability, Genome
BRAF p.Gly469Glu
EGFR NP_005219.2:p.Leu747_Ala755del
NP_002515.1 :p.Gln61Pro
KRAS1 c.34_35GG>CT
Gene Deregulation
JAK2 NP_004963.1:p.Gly935Arg
FGFR-2 P253R
ERBB1 c.2231_2232ins18
Deletion, Sequence
BRAF G469E
BRAF G469A
EGFR c.2303_2304ins9
KRAS NM_004985.3:c.37_39delGGCinsCGT
Deletion 3q27
BRAF G469V
BRAF G469S
BRAF G469R
KRAS p.Gly13Asn
Duplication 14qter
KRAS p.Gly13Asp
Centrosome alteration
ERBB1 c.2155G>T
ERBB c.2239_2256del18
PIK3CA p.Glu545Lys
EGFR NP_005219.2:p.Thr751_Glu758del
EGFR NM_005228.3:c.2290_2291ins12
KRAS NM_004985.3:c.34_35delGGinsTT
KRAS NM_004985.3:c.34_35delGGinsTA
EGFR NP_005219.2:p.A750_K754del
BRAF NP_004324.2:p.Gly469Glu
Hypersegmented neutrophil
FGFR2 NP_000132.3:p.K659E
Neuronal achromasia
ERBB2 A775_G776insYVMA
stress oxidative
EGFR H773_V774insGH
PIK3CA c.1633G>C
PIK3CA c.1633G>A
ERBB1 c.2247_2273del27
Abnormality, Chromosomal
chromosomal mutation
c-K-ras G12Y
KRAS2 c.38_39GC>AA
KRAS2 c.38_39GC>AG
EGFR c.2311_2312ins12
EGFR NP_005219.2:p.Glu746_Ser752del
KRAS NP_004976.2:p.Gly12Phe
c-K-ras G12V
KRAS Gly12Ser
ERBB1 c.2572_2573CT>AA
ERBB1 c.2572_2573CT>AG
KRAS NP_004976.2:p.A146X
Chromosome Breaks
EGFR NP_005219.2:p.Leu858Lys
Ki-Ras Q61K
Ki-Ras Q61H
Ki-Ras Q61L
Ki-Ras Q61D
Ki-Ras Q61E
Ki-Ras Q61X
Ki-Ras Q61R
Ki-Ras Q61P
chromosome marker
Intestinal Metaplasia
Fragility, Chromosomal
EGFR p.P753_I759del
NRAS p.G12X
Breaks, Chromosome
EGFR NP_005219.2:p.Asp770fs*61
Trisomy 7
EGFR p.Leu858Met
Oxidative Stresses
KRAS c.38_39GC>AA
EGFR c.2283_2284ins12
KRAS c.38_39GC>AG
KRAS c.38_39GC>AT
Trans-Synaptic Degeneration
BRAF NP_004324.2:p.Leu597Arg
p110-alpha c.3141T>G
chromosomal abnormality
EGFR NM_005228.3:c.2231_2232insTAAAATTCCCGTCGCTAT
FGFR2 NP_000132.3:p.Y375C
Extravascular haemolysis
PIK3CA p.Cys420Arg
BRAF NM_004333.4:c.1799T>A
JTK10 c.2792A>G
BRAF NM_004333.4:c.1799T>C
BRAF NM_004333.4:c.1799T>G
Neuron Degenerations
AKT1 c.49G>A
EGFR NM_005228.3:c.2232_2233insAAAATTCCCGTCGCTATC
EGFR NM_005228.3:c.2250_2273del24
EGFR NM_005228.3:c.2313_2314insAAC
Mutation, Out-of-Frame
FGFR2 p.P253R
FLT3-ITD Mutation
KRAS Gly13Val
Mesothelial metaplasia
BEK c.1647T>G
EGFR NP_005219.2:p.P772_H773insYNP
KRAS c.37G>A
KRAS c.37G>C
B-RAF1 c.1799_1800TG>AA
Platelet destruction
ERBB c.2156G>A
ERBB c.2156G>C
B-RAF1 c.1799_1800TG>AT
KRAS c.37G>T
PI3Kalpha E542K
Ergastoplasmic alteration
Chromosomal Abnormalities
PI3Kalpha E542X
PI3Kalpha E542V
PI3Kalpha E542Q
chromosome breakage
EGFR c.2154_2155GG>TT
ERBB1 c.2582T>G
ERBB1 c.2322_2322G>CCACGTG
KRAS NP_004976.2:p.Gly12Trp
PI3K c.1634A>C
PI3K c.1634A>G
EGFR A763_Y764insFQEA
atypicals cells
PI3K c.1634A>T
EGFR NP_005219.2:p.S752_I759del
Chdiak-Higashi cell
HER1 c.2310_2311insGGGGAC
NRAS p.Gln61Xxx
EGFR NM_005228.3:c.2315_2316insGACACACCC
Inversion, Chromosomal
EGFR NP_005219.2:p.Ala763_Tyr764insPheglnGluAla
JAK2 p.Arg938Leu
ERBB c.2303_2304ins9
KGFR Pro253Arg
EGFR c.2307_2308insGACAACGTG
chromosome aberrations
FGFR-2 K659E
Nonsense mutation
Breaks, Chromosomal
PI3K c.1625A>T
BRAF c.1405G>A
BRAF c.1405G>C
KRAS1 c.34G>C
KRAS1 c.34G>A
KRAS1 c.34G>T
Suppressor Mutations
EGFR NM_005228.3:c.2319_2320insCAC
EGFR NP_005219.2:p.D770_N771insGD
Chromosomal Breakages
EGFR NP_005219.2:p.D770_N771insGL
ERBB c.2307_2308ins15
PIK3CA NP_006209.2:p.Glu542Lys
KRAS Gly12Leu
EGFR V769_D770insASV
EGFR V769_D770insMASVD
Oxidative Stress
EGFR V834del
FGFR2 NP_000132.3:p.Pro253Arg
EGFR NP_005219.2:p.Lys745_Glu746insValProValAlaIleLys
ECT1 c.758C>G
JAK2 Val617Phe
Chromosomal Break
EGFR p.L747_A750del
EGFR c.2308_2309insGGGTCGTGG
EGFR c.2155G>A
Dysfunction, Proteostasis
EGFR c.2155G>T
ERBB c.2238_2252del15
DNA Crosslinking
cabots rings
JAK2 Tyr931Cys
KRAS Ala146Xxx
EGFR NP_005219.2:p.Glu746_Thr751delGluLeuArgGluAlaThr
PDGFR-2 c.2525A>T
Polysomy 17
Polysomy 10
Translocation, Chromosomal
Degeneration, Nissl
EGFR NP_005219.2:p.V765_M766insMAS
EGFR p.Glu746del
NRAS c.181_183CAA>AAG
Dominant-Negative Mutation
EGFR NP_005219.2:p.Leu747_Lys754del
ERBB c.2240_2254del15
EGFR c.2307_2308ins9
Cytoplasmic hyalinization
chromosome mutation
EGFR NP_005219.2:p.P772_H773insDNP
HER1 c.2320_2321ins12
FGFR2 NP_000132.3:p.C382R
EGFR NM_005228.3:c.2236_2250del15
KRAS NM_004985.3:c.38_39delGCinsTT
KRAS NM_004985.3:c.38_39delGCinsTG
ERBB c.2307_2308insTGCGTG
EGFR p.D770_N771insAPW
p110-alpha c.3140A>T
p110-alpha c.3140A>G
Out-of-Frame Mutation
EGFR p.K745_A750del
Minimal Aneuploidy
Trisomy 2q37
EGFR c.2302_2303ins9
BRCA1 Mutation
PIK3CA p.His1047Tyr
CD332 c.1144T>C
PIK3CA c.3140A>T
N-ras c.182_183AA>GG
EGFR NP_005219.2:p.P772_H773insQV
EGFR p.Leu861Pro
PIK3CA NP_006209.2:p.H1047X
Stress, Genotoxic
p110-alpha c.1625A>G
PI3Kalpha H1047L
PIK3CA NP_006209.2:p.H1047Q
p110-alpha c.3139C>T
p110-alpha c.1625A>T
PI3Kalpha H1047Y
PI3Kalpha H1047X
PI3Kalpha H1047R
PI3Kalpha H1047Q
PI3Kalpha H1047T
EGFR D770_N771insSVQ
EGFR D770_N771insSVP
PIK3CA c.3140A>G
ERBB1 c.2319_2320ins9
EGFR R748_S752del
EGFR D770_N771insSVD
c-K-ras Q61X
EGFR NP_005219.2:p.E709fs*1
EGFR NM_005228.3:c.2307_2308insGCCAGCGTG
c-K-ras Q61R
c-K-ras Q61L
c-K-ras Q61H
c-K-ras Q61K
c-K-ras Q61D
c-K-ras Q61E
KRAS Gly13Cys
ERBB c.2322_2323insCACGTG
PIK3CA H1047Q
PIK3CA H1047R
chromosome inversions
PIK3CA H1047T
AML1 Mutation
PIK3CA H1047X
PIK3CA H1047Y
PIK3CA H1047L
Chromosome break
EGFR c.2238_2252del15
ERBB c.2253_2276del24
NRAS Gln61Leu
EGFR NP_005219.2:p.Val769_Asp770insAlaSerVal
EGFR NM_005228.3:c.334_1137del804
Frameshift Mutations
EGFR NM_005228.3:c.2239_2256delTTAAGAGAAGCAACATCT
KRAS Gly13Asn
EGFR p.K745_E749del
KRAS Gly13Asp
KRAS p.Gln61Xxx
PIK3CA NP_006209.2:p.Glu545Xxx
EGFR NP_005219.2:p.Asp770_Asn771insGlyAsp
Chylomicron alteration
ERBB c.2247_2273del27
EGFR NM_005228.3:c.2302_2303ins9
PIK3CA NP_006209.2:p.His1047Xxx
PIK3CA E545Q
PIK3CA E545K
KRAS2 c.34_35GG>AT
PIK3CA E545A
PIK3CA E545G
PIK3CA E545D
EGFR V769_D770insDNV
ERBB c.2582T>A
ERBB c.2582T>G
Nucleolar hypertrophy
RET/PTC Rearrangement
N-ras c.181_182CA>TT
PIK3CA NM_006218.1:c.1624G>C
PIK3CA NM_006218.1:c.1624G>A
EGFR NP_005219.2:p.V834del
FGFR2 p.N549H
FGFR2 p.N549K
Giant mitochondria
EGFR NP_005219.2:p.His773_Val774insProHis
EGFR NP_005219.2:p.Gly719Ser
c-K-ras G13V
KRAS Gly13Ala
NP_002515.1 :p.Gln61Arg
EGFR Gly719Val
EGFR NP_005219.2:p.Asp770_Asn771insAsnProHis
EGFR c.2311_2312insGCGTGGACA
NRAS c.181_182CA>AG
FLT3/TKD Mutation
KGFR Lys659Glu
Chromosome Deletion
PIK3CA c.1634A>C
PIK3CA p.His1047Leu
EGFR p.K745_L747del
Cabot rings
Base-Base Mismatch
KGFR c.1647T>G
KGFR c.1647T>A
KRAS c.35G>C
KRAS c.35G>A
EGFR NP_005219.2:p.Pro772_His773insAspHisPro
C-K-RAS c.35_36GT>AC
C-K-RAS c.35_36GT>AA
KRAS c.35G>T
EGFR NP_005219.2:p.Asp770_Asn771insAlaProTrp
AKT1 NM_001014431.1:c.49G>A
EGFR NM_005228.3:c.2233_2247del15
KRAS NP_004976.2:p.Gly12Ile
EGFR NP_005219.2:p.L747_P753del
BRAF Gly469Arg
CD332 c.1124A>G
Duplication Xp3
EGFR NM_005228.3:c.2283_2284ins12
EGFR p.G719C
EGFR p.G719A
EGFR p.G719D
EGFR p.G719X
KI-RAS c.35_36GT>TC
Shortening, Telomere
EGFR p.G719V
BRAF NM_004333.4:c.1405G>C
Mutation, Suppressor
Chromosome Inversion
KRAS2 c.180_181TC>CA
EGFR NP_005219.2:p.Ala750_Lys757del
ERBB c.2310_2311insAACCCCCAC
KRAS NP_004976.2:p.G13D
EGFR c.2318_2319insCCCCCA
NRAS c.181_182delCAinsTT
Squamous Metaplasia
NRAS NM_002524.4:c.183A>C
NRAS NM_002524.4:c.183A>G
Break, Chromosomal
NRAS NM_002524.4:c.183A>T
KI-RAS c.180_181TC>CA
IGH/MAF Translocation
EGFR p.L747_T751del
NRAS NM_002524.4:c.181_183delCAAinsAAG
BIRC3-MALT1 Translocation
BRAF NP_004324.2:p.Val600Leu
PIK3CA His1047Leu
EGFR D770_N771insNPH
JAK2 p.G935R
EGFR D770_N771insAPW
Uniparental Heterodisomies
HER1 c.2235_2246del12
Chromosome fragment
ERBB1 c.2257_2277del21
PIK3CA c.1258T>C
KRAS Gln61Asp
KRAS2 c.35_36GT>AC
BRAF NM_004333.4:c.1798_1799delGTinsAA
KGFR c.1144T>C
MYC Translocation
Nerve Degeneration
Ki-Ras G12S
Maturation acceleration
EGFR p.S768_V769insAWT
Duplication, Chromosome
HER1 c.2283_2284ins12
KRAS2 C.36T>C
EGFR NP_005219.2:p.L747del
True hypertrophy
EGFR c.2309_2310AC>CCAGCGTGGAT
EGFR p.E746_R748del
EGFR NP_005219.2:p.Glu746_Pro753del
PIK3CA NM_006218.1:c.3139C>T
EGFR p.Gly719Asp
Mitochondrial hyperplasia
BRAF p.Val600Lys
KRAS NM_004985.3:c.35_36delGTinsTC
EGFR E746_P753del
KRAS1 c.34_35GG>TT
EGFR c.2231_2232ins18
EGFR NP_005219.2:p.Val769_Asp770insGlyValVal
HER-2/neu c.2325_2326ins12
Reactions, Axon
KRAS Gly12Trp
BRAF p.Val600Met
EGFR c.2310_2311ins9
EGFR L747del
KRAS NP_004976.2:p.Gln61Xxx
EGFR p.N756_L760del
PIK3CA p.C420R
Oncogene Deregulation
EGFR c.2310_2311insAAC
ERBB c.2310_2311insGGGGAC
degeneration neuron
Uniparental Isodisomy
Chromosome 13q-mosaicism
BRAF L597V
BRAF L597Q
BRAF L597R
BRAF L597S
Instability, Genomic
PI3K c.3141T>G
KRAS2 c.34G>A
KRAS2 c.34G>C
JAK2 p.R938L
EGFR p.A750_E758del
KRAS2 c.34G>T
HER1 c.2257_2277del21
EGFR p.V769_D770insGSV
HER1 c.2573_2574TG>GT
BRAF c.1798_1799GT>AA
EGFR p.L747_K754del
EGFR NM_005228.3:c.2235_2249del15
HER1 c.2321_2322insCCACGT
HER1 c.2219_2220ins18
c-K-ras Q61P
frameshift mutation
B-RAF1 c.1405_1406GG>TC
chromosomal aberrations
ERBB1 c.2307_2308insTGCGTG
FGFR2 NP_000132.3:p.Asn549His
KRAS1 c.35G>A
NRAS NM_002524.4:c.182A>T
KRAS2 c.180_181TC>AA
EGFR NM_005228.3:c.2236_2237insTTCCCGTCGCTATCAAGG
KI-RAS c.183A>C
NRAS NM_002524.4:c.182A>G
NRAS NM_002524.4:c.182A>C
BRAF NM_004333.4:c.1791A>G
KRAS NP_004976.2:p.Gly13Ala
Aberration, Chromosome
C-K-RAS c.37_38GG>AA
Translocations, Chromosomal
PIK3CA NP_006209.2:p.Glu545Gly
HER1 c.2239_2262del24
PIK3CA NP_006209.2:p.Glu545Gln
EGFR V769_D770insGSV
EGFR p.L861F
EGFR p.L861V
EGFR p.L861R
EGFR p.L861Q
EGFR p.L861P
Neuron Degeneration
KRAS NP_004976.2:p.Gln61Asp
HER1 c.2319_2320ins9
KRAS c.39C>T
KRAS c.39C>G
KRAS c.39C>A
ERBB1 c.2572C>A
KI-RAS c.180_181TC>AA
EGFR c.2308_2309insGCAGCGTGG
Cytoplasmic droplets
C-K-RAS c.38_39GC>TT
HER1 c.2307_2308ins9
KRAS NP_004976.2:p.Gly13Asn
KRAS NP_004976.2:p.Gly13Asp
Inverted Sequence
KRAS Gly12Phe
Genetic Alteration
EGFR Y764_V765insHH
BRAF NM_004333.4:c.1405_1406delGGinsTC
HFE gene.c.845G>A
BRAF c.1405_1406delGGinsTC
EGFR c.2247_2273del27
Novel Mutation
ERBB c.2233_2247del15
HER1 c.2369C>T
Impaired phagocytosis
Abnormalities, Cytogenetic
PIK3CA NP_006209.2:p.His1047Thr
Gene Fusion
EGFR L747_E749del
Disomy 9q21
Complex Karyotype
Instabilities, Chromosomal
squamous metaplasia
EGFR p.V765_M766insMAS
Endothelial metaplasia
KRAS G13A
EGFR NP_005219.2:p.V769_D770insGVV
EGFR c.2309_2310insATGGCCAGCGTGGA
EGFR p.P772_H773insYNP
Nucleolar alteration
HER1 c.2310_2311insAAC
Fragility, function
BEK c.1975A>G
Extracellular alteration
HER1 c.2232_2233ins18
EGFR c.2313_2314insAAC
ERBB1 c.2311_2312ins12
Abnormal haematopoiesis
C-K-RAS c.180_181TC>CA
FGFR2 p.Tyr375Cys
EGFR c.2307_2308insGCCAGCGTG
N-ras c.181C>A
N-ras c.181C>G
EGFR p.Leu861Gln
B-RAF1 c.1406G>A
B-RAF1 c.1406G>C
B-RAF1 c.1406G>T
ECT1 c.1975A>G
CPE VIRAL
Deleterious Mutation
EGFR NP_005219.2:p.Pro772_His773insAspAsnPro
EGFR K745_E749del
KRAS c.182A>C
Maturation deceleration
EGFR p.S752_I759del
Erythrocyte destruction
Chromosome Duplications
KRAS c.182A>T
ERBB c.2234_2236delAGG
BRAF NM_004333.4:c.1397G>A
BRAF NM_004333.4:c.1397G>C
ERBB1 c.2236_2237ins18
EGFR p.Leu861Arg
ERBB c.2236_2250del15
KI-RAS c.38_39GC>TT
NEU c.2324_2325ins12
Inverted Chromosome
NP_002515.1 :p.Gln61Leu
ERBB1 c.2234_2236delAGG
Ki-Ras G12F
C-Myc Translocation
EGFR M766_A767insAI
axon reaction
KRAS Gly12Glu
EGFR NP_005219.2:p.K745_E749del
PDGFR-Alpha D842V
EGFR p.L858M
EGFR p.L858K
EGFR p.L858G
EGFR p.L858A
PIK3CA NP_006209.2:p.Glu542Gly
EGFR p.L858R
EGFR p.L858Q
EGFR p.L858P
PI3K c.1624G>A
PI3K c.1624G>C
DNA damage
KRAS p.Gln61Pro
PIK3CA c.3141T>G
BRAF NP_004324.2:p.Val600Asp
ERBB2 NP_004439.2p:A775_G776insYVMA
ERBB c.2308_2309insACGGCG
PIK3CA NP_006209.2:p.Glu545Asp
BRAF p.V600A
Abnormal hematopoiesis
BRAF p.V600G
Oncogene Activation
BRAF p.V600E
BRAF NP_004324.2:p.Leu597Val
BRAF p.V600K
BRAF NP_004324.2:p.Val600Lys
KRAS Gln61His
HER1 c.2313_2314insAAC
IGH@-MAF Translocation
FGFR2 NP_000132.3:p.S252W
EGFR NP_005219.2:p.Leu858Ala
BEK c.1124A>G
EGFR c.2321_2322insCCACGT
chromosomal deletion
EGFR NM_005228.3:c.2254_2277del24
EGFR NM_005228.3:c.2582T>G
Chromosomal Rearrangements
KRAS p.Gly12Trp
EGFR Leu861Gln
JAK2 p.Val617Phe
NRAS p.Gln61Lys
EGFR NP_005219.2:p.V769_D770insDNV
Paracentric inversion
FGFR2 c.1645A>C
Frameshift Mutation
Aplastic crisis
FGFR2 c.755C>G
EGFR E746_E749del
HER1 c.2303_2304ins9
Inversions, Sequence
NP_004324.2:p.Val600 Mutation
BRAF p.Val600Leu
genetic translocations
EGFR c.2319_2320ins9
Degeneration, Neuron
JAK2 Mutation
C-K-RAS c.37G>T
Mutations, Point
ERBB1 c.2308_2309insACGGCG
NPM1 Mutation
KI-RAS c.182A>T
FGFR2 Tyr375Cys
EGFR p.E709fs*1
KI-RAS c.182A>G
KI-RAS c.182A>C
C-K-RAS c.180_181TC>AA
Nerve Degenerations
EGFR D770_N771insDG
Deletion 21q22
ERBB c.2308_2309ins9
EGFR c.2309_2310delACinsCCAGCGTGGAT
ERBB c.2239_2247del9
KRAS p.Gly12Ala
intestinal metaplasia
EGFR p.A750_K757del
Cilia alteration
ERBB1 c.2236_2250del15
FGFR2 N549H
FGFR2 N549K
KRAS p.Gln61Lys
EGFR NP_005219.2:p.A763_Y764insFQEA
EGFR NP_005219.2:p.Gly719Asp
PIK3CA E545X
KRAS Q61H
KRAS Q61L
KRAS Q61D
KRAS Q61E
KRAS Q61X
disease-causing mutation
KRAS Q61R
KRAS Q61P
KRAS c.183A>C
AKT1 p.E17K
novel mutation
BRAF p.Gly469Arg
KRAS c.183A>T
EGFR NM_005228.3:c.2310_2311insGGC
Chromosome Inversions
BRAF Gly466Val
KRAS p.Gly12Ile
EGFR Leu861Phe
EGFR NM_005228.3:c.2310_2311insGGT
p110alpha C420R
ABNORM CHROMOSOME
PDGFRA NP_006197.1:p.Asp842Val
Chromosomal Alterations
FGFR2 NP_000132.3:p.Asn549Lys
EGFR NP_005219.2:p.Pro753_Ile759del
NRAS G13X
BRAF p.Gly466Glu
Inversions, Chromosome
C-K-RAS c.181C>A
C-K-RAS c.181C>G
PIK3CA E545V
KRAS2 c.35_36GT>TC
KRAS NP_004976.2:p.Gly12Arg
FGFR2 p.S252W
EGFR p.P772_H773insPR
AKT1 E17K
Ki-Ras G13N
HER1 c.2322_2323insCACGTG
Ki-Ras G13E
Ki-Ras G13D
Duplications, Chromosome
Ki-Ras G13A
Ki-Ras G13C
BRAF p.Gly466Arg
EGFR NP_005219.2:p.H773_V774insGNPH
Ki-Ras G13V
inflammatory atypia
Ki-Ras G13S
Ki-Ras G13R
Wallerian Degeneration
ERBB1 c.2239_2247del9
Duplications, Chromosomal
CHROMOSOME ABNORM
BRAF NP_004324.2:p.Gly469Arg
pathologic autolysis
Chromosomal Breaks
NRAS NM_002524.4:c.181C>G
NRAS NM_002524.4:c.181C>A
KRAS NP_004976.2:p.G12I
KRAS NP_004976.2:p.G12L
KRAS NP_004976.2:p.G12N
KRAS NP_004976.2:p.G12A
KRAS NP_004976.2:p.G12C
KRAS NP_004976.2:p.G12E
KRAS NP_004976.2:p.G12D
KRAS NP_004976.2:p.G12F
KRAS NP_004976.2:p.G12Y
Trisomy 3
Trisomy 6
point mutation
Trisomy 4
Trisomy 5
KRAS NP_004976.2:p.G12S
KRAS NP_004976.2:p.G12R
KRAS NP_004976.2:p.G12W
KRAS NP_004976.2:p.G12V
BRAF Gly469Glu
ERBB2 c.2325_2326insTACGTGATGGCT
EGFR NP_005219.2:p.L858M
EGFR NP_005219.2:p.L858K
EGFR NP_005219.2:p.L858G
EGFR NP_005219.2:p.L858A
EGFR NP_005219.2:p.L858W
EGFR NP_005219.2:p.L858R
EGFR NP_005219.2:p.L858Q
EGFR NP_005219.2:p.L858P
ERBB1 c.2582T>A
Breakages, Chromosomal
Squamous metaplasia
KRAS c.37_39delGGCinsCGT
EGFR NP_005219.2:p.Ala767_Ser768insThrLeuAla
HER1 c.2234_2236delAGG
KRAS NM_004985.3:c.37G>A
KRAS NM_004985.3:c.37G>C
KRAS NM_004985.3:c.37G>T
PIK3CA Glu1047Arg
B-RAF1 c.1405_1407GGA>AGT
Gene Duplication
B-RAF1 c.1405_1407GGA>AGC
Mesangial hyperplasia
NRAS Gly12Xxx
PIK3CA NP_006209.2:p.H1047L
KRAS NM_004985.3:c.38_39delGCinsAT
JAK2 R938L
PIK3CA NP_006209.2:p.H1047T
PIK3CA NP_006209.2:p.H1047R
KRAS NM_004985.3:c.38_39delGCinsAA
Uniparental Heterodisomy
KRAS NM_004985.3:c.38_39delGCinsAG
PIK3CA NP_006209.2:p.H1047Y
chromosome inversion
KRAS c.180_181delTCinsCA
reciprocal translocation
Axon Reactions
ECT1 c.1115C>G
cabot rings
KRAS p.Gly13Ala
NRAS c.182_183AA>TG
EGFR E746_T751del
oxidative stress
ERBB c.2309_2310AC>CCAGCGTGGAT
Degenerations, Retrograde
HER1 c.2581C>G
ERBB c.2125_2129delGAAAC
BEK c.755C>G
BEK c.1144T>C
EGFR p.L747del
KRAS p.Gly13Val
BRAF p.Val600Asp
EGFR NM_005228.3:c.2319_2320insCCCCAC
KI-RAS c.183A>T
PIK3CA p.Glu545Val
EGFR P772_H773insQV
NP_002515.1 :p.Gln61Lys
CASP10 Mutation
HER1 c.2239_2247del9
EGFR NP_005219.2:p.T751_E758del
Metaplastic keratinization
EGFR NP_005219.2:p.Ile789_Leu792del
ERBB1 c.2310_2311insAACCCCCAC
JAK2 Arg938Leu
EGFR p.Leu861Phe
EGFR c.2573_2574TG>GT
JAK2 NP_004963.1:p.R938L
FGFR-2 Cys382Arg
Antibody-Dependent Enhancement
FGFR2 p.Cys382Arg
FGFR-2 Asn549His
EGFR NP_005219.2:p.Ala750_Glu758del
EGFR p.Leu858Gly
C-K-RAS c.34_35GG>CT
EGFR p.Leu858Gln
chromosomal instability
EGFR L747_P753del
Reactions, Axonal
BRAF NP_004324.2:p.Gly469Ala
Deletion 4p
Deletion 14q31
Dysfunctions, Proteostasis
JAK2 NM_004972.3:c.1848_1849delTGinsCT
PIK3CA p.H1047X
PIK3CA p.H1047Y
chromosome translocations
EGFR NM_005228.3:c.2238_2252del15
PIK3CA p.H1047Q
robertsonian translocations
Cytoplasmic deposition
KRAS c.37_38GG>AA
JAK2 Met929Ile
Monosomies, Partial
Toxic vacuolisation
EGFR c.2239_2262del24
ERBB1 c.2125_2129delGAAAC
PDGFRA p.D842V
FGFR2 c.1975A>G
Monosomy Xq28
clastogenesis
NM_005228.3:c.2235_2252del18
NP_005219.2:p.His773_Val774insGly
NP_005219.2:p.Gly719Val
NM_005228.3:c.2308_2309insACGGCG
Dyskaryosis
NP_005219.2:p.D770_N771insD
NP_005219.2:p.D770_N771insG
NP_005219.2:p.D770_N771insN
Erythrocytoschisis
NP_005219.2:p.V765_M766insMAS
NP_005219.2:p.Leu861Val
NM_005228.3:c.2240_2254del15
VNTR
NP_000132.3:p.S252W
NM_005228.3:c.2253_2276del24
NP_004324.2:p.Leu597Gln
Epithelialisation
NM_002524.4:c.181_183delCAAinsAAG
NM_005228.3:c.2311_2312ins9
NP_004976.2:p.Gly13Cys
NM_005228.3:c.2320_2321ins12
NM_005228.3:c.2319_2320insCCCCAC
Tetrasomies
RFLPs
NM_005228.3:c.2283_2284ins12
Triploid
NM_005228.3:c.2232_2233insAAAATTCCCGTCGCTATC
NM_004448.2:c.2325_2326ins12
NP_005219.2:p.Leu747_Glu749delLeuArgGlu
NP_004976.2:p.Gly12Cys
Tetraploidies
NP_005219.2:p.M766_A767insAI
NP_005219.2:p.S752_V769del
NM_005228.3:c.2290_2291ins12
NM_004333.4:c.1789_1790delCTinsTC
epithelialization
NM_000141.4:c.1645A>C
NM_005228.3:c.2309_2310AC>CCAGCGTGGAT
NP_005219.2:p.Pro772_His773insAspHisPro
NP_004963.1:p.Ile960Val
NM_004985.3:c.181C>A
NM_004985.3:c.181C>G
NM_002524.4:c.181_182delCAinsAG
NP_005219.2:p.Val765_Met766insMetAlaSer
NP_005219.2:p.D770_N771insGD
NP_004324.2:p.Gly469Arg
NP_005219.2:p.D770_N771insGL
Hyperchromia
NM_005228.3:c.2308_2309insGCAGCGTGG
NP_004976.2:p.Gly13Arg
NM_006218.1:c.3141T>G
Metaplasia
NP_006209.2:p.Glu545Gln
NP_005219.2:p.Glu746_Pro753del
aneuploid
NM_005228.3:c.2231_2232insTAAAATTCCCGTCGCTAT
NP_005219.2:p.Val834del
NM_004985.3:c.38G>C
NM_005228.3:c.2322_2322G>CCACGTG
NM_004985.3:c.38G>T
NM_002524.4:c.180_181AC>TA
NM_005228.3:c.2240_2254delTAAGAGAAGCAACAT
NM_000141.4:c.755C>G
Chromatolysis
NM_006218.1:c.3139C>T
Epidermalization
hyperchromia
NP_004324.2:p.Val600Asp
NP_005219.2:p.G719X
NP_001138385.1:p.Cys383Arg
hyperchromasia
Tetrasomy
NP_004976.2:p.Gln61Leu
NP_005219.2:p.Glu746_Glu749del
NP_005219.2:p.Leu747_Ala750del
NM_004985.3:c.35_36delGTinsTC
NP_004976.2:p.Ala146Xxx
NP_005219.2:p.His773_Val774insAsnProHis
NM_004985.3:c.182A>G
NM_004985.3:c.182A>C
NM_004985.3:c.182A>T
NM_005228.3:c.2298_2299insGCCATA
NP_005219.2:p.Glu746_Thr751del
NM_004333.4:c.1405_1406GG>TC
NP_006209.2:p.Glu545Gly
NM_004333.4:1798G>T
NM_006218.1:c.1634A>C
NM_006218.1:c.1634A>G
NM_004333.4:1798G>A
CPE
NM_005228.3:c.2239_2256delTTAAGAGAAGCAACATCT
NM_005228.3:c.2235_2249delGGAATTAAGAGAAGC
NP_005219.2:p.Leu858Gln
NP_005219.2:p.Leu858Gly
NP_004963.1:p.V617F
Haploinsufficiency
NP_005219.2:p.Glu746_Thr751delGluLeuArgGluAlaThr
NP_004963.1:p.Val617Phe
NM_004448.2:c.2325_2326insTACGTGATGGCT
NP_005219.2:p.Leu858Met
NP_004324.2:p.Leu597Ser
NP_005219.2:p.D770_N771insMATP
NM_004333.4:c.1397G>A
NP_005219.2:p.Glu746del
Tetraploids
NP_004324.2:p.Gly469Val
NP_005219.2:p.Gly719Xxx
hyperchromatism
NP_004976.2:p.Gly13Ala
Lytotoxicity
NM_000141.4:c.758C>G
NP_005219.2:p.V769_D770insGSV
NM_005228.3:c.2154_2155GG>TT
Near-Haploidy
Mosaicism
NP_005219.2:p.Glu746_Ser752del
Koilocytosis
Frameshift
NM_004333.4:1799_1800TG>AT
NM_004333.4:1799_1800TG>AA
NP_005219.2:p.Gly719Ser
NM_004333.4:c.1406G>T
NM_004333.4:c.1406G>A
NM_004333.4:c.1406G>C
NM_004333.4:c.1799_1800delTGinsAA
NM_004333.4:c.1799_1800delTGinsAT
Hyperdiploidy
Tetraploidy
NP_000132.3:p.N549K
NP_000132.3:p.N549H
NM_005228.3:c.2302_2303ins9
NP_005219.2:p.V834del
inv
NP_005219.2:p.Pro772_His773insGlnVal
ins
NP_004976.2:p.Gly12Ala
NP_005219.2:p.Leu858Trp
karyorrhexis
NP_005219.2:p.Leu861Pro
NM_004985.3:c.35G>A
NP_000132.3:p.K659E
NM_004985.3:c.35G>T
NP_005219.2:p.Thr790Met
NP_004963.1:p.R938L
NP_006209.2:p.Glu545Lys
NP_005219.2:p.Asp770_Asn771insAlaProTrp
NP_006197.1:p.Asp842Val
NP_004963.1:p.Glu985Lys
NM_004985.3:c.37_39delGGCinsCGT
NP_005219.2:p.Ser752_Ile759delSerProLysAlaAsnLysGluIle
NM_006218.1:c.1633G>C
mutants
NM_004333.4:c.1789_1790CT>TC
Karyolysis
NP_004976.2:p.Gly12Ser
Aneuploidy
NM_002524.4:c.180_181delACinsTA
Aneuploids
NM_000141.4:c.1115C>G
NP_004976.2:p.Gly13Val
NP_005219.2:p.K745_E746insVPVAIK
NM_005228.3:c.2310_2311insGCACCGTGG
NM_002524.4:c.182A>C
NM_002524.4:c.182A>G
hypocellular
NM_002524.4:c.182A>T
NP_005219.2:p.Pro772_His773insThrHisPro
NM_005228.3:c.2573_2574TG>GT
Achromasia
NM_005228.3:c.2310_2311insGGC
NM_005228.3:c.2310_2311insGGT
Polyploidies
Hypotriploidy
karyolysis
NM_004985.3:c.35_36GT>TC
Hypoploidy
NP_000132.3:p.Asn549His
NM_000141.4:c.1647T>G
NM_000141.4:c.1647T>A
Macronucleus
NM_005228.3:c.2235_2249del15
NP_000132.3:p.Ser372Cys
NM_005228.3:c.2322_2323insCACGTG
NM_004985.3:c.37G>T
NM_004985.3:c.37G>A
NM_004985.3:c.37G>C
NP_005219.2:p.Leu858Pro
NM_004333.4:c.1396G>C
NM_004985.3:c.34_36delGGTinsTGG
NM_004985.3:c.34_36delGGTinsTGC
Polyploid
NM_004333.4:c.1791A>G
NP_004439.2:p.Ala775_Gly776insTyrValMetAla
Near-Haploid
polyploidy
translocation
NP_004976.2:p.Gly13Glu
NM_005228.3:c.2310_2311insGGGTTA
NP_001138385.1:p.N550H
NP_001138385.1:p.N550K
polyploid
NM_005228.3:c.2156delG
NM_004985.3:c.38_39delGCinsTG
NM_004985.3:c.38_39delGCinsTT
t
NM_004985.3:c.180_181delTCinsAA
Truncation
NP_004976.2:p.Gln61Lys
NM_005228.3:c.2238_2252del15
NM_005228.3:c.2311_2312insTGGCCACCCCCA
NP_005219.2:p.Asp770_Asn771insSerValAsp
RFLP
NP_005219.2:p.Val769_Asp770insMetAlaSerValAsp
NP_001014431.1:p.Glu17Lys
NP_004976.2:p.Gln61Arg
RER
NP_001138385.1:p.Ser373Cys
Polyploids
Epidermalisation
NP_004976.2:p.Gln61Glu
NP_004324.2:p.Gly469Glu
NP_006209.2:p.Glu545Xxx
Polysomy
NM_005228.3:c.2307_2308insATGGCCAGCGTGGAC
NP_005219.2:p.P772_H773insPR
NP_005219.2:p.His773_Val774insHis
NP_005219.2:p.V774del
NP_004963.1:p.E985K
oncocytosis
NM_005228.3:c.2572_2573CT>AG
NM_005228.3:c.2572_2573CT>AA
NM_004985.3:c.180_181delTCinsCA
NP_006209.2:p.His1047Thr
NM_005228.3:c.2309_2310insATGGCCAGCGTGGA
NM_005228.3:c.2236_2237insTTCCCGTCGCTATCAAGG
NM_004333.4:c.1405_1407GGA>AGT
NM_004333.4:c.1405_1407GGA>AGC
NP_004963.1:p.Arg938Leu
Hypochromia
NM_005228.3:c.2308_2309insGGGTCGTGG
NM_002524.4:c.181_183CAA>AAG
NP_005219.2:p.Arg748_Pro753del
NM_004985.3:c.183A>T
NM_004985.3:c.183A>C
NP_004976.2:p.Gln61Pro
Eight-Twenty-One
hyperparakeratosis
dyskaryosis
NP_005219.2:p.Pro772_His773insTyrAsnPro
NM_005228.3:c.2307_2308insTGCGTG
NM_005228.3:c.2303_2304insTGTGGCCAG
satellitosis
NP_004324.2:p.Gly466Arg
NM_005228.3:c.2309_2310ins14
C-MycT
NP_005219.2:p.Asp761_Glu762insGluAlaPheGln
NM_005228.3:c.2283_2284insGAAGCCTTCCAG
NP_004963.1:p.M929I
NP_005219.2:p.Ala750_Lys754del
NP_005219.2:p.His773_Val774insGlyHis
NP_004976.2:p.Gln61His
NP_004976.2:p.Gly12Tyr
NP_005219.2:p.Ala763_Tyr764insPheglnGluAla
Hypochromatism
Oncocytosis
NM_005228.3:c.2573T>A
NM_005228.3:c.2573T>G
NP_004324.2:p.Val600Ala
NM_002524.4:c.181_182CA>AG
NP_005219.2:p.D770fs*61
NP_004976.2:p.Gly12Trp
PHF
Transversion
NP_005219.2:p.Asp770_Asn771insSerValGln
epithelialisation
NM_004985.3:c.34G>A
NM_004985.3:c.34G>C
NM_004985.3:c.34G>T
Deletion
NM_005228.3:c.2308_2309ins9
NP_005219.2:p.Asp770_Asn771insGly
NP_005219.2:p.Lys745_Glu746insValProValAlaIleLys
NM_004985.3:c.35_36delGTinsAA
NM_004985.3:c.35_36delGTinsAC
NM_004985.3:c.35_36delGTinsAG
Hypertriploidy
Del
NM_006218.1:c.1635G>T
metaplasia
metaplasis
NM_006218.1:c.1635G>C
NM_004448.2:c.2324_2325ins12
NM_005228.3:c.2156G>A
NM_005228.3:c.2156G>C
NM_004333.4:c.1798_1799delGTinsAG
NP_006209.2:p.His1047Xxx
NM_004333.4:c.1798_1799delGTinsAA
NM_005228.3:c.2307_2308insGACAACGTG
NP_006209.2:p.Glu542Gln
NP_006209.2:p.Glu542Gly
NP_004976.2:p.Gly12Asn
i
NP_004976.2:p.Gly12Asp
neurodegeneration
Karyomegaly
NM_004985.3:c.38_39GC>TG
NM_004985.3:c.38_39GC>TT
mutation
NM_004985.3:c.38_39delGCinsAG
NM_004985.3:c.38_39delGCinsAA
NM_004985.3:c.38_39delGCinsAT
NM_004985.3:c.180_181TC>AA
dup
NM_006218.1:c.1258T>C
EGFRvIII
NP_004976.2:p.Gly13Ser
Amyloidogenesis
Endoreplication
NM_005228.3:c.2236_2250del15
NP_006209.2:p.Glu545Val
NP_004963.1:p.G935R
NP_005219.2:p.I789_L792del
NM_005228.3:c.2310_2311ins9
NP_000132.3:p.Lys659Glu
NM_004985.3:c.37_39GGC>CGT
MSI-H
MSI-L
NP_005219.2:p.Leu747del
NM_006218.1:c.1624G>A
NM_006218.1:c.1624G>C
Myelophthisis
NP_000132.3:p.Cys382Arg
NM_004985.3:c.180_181TC>CA
NP_006209.2:p.Glu1047Arg
NP_005219.2:p.Arg748_Ser752del
MLL-PTD
NM_004985.3:c.34_35delGGinsTT
NM_004985.3:c.34_35delGGinsTA
NP_005219.2:p.Leu747_Lys754del
NM_006218.1:c.1634A>T
NP_005219.2:p.H773_V774insH
NP_005219.2:p.H773_V774insG
NP_004324.2:p.Gly469Ser
NP_001138385.1:p.Asn550Lys
NM_004985.3:c.35G>C
NM_004333.4:1799T>A
NM_004333.4:1799T>G
NP_004963.1:p.Y931C
NP_005219.2:p.Glu746_Ala750del
NM_006206.4:c.2525A>T
Epithelialization
dic
phototoxicology
Hyperploidy
Endoreduplications
NM_005228.3:c.2582T>A
NM_005228.3:c.2582T>G
NM_002524.4:c.182_183AA>TG
NM_002524.4:c.181C>A
NM_002524.4:c.181C>G
NM_005228.3:c.2257_2277del21
Erythrocytorrhexis
NP_005219.2:p.Gly719Cys
idic
NM_004333.4:c.1405_1407delGGAinsAGC
NP_001138385.1:p.C383R
NP_006209.2:p.Glu542Val
NM_002524.4:c.181_182CA>TT
NM_004985.3:c.35_36GT>AC
NM_004985.3:c.35_36GT>AA
NM_004985.3:c.35_36GT>AG
NM_004985.3:c.34_35GG>TT
NM_004985.3:c.34_35GG>TA
NP_005219.2:p.Gly719fs*29
NM_005228.3:c.2250_2273del24
NP_005219.2:p.D770_N771insNPH
NM_005228.3:c.2310_2311insAGCGTGGAC
NP_005219.2:p.Ala750_Glu758del
NP_004324.2:p.Gly466Val
NM_005228.3:c.2310_2311insGGGGAC
NP_004324.2:p.Gly466Ala
NP_001138385.1:p.Y376C
NM_000141.4:c.1124A>G
NP_004324.2:p.Val600Met
NP_005219.2:p.D770_N771insDG
NP_005219.2:p.D770_N771insSVQ
NP_004324.2:p.Leu597Arg
NP_004976.2:p.Gly13Asp
NP_005219.2:p.Met766_Ala767insAlaIle
Dicentric
NP_004976.2:p.Gly13Asn
Transition
NP_005219.2:p.T751_E758del
NP_000132.3:p.S372C
NM_004333.4:c.1799T>C
NP_005219.2:p.His773_Val774insGlyAsnProHis
NM_005228.3:c.2154_2155delGGinsTT
NM_005228.3:c.2318_2319insCCCCCA
NM_005228.3:c.2233_2247del15
NM_004985.3:c.37_38GG>AA
NP_001138385.1:p.Asn550His
NP_004963.1:p.Gly935Arg
NM_002524.4:c.182_183AA>GG
Satellitosis
NP_005219.2:p.Leu858Lys
Haploinsufficiencies
NP_004324.2:p.Val600Glu
NP_004324.2:p.Val600Gly
NM_005228.3:c.2307_2308insGCCAGCGTG
NP_006209.2:p.His1047Tyr
der
NP_004324.2:p.Val600Arg
del
Hypochromasia
NP_004324.2:p.Gly469Ala
NP_005219.2:p.Val769_Asp770insCysVal
NM_005228.3:c.2307_2308ins9
NP_005219.2:p.H773_V774insGH
NM_006218.1:c.1633G>A
NP_000132.3:p.Y375C
NP_005219.2:p.Y764_V765insHH
Duplication
NP_005219.2:p.N771_P772insN
NP_005219.2:p.N771_P772insH
NM_005228.3:c.2319_2320insAACCCCCAC
Cytotoxicity
Estatrophy
NM_004985.3:c.38_39GC>AA
NM_004985.3:c.38_39GC>AG
NM_004985.3:c.38_39GC>AT
NP_004324.2:p.Leu597Val
rflp
NP_005219.2:p.Ile789_Leu792del
Mutation
NM_005228.3:c.2219_2220insTCCCGTCGCTATTAAAAT
NM_005228.3:c.2573_2574delTGinsGT
NP_005219.2:p.P772_H773insTHP
Translocation
NM_005228.3:c.2311_2312insGCGTGGACA
NM_002524.4:c.181_182delCAinsTT
NP_005219.2:p.Asp770_Asn771insGlyAsp
NP_004976.2:p.Gly12Ile
NM_005228.3:c.2239_2247delTTAAGAGAA
NP_005219.2:p.D770_N771insSVP
NM_005228.3:c.2155G>T
NP_004976.2:p.Gly12Val
NP_000132.3:p.Asn549Lys
NM_005228.3:c.2155G>A
Inversion
NP_005219.2:p.D770_N771insSVD
NP_005219.2:p.Leu861Gln
koilocytosis
NP_005219.2:p.H773_V774insGNPH
NP_005219.2:p.I740_P741insPVAIKI
NP_005219.2:p.I744_K745insKIPVAI
AGUS
Fragility
NM_004333.4:c.1405G>A
NM_004333.4:c.1405G>C
ABD
NP_005219.2:p.Val769_Asp770insGlyValVal
NM_005228.3:c.2234_2236delAGG
NP_000132.3:p.Ser252Trp
NM_005228.3:c.2239_2256del18
NM_005228.3:c.2310_2311insAACCCCCAC
NP_000132.3:p.P253R
NP_001138385.1:p.Lys660Glu
Mutated
NM_004985.3:C.36T>C
NP_000132.3:p.Tyr375Cys
NM_004972.3:c.1849G>T
NP_001138385.1:p.K660E
NP_005219.2:p.V774_C775insHV
NM_000141.4:c.1144T>C
NM_005228.3:c.2319_2320ins9
NM_002524.4:c.182_183delAAinsTG
Polyploidy
NP_005219.2:p.Gly719Ala
NM_005228.3:c.2319_2320insCAC
add
NP_006209.2:p.Glu545Asp
NP_005219.2:p.Asp770_Asn771insAspGly
NM_004985.3:c.34_36GGT>TGC
NM_004985.3:c.34_36GGT>TGG
NM_005228.3:c.2313_2314insAAC
NP_005219.2:p.Ala750_Lys757del
NP_005219.2:p.A763_Y764insFQEA
NM_005228.3:c.2302_2303insCGCTGGCCA
NP_004976.2:p.Gln61Xxx
NM_005228.3:c.2236_2253delGAATTAAGAGAAGCAACA
NM_004333.4:c.1405_1407delGGAinsAGT
NP_005219.2:p.V769_D770insGVV
-17p13
NP_005219.2:p.Pro772_His773insAspAsnPro
NP_004963.1:p.Tyr931Cys
NP_001138385.1:p.S373C
NP_006209.2:p.Glu542Xxx
HPOCROM
NM_005228.3:c.2254_2277delTCTCCGAAAGCCAACAAGGAAATC
NP_005219.2:p.Leu747_Ser752delLeuArgGluAlaThrSer
NM_005228.3:c.2247_2273del27
patching
NM_005228.3:c.2581C>G
chromatolysis
NM_004333.4:1798_1799GT>AA
NM_004972.3:c.1848_1849TG>CT
NM_004333.4:1798_1799GT>AG
NM_006218.1:c.1625A>G
NM_006218.1:c.1625A>T
hsr
NP_005219.2:p.H773_V774insPH
NM_005228.3:c.2320_2321insGCAACCCCCACG
NP_004963.1:p.I960V
NP_005219.2:p.Leu858Ala
NP_005219.2:p.V769_D770insMASVD
NM_006218.1:c.3140A>G
NM_006218.1:c.3140A>T
NM_004985.3:c.34_35delGGinsAT
NM_004985.3:c.34_35delGGinsAA
Amplification
Triploidy
NM_005228.3:c.2572_2573delCTinsAG
NM_005228.3:c.2572_2573delCTinsAA
NP_005219.2:p.Asn756_Leu760del
NP_005219.2:p.Ser768_Val769insAlaTrpThr
NM_005228.3:c.2246_2260del15
NM_005228.3:c.2303_2304ins9
NP_000132.3:p.Pro253Arg
NP_005219.2:p.Leu861Arg
NP_005219.2:p.Val769_Asp770insAspAsnVal
NP_005219.2:p.Ala767_Ser768insThrLeuAla
NP_005219.2:p.Glu709fs*1
genotoxicity
Hyperchromasia
NM_005228.3:c.2239_2247del9
NP_004976.2:p.Gly12Phe
Megalocyte
NM_005228.3:c.2321_2322insCCACGT
NM_004985.3:c.34_35delGGinsCT
Hyperparakeratosis
NM_005228.3:c.2239_2262del24
NP_005219.2:p.Asp770_Asn771insSerValPro
NP_005219.2:p.Asp770_Asn771insMetAlaThrPro
NP_005219.2:p.P753_I759del
Neuronophagia
NM_004985.3:c.38G>A
NM_005228.3:c.2125_2129delGAAAC
aneuploidies
NM_004333.4:c.1789C>G
NM_005228.3:c.2236_2253del18
Clasmatodendrosis
NP_005219.2:p.Gly719Asp
NP_005219.2:p.P772_H773insYNP
NP_005219.2:p.Val769_Asp770insGlyVal
NM_005228.3:c.2232_2233ins18
NP_005219.2:p.Leu861Phe
NP_005219.2:p.Asp770_Asn771insAsnProHis
NM_005228.3:c.2235_2246del12
NP_006209.2:p.Glu545Ala
NP_005219.2:p.S752_I759del
NM_004333.4:c.1397G>C
NM_004333.4:c.1397G>T
NP_005219.2:p.Val769_Asp770insGlySerVal
NP_005219.2:p.Asp770_Asn771insAsn
cytotoxicity
NP_004976.2:p.Gly12Leu
NP_005219.2:p.A750_K754del
NM_005228.3:c.2219_2220ins18
NP_004976.2:p.Gly12Glu
fragility
NM_005228.3:c.2310_2311insAAC
NP_005219.2:p.Val769_Asp770insAlaSerVal
NM_004972.3:c.1848_1849delTGinsCT
mosaicism
NP_005219.2:p.Val774del
NP_005219.2:p.V769_D770insCV
NP_005219.2:p.Val774_Cys775insHisVal
NM_004985.3:c.39C>T
NM_004985.3:c.39C>G
NM_004985.3:c.39C>A
Hypodiploidy
NP_005219.2:p.Ile744_Lys745insLysIleProValAlaIle
NM_004333.4:1797_1799AGT>GAG
NP_004963.12:p.Met929Ile
NM_004985.3:c.34_35GG>AT
NM_004985.3:c.34_35GG>AA
NM_005228.3:c.2572C>A
NM_005228.3:c.2572C>T
NM_002524.4:c.182_183delAAinsGG
NM_004972.3:c.2792A>G
UV-Mutagenesis
Mutant
NM_005228.3:c.2254_2277del24
NP_005219.2:p.Lys745_Glu749del
NM_005228.3:c.2302_2303insTCCAGGAAGCCT
NM_005228.3:c.2369C>T
NP_006209.2:p.Glu542Lys
NP_004976.2:p.Gln61Asp
NP_006209.2:p.His1047Leu
NP_005219.2:p.P772_H773insQV
Endoreplications
NM_005228.3:c.2308_2309insCCAGCGTGG
NP_005219.2:p.Leu747_Pro753del
NP_005219.2:p.Lys745_Ala750del
NP_005219.2:p.Leu858Arg
NM_005228.3:c.delGinsCCACGTG
Anisokaryosis
NP_006209.2:p.His1047Gln
Hyperchromatism
hypochromia
NP_000132.3:p.C382R
NM_005228.3:c.2311_2312ins12
NP_005219.2:p.D770_N771insAPW
hypochromasia
Aneuploid
NP_005219.2:p.Asp770fs*61
NP_004324.2:p.Val600Leu
NP_004324.2:p.Gly466Glu
NM_004985.3:c.34_35GG>CT
Karyorrhexis
NP_005219.2:p.Leu747_Thr751del
NP_005219.2:p.Thr751_Glu758del
aneuploidy
agus
NP_005219.2:p.P772_H773insDNP
Neurodegeneration
NM_005228.3:c.2315_2316insGACACACCC
tetrasomy
NP_005219.2:p.Pro753_Ile759del
NP_005219.2:p.V769_D770insGV
NP_006197.1:p.D842V
NM_004333.4:c.1790T>A
NM_004333.4:c.1790T>G
myelophthisis
NP_005219.2:p.Ser752_Val769del
NM_005228.3:c.2307_2308ins15
NP_005219.2:p.N756_L760del
NP_005219.2:p.Ile740_Pro741insProValAlaIleLysIle
NP_005219.2:p.Leu747_Ala755del
NP_004324.2:p.Val600Lys
NP_005219.2:p.Asp770_Asn771insGlyLeu
Endoreduplication
NP_005219.2:p.Ser768_Val769insValAlaSer
Aneuploidies
NP_005219.2:p.P772_H773insDHP
NP_005219.2:p.Glu746_Arg748del
Nonsense
Macrocytosis
NM_004985.3:c.37_38delGGinsAA
mutant
NM_005228.3:c.2309_2310delACinsCCAGCGTGGAT
NM_005228.3:c.2231_2232ins18
NM_004448.2:c.2324_2325insATACGTGATGGC
Tetraploid
NM_004333.4:c.1797_1799delAGTinsGAG
NP_006209.2:p.Cys420Arg
NM_001014431.1:c.49G>A
Neutrophils.hypersegmented
NP_005219.2:p.H773_V774insNPH
NP_004976.2:p.Gly12Arg
NM_005228.3:c.2236_2237ins18
NM_002524.4:c.183A>T
NM_002524.4:c.183A>G
NM_002524.4:c.183A>C
NM_004333.4:c.1405_1406delGGinsTC
NM_000141.4:c.1975A>G
NP_001138385.1:p.Tyr376Cys
